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1. Outline of the project 
Due to the current rise of exposure to natural and synthetic compounds in our daily life, the 
debate concerning the safety of many substances is becoming increasingly relevant. 
The estrogenic activity of various compounds, described as xenoestrogens, is the major part 
of this debate. Humans beings are exposed to these substances from different environmental 
contaminations ranging from conscious intake of estrogenic substances, as in contraception or 
in hormone replace therapy (HRT), to unconscious exposure, from food, the use of synthetic 
material in daily life and air and water pollution. At this point the need for methods to 
investigate the activity and the safety of these substances is becoming increasingly important. 
Classical methods for the analysis of the estrogenic activity of substances, like batteries of in 
vivo test systems on the rat uterotrophic assay are not able to describe the different pathways 
of action of recently discovered estrogenic substances. This evidence was already shown by 
the Organization for Economic Cooperation and Development (OECD), introducing new test 
guidelines for the investigation of effects of endocrine disruptors (according to enhanced Test 
Guideline 407). As reviewed by Nilsson (Nilsson et al., 2001), after the interaction of the 
estrogens with the Estrogen Receptor (ER) in the cells, the mechanism of activation possible 
is not only via direct binding of the ER to the Estrogen Responsive Elements (EREs) present 
in the promoter region of the target gene, very well described for many target genes, but that 
also other mechanisms are used: the interaction of the ER with the AP-1, Sp-1 and NFkB 
modes, that are discovered but not yet comprehensively described. 
The aim of my work is to produce a microarray DNA chip for the investigation of the 
estrogenic activity of different compounds present in the environment. The chip will consist 
of a selection of 100 genes that are estrogen responsive and it will cover the spectrum of 
activities of estrogenic compounds in various organs of the body. In the gene selection, genes 
were chosen that are estrogen responsive in the classical target tissues of estrogens, linked to 
reproduction, like uterus and mammary gland, and also in tissues not related to reproduction 
like liver, bones and capillars. In addition, other genes are included to monitor different 
pathways that are related to disease states; control of cell proliferation, apoptosis or cancer 
related genes. Currently these kinds of investigations are already in process, but by other 
methods which are more time consuming and with a lower throughput e.g. the gene 
expression profiling using the real time RT-PCR. The use of microarray’s satisfies the need 
for a less time consuming, high throughput method, to obtain a fast characterization of the 
gene expression finger print of the candidate substances and their mechanism of action in the 
organism. 
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2. Overview on estrogens 
The number of xenoestrogens, substances with estrogenic activity not derived from any 
human source, is constantly increasing. Some studies like the “million women study” (1999) 
concerning the use of classical methods in HRT did not deliver good results about the safety 
of the classical methods in HRT like estrogen and progesterone. It is already been observed 
that, in western society, the causes of several cancers including breast, endometrium, ovary, 
liver, and prostate cancers, have been linked to inappropriate and/or prolonged exposure to 
synthetic steroidal hormones (Yager et al., 1996). 
Currently, xenoestrogens are in contact with human beings constantly during everyday life 
from many different sources. They can be related to the health care as with HRT, treatment of 
hormonal dysfunction, or in the use of contraceptives. Xenoestrogens could also come in 
contact with us unintentionally: consuming foods containing substances with estrogenic 
activity, like phytoestrogens in soy beans and hop, as well as by the consumption of meat 
derived from animals treated by hormones to enhance their growth. There are also many other 
possibilities of contamination from the use of synthetic material in daily life. These range  
from the wearing of synthetic clothes to the use of plastic in the alimentary industry, including 
bottles and cutlery. There is also other evidences of a contamination of xenoestrogens by the 
pollution of the environment through air and water, for instance there are studies on the 
estrogenic potential of the Venice lagoon waters too (Pojana et al., 2004). 
The question of the real activity and safety of these substances is still open. The three days 
uterotrophic assay alone, consisting in the assessment of uterus wet weight after three days 
treatment with a specific substance in ovariectomised (ovx) or juvenile rats, is not sufficient 
to elucidate the molecular mechanism of action of these “new” compounds. New methods are 
needed to investigate their effects in detail. 
One possible method to investigate the activity of these substances in depth is the gene 
expression profiling of selected genes, already described in literature, that are estrogen 
regulated according to the four different mechanisms of action reviewed by Nilsson (Nilsson 
et al., 2001) described in paragraph 2.3 of this section: the activation of estrogenic mechanism 
by ERE, the first to be discovered, classical mechanism of action of estrogen after diffusion 
into the cell, and the three alternative mechanisms of action through the AP-1, Sp-1 and 
NFκB pathways. For the classical mechanism of action, through ERE, a comprehensive set of 
genes are already described, but for the other three major mechanisms there are insufficient 
genes described as potential molecular markers. 
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The gene expression analysis of these target genes is mostly performed by real time RT-PCR. 
This method allows a really sensitive study of the gene expression but is limited by the low 
number of genes to be assessed in a reasonable amount of time. 
  
2.1 Estrogen target tissues 
The main targets of sexual hormones are tissues related to reproduction like the uterus 
mammary gland, vagina, ovary or urogenital tract. Other tissues, which were not previously 
included in the list of sex hormone target organs, as with the liver, central nervous system 
(CNS) skin and many other organs, represent sensitive novel targets of estrogen exposure (fig. 
1). Other organs like bones, even though not related to reproduction present since a long time, 
a high sensitivity to estrogenic substances. It’s then possible to talk about a pleiotropic effect 
of estrogen in the body (Huber et al., 2002; Muller, 2004). 
 
Fig. 1: Target tissues of the sexual hormones (Vollmer et al., 2002). 
 
 
2.2 Estrogen receptors 
Since 1962, it has been clear that the biological activity of estrogen is mediated by a receptor 
protein (Jensen & Jacobsen 1962). In 1986 two groups reported, independently, the cloning of 
the first Estrogen Receptor (ER) gene (Green et al., 1986; Greene et al., 1986). A second type 
of ER had been discovered in 1996, it was identified in a rat prostate cDNA library (Kuiper et 
al., 1996). The first identified ER is now called ERα and the second one ERß, since then 
many isoforms of both subtypes have been described, consisting of ablation of some exonic 
regions (Shupnik et al., 2002) or in the case of the ERß2 the insertion of short sequences, 54 
nucleotides, between the 5th and 6th exon (Chu & Fuller, 1997). 
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Structurally the two receptors are characterized by six individual domains with those 
functional important domains (fig. 2): the NH2-terminal (A/B domain), the DNA-binding 
domain (DBD) (C domain) and the ligand binding domain (LBD) (D/E/F domain). The N-
terminal domain encode for an independent activation function (AF1) (Berry et al., 1990), 
which is involved in the protein-protein interaction and transcriptional activation of the target-
gene (Onate et al., 1998). The DBD plays an important role in the dimerization and the 
binding of the receptor to specific DNA sequences (Schwabe et al., 1993). The LBD mediates 
ligand binding, receptor dimerization and transactivation of the target gene (Tsai et al., 1994). 
 
Fig. 2: Domain structure of an estrogen receptor, with division by domain. AF: activation function, DBD: DNA 
binding domain, LBD ligand binding domain (according to Nilsson et al., 2001). 
 
The two receptors present a high level of amino acid sequence homology (fig. 3). In human 
beings the homology of the DBD (C domain) is 97 %, the LBD (E domain) presents also the 
60% of homology, for the other region the level is lower, between 20 and 30% (Saunders, 
1998). 
 
Fig. 3: Homology of estrogen receptors (ER), reported in percentage, in comparison to the human ERß (hERß). 
Rat ERß (rERß), mouse ERß (mERß) and hERα, according to the different domains (Saunders, 1998). 
 
The receptors are also phylogenetic conserved. The ERß, for example, presents a high degree 
of homology between human, rat and mouse (fig. 3) (Kuiper et al., 1996; Tremblay et al., 
1997). A homologue of the mammalian ERß is present also in fish (Tchoudakova et al., 1999; 
Chang et al., 1999). The phylogenetic tree of the cloned estrogen receptors is shown in fig. 4 
(Nilsson et al., 2001). 
 
 
A/B C D FE
rERß
hERß
mERß
hER_
79,6% 98,5% 85,6% 98,6%93,4%
17,5% 97,0% 30,0% 17,9%59,1%
80,6% 98,5% 84,8% 78,6%91,9%
A/B C D E F
AF-1 DBD AF-2LBD
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Fig. 4: Phylogenetic tree of the cloned ER (Nilsson et al., 2001). 
 
The two types of ER are not distributed equally in the body. Both receptors are present in 
breast, CNS, cardiovascular system, bone tissue and the urogenital tract. In the liver, only the 
presence of ERα is reported and ERß is predominantly present in the gastrointestinal tract, as 
shown in fig. 5 (reviewed by Gustafsson, 1999). 
 
 
Fig. 5: Distribution of ERα and ERß in the body in the different organs, according to Gustafsson (1999). 
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2.3 Mechanism of estrogens action 
After diffusion into the cell through the membrane, estrogens can operate with or without 
interaction with their respective receptors. In the first case, the ER mediated response, the 
activated receptor-ligand complex, with possible interaction with other co-factors, acts 
through specific regions of target genes to influence their gene expression. Interaction with 
the respective receptors can also follow another path, commonly described as the 
non-genomic pathway, in which the complex estrogen-receptor moves not to the nucleus but 
to the cellular membrane and activates the Src (steroid receptor-coactivator) / Shc (Src-
homology/collagen protein) / ERK (extracellular signal-regulated kinase) signaling cascade 
(Kousteni et al., Science 2002). In the non-genomic pathways the liganded receptor is 
recruited to the membrane thereby activating signal transduction cascades. In the second case 
estrogens can affect cellular processes through other mechanisms without interaction with the 
receptor. In this receptor independent mechanism of action, the estrogens can bind and alter 
enzymatic activities in membranes isolated from target cells, they can also influence the 
activities of purified enzymes and change cell permeability and polarization; all these actions 
are performed excluding transcriptional activities (Weiss et al., 1998). This receptor 
independent mechanism of action presents a rapid time course and insensitivity to 
transcriptional and translational inhibitors, confirming the assumption that genomic effects 
are not involved (Falkenstein et al., 2000). 
In this work only the ER mediated and genetic mechanisms of action will be taken into 
consideration, because it’s possible to study them through gene expression analysis. 
In the ER mediated mechanism the receptor dimerizes, after binding with the ligand (an 
estrogenic substance) in three possible ways: as a homodimer of ERα, ERß, or as heterodimer 
ERα/ERß (Cowley et al., 1997; Pettersson et al., 1997). Thereafter the dimer can bind to the 
ERE present in the promoter region of the target gene (fig. 6). 
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Fig. 6: Model of the homodimerization (upper part of the image) /heterodimerization (lower part of the image) of 
the estrogen receptor (ER) after the binding with the ligand (E2), and interaction with the estrogen responsive 
element (ERE) present in the promoter region of the target gene. 
 
The ER can play a role in gene expression regulation also without interacting directly with the 
genomic DNA sequence (review by Nilsson et al. 2001). Besides the classical mechanism of 
estrogen action through the ERE sequence, there are alternative pathways via direct 
protein-protein interactions. There is also the possibility of interaction with other proteins. An 
example is the Sp-1 activation mechanism, the estrogenic ligand binds the ER, and without 
the need to dimerize this complex, can interact with the Sp-1 protein and through this bond 
activate the transcription of the target gene (fig. 7B). 
Another case of indirect activation of transcription is the AP-1 mode. The activated ER 
interacts with the Ap-1 dimer, formed by the sub-units c-Fos and c-Jun, thereafter the whole 
complex binds the promoter region of the target gene, enhancing its transcription (fig. 7C). 
The last major mechanism of modulation of gene expression reviewed by Nilsson is the 
inhibition of activity of the NFκB protein. Under normal conditions, this protein binds the 
NFκB response element in the promoter of a target gene enhancing its transcription. The ER, 
after activation by binding with the estrogenic substances, can interact with the NFκB 
complex detaching it from the promoter and deactivating the target gene (fig. 7D). 
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Fig. 7: Model representing the four different mechanisms of activity of estrogen (E2) or estrogenic substances 
through estrogen receptors (ERs). Panel “A” represents the classical interaction between the activated receptor 
with estrogen response elements (EREs) and DNA. In the other three panels the indirect effects of ER on 
transcription interaction are reported. This occurs through protein-protein interaction with the Sp-1 (panel “B”), 
AP1 (panel “C”), and NFκB proteins (panel “D”) (Nilsson et al., 2001). 
 
2.4 Xenoestrogens 
Xenoestrogens are compounds which possess estrogenic proprietis but their chemical 
structure does not necessarily resemble that of female sex hormones. This definition includes 
all substances that present estrogenic activity, for simplicity the xenoestrogens can be grouped 
according their source in the environment: phytoestrogens (produced by plants) and synthetic 
estrogens (synthesized in laboratory), which are mostly environmental pollutants. 
 
2.4.1 Phytoestrogens  
Phytoestrogens are members of the class of polyphenolic compounds synthesized by plants. 
They may act as fungicides, repel the herbivores (for their “bad taste”), regulate plant 
hormones, and protect plants against ultraviolet radiation (Barrett, 1996). Their abiltiy to 
mimic the estrogen activity was described more than 20 years ago (Martin et al., 1978). The 
phytoestrogens can be subdivided into three classes according to their molecular structure: 
isoflavons, coumestans and lignans. In this work only 4 phytoestrogens will be described and 
used, those that belong to the group of isoflavonoids, two isoflavones, Genistein (Gen) and 
Daidzein (Dai), and two flavones, 8-Prenylnaringenin (8PN) and 
6-(1,1-dimethylallyl)naringenin (6DMAN). 
A  B     C      D 
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Exposure to Gen is mainly from the consumption of soy and soy products like soymilk and 
tofu. It is one of the best described phytoestrogens due to many years of investigation and its 
capacity to bind the ER (Mathieson et al., 1980). Gen can stimulate osteoblastic bone 
formation, inhibit osteoclastic bone resorption and prevent bone loss in ovariectomised rats 
(Fanti et al., 1998). It can also induce, although with lower efficiency, the same effects of 
17-ßEstradiol (E2) in rat tissue and cell culture (Dopp et al., 1999; Diel et al., 2001). 
The consumption of Dai, like Gen, occurs mainly by the consumption of soy. Its weak 
agonistic and antagonistic activity was already tested in different in vitro and in vivo models 
(Kuiper et al., 1998; Diel et al., 2001; Wober et al., 2002). 
The flavone 8PN, described for the first time in Anaxagorea luzonensis (Kitaoka et al., 1998) 
is consumed principally from the female flower of hops, used in the beer brewery. The 
estrogenic activity of 8PN was detected for the first time in 1999 (Milligan et al., 1999) and 
further characterized thereafter (Zierau et al., 2002, 2004; Diel et al., 2004). However the 
estrogenic activity of hops was known from evidence such as the menstrual disturbance of 
female hops hand pickers, or the use of hop baths for the treatment of gynecological disorder. 
6DMAN isolated from the African tree Monotes engleri (Seo et al., 1997), has been 
characterized due to interesting estrogenic activity in in vitro systems (Zierau et al., 2002). 
 
2.4.2 Synthetic estrogens 
Synthetic substances with an estrogenic activity can be divided in two main groups, one 
consisting of substances created for pharmaceutical applications; for example, oral 
contraceptives or the control of disease as in HRT. The other group of substances disturbs the 
production or function of sex hormones. To this group of substances belong compounds 
which are synthesized for other purposes, and which also act as environmental pollutants, as 
with pesticides. Other compounds present in everyday life have been shown to have 
estrogenic activity such as in plastic containers for food and beverages. 
This second group of xenoestrogens, described as environmental pollutants, comprises of 
many other substances. For instance the DDT mixture, a famous pesticide with estrogenic 
activity, particularly the o,p’-DDT (Robison et al., 1982). Bisphenol A is an industrial 
compound (plasticizer) that showed estrogenic activity in in vitro systems (Krishnan et al., 
1993; Sumpter & Jobling 1995; Wober et al., 2002). Alkylphenols, like Nonylphenol (NP) 
and Octylphenol (OP), that are derived from the degradation of alkylphenol polyethoxylates, 
non-ionic surfactant, widely used in detergents, paints, pesticides cosmetics and other 
formulated products (Jobling, 1994). 
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In my study one representative of each group will be described and used, 17α-ethinylestradiol 
(EE) will represent compounds created with the purpose of pharmacological application, and 
NP as an exponent of the synthetic substances with unintended estrogenicity. 
EE is the result of modification of the natural estrogen E2, and it is commonly used in oral 
contraceptives. 
NP, as already described, belongs to the alkylphenol family, its estrogenic activity was 
already described in several in vitro systems (Shelby et al., 1996; Wober et al., 2002). 
 
3. Gene selection to study the estrogenic activity of different compounds 
3.1 Genes used in the real time RT-PCR experiment 
Cytochrome c Oxydase Subunit 1 (1A): 
1A was use as reference for the gene expression analysis in all real time RT-PCR experiment 
it is an established reference gene in many experiment of gene expression analysis performed 
by real time RT-PCR in different rat tissues treated by E2 (Diel et al., 2001, 2004; Zierau et 
al., 2004). 
Complement C3: 
Complement C3 is the major estrogen responsive gene in the rat uterus (Sundstrom et al., 
1989) used since many years as positive control gene for the estrogenic activity of different 
compounds in rat uterus (Rivera-Gonzalez et al., 1998; Diel et al., 2001, 2004; Zierau et 
al., 2004) 
Clusterin (Clu): 
This gene was isolated for the first time as Clusterin in 1983 (Blaschuk et al., 1983) and is 
also reported in literature as Testosterone Repressed Protein Message 2 (TRPM-2) (Leger et 
al., 1987), or Sulfated GlycoProtein 2 (SGP-2) or Apolipoprotein J, isolated from different 
tissues. It is easy to understand that this protein plays different roles in different tissues. This 
gene produces an anti-apoptotic protein regulated by androgen in prostate (July et al., 2002). 
It is repressed by E2 treatment in liver and uterus of ovariectomised rats (Diel et al., 2003). It 
is multifunctional and involved in apoptosis, spermatogenesis, promotion of cell-cell 
interaction, modulation of complement systems and tissue regeneration and remodeling 
(Joseph et al., 1994). 
Proliferating Cell Nuclear Antigen (PCNA): 
PCNA is an auxiliary protein present during late G1 phase and S phase of the cell cycle. It is 
an established proliferation marker (Sullivan et al., 1993; Lorz et al., 1994). 
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Insulin-like Growth Factor Binding Protein 1 (IGFBP-1): 
The proteins of IGFBP family can bind IGF with high affinity, for this reason they are used as 
IGF depot, to collect IGF in a tissue, and release it when necessary. The estrogen 
responsiveness of IGFBP-1 in liver of ovariectomised rat has already been shown by Diel 
(Diel et al., 2004). 
Calcium Binding Protein 9 kDalton (CaBP9k): 
CaBP9k is involved in Ca²+ ion transport, it is extremely estrogen responsive in rat liver, liver 
cell line, (Diel et al., 1995; Geis et al., 2005) and in rat uterus (Rivera-Gonzalez, 1998). 
Carbonic Anhydrase II (CAII): 
CAII enzyme catalyzes the dissolution of CO2 in water (CO2 + H2O ↔ HCO-3+ H+). It is 
necessary for osteoclastic activity, and presents an interesting regulation profile to estrogens 
given by the presence of an AP-1 binding site in the promoter, hence one example of the non 
classical mechanisms of estrogen activity (David et al., 2001). It is down regulated by E2 in 
osteoblast and osteoclast of ovariectomised rats (Williams et al., 1999). It plays an important 
role in the osteoclast differentiation, and bone resorption. It is also involved in the regulation 
of intracellular pH and Ca²+ concentration (Lehenkari et al., 1998). Up-regulation of CA II 
brings an increase in the osteoporotic process and bone resorption in ovariectomised rats. 
Estrogen loss results in an up-regulation of CA II and E2 supplementation reduces gene 
expression of CA II after 18 h (Zheng et al., 1995). CA II is involved in CO2 exchange, fluid 
secretion and pH regulation (Fleming et al., 1994). CA II is also an essential metabolic 
enzyme of the CNS, it is key in the production and regulation of cerebral fluids (Nogradi et 
al., 1993). It plays a role in the degradation of lurcher Purkinje cells and its related protein 
(CARP) has an important activity in the development and maturation of the celebrellar cortex 
(Nogradi et al., 1997). It is insufficient to consider this gene as a simple representative of the 
estrogen responsive genes in bone only. 
 
 
3.2 List of the 100 genes to include in the final microarray chip 
In tab. 1 100 genes are listed which have been chosen to be included on the final DNA chip 
for the detection of estrogenic effects of different substances in the environment. They are 
classified according to the tissues where they show their major estrogenic response (bone, 
vessel, uterus, breast and liver) or as representatives of a specific biological pathway 
(apoptosis, pathophysiological conditions, cancer and heat shock proteins) or as marker for 
cell cycle progression. The list also includes control genes which are constitutively expressed 
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following exposure to estrogenic substances, commonly referred as housekeeping genes. The 
housekeeping genes are constitutively expressed, because their function is vital for the 
organism, for this reason they are generally independent from external influence. They were 
used as control genes, for the normalization of the signals stemming from differentially 
treated samples for gene expression analysis. The list also contains a newly identified 
sequence that presents an interesting regulatory pattern in the uterus of ovariectomised rats 
following treatment by E2. 
 
Tab. 1: List of 100 genes chosen for the detection of estrogenic activity of substances in the environment.  
 
 
3.3 List of the 16 genes used during establishment of the method 
The different genes represented on the DNA chip for establishment of the microarray 
technique are reported and described according to the enclosure of the proposed chip (tab. 2). 
These genes are also used in the first gene expression experiment reported in paragraph 3.5 of 
Target Gene Target Gene
Each Cell cycle Inhibitor of Differentiation
tissue Estrogen Receptor ß progression Cyclin D1 and E
Clusterin Proliferating Cell Nuclear Antigen
Progesterone Receptor Ki-67
Calcium Binding Protein 9 k Dalton HSP Heat Shock Proteins (27 & 70)
Bone Macrophage Colony Stimulating Factor
Osteoprotegerin Cancer ER Binding Fragment Associated Antigen 9
Alkaline Phosphatase Transforming Growth Factor-ß
Type 1 Collagen Wnt-1 Inducible Signaling Pathway protein 2 
Tartrate-Resistant Acid Phosphatase pS2
Carbonic Anhydrase II High Mobility Group 1
Matrix Metalloproteinase (2-9-13) CD-22
Vessel Nitric Oxide Synthase (inducible & endothelial) Breast Cancer 1
Vascular Endothelial Growth Factor Angiopoietin 2
VEGF Receptor (1 & 2) Early Growth Response (1 & 3)
Cyclooxygenase 2 Thrombospondin 1
Liver Apolipoprotein A1 Apoptose Bcl-2; Bcl-XL; Bcl-w; Mcl-1
Cholesterol 7a-Hydroxylase Bax; Bad; Bak; Bik; Bid 
Insulin-like Growth Factor (1 & 2) Death Associated Protein 3
IGF Binding Protein family (1-7) C-Myc
C-fos Interleukin (4 & 6)
C-jun Fas ligand
Major Acute Phase protein Embigin
Uterus Complement C3 Programmed Cell Death 9
Interleukin 4 Receptor Caspase family (2-3-6-8)
Metallothionein Caspase Activated DNAse
Tumor Necrosis Factor regulated protein 6 Inhibitor of Caspase Activated DNAse
Inositol 1-Monophosphate Synthase Death associated protein kinase
Creatine Kinase B Tumor Necrosis Factors
Aquaporin-water channel gene TNF receptors (1 & 2)
Uterine Ovarian Specific Gene 44 Control Cytochrome c Oxydase  Subunit 1
Syndecan-3 Cyclophilin
Telomerase-Associated protein 1 ß-Actin
Secretin Hexokinase1
Wilms’ tumor gene Ubiquitin
Breast Msx-2  Novel Fragment r52
Cathepsin D
Transferrin
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the result section. Some of these genes have been chosen because of their proven sensitivity to 
estrogenic treatment in different target tissues e.g. bone, liver and uterus. Other genes have 
been chosen because of their interesting role in different metabolic pathways like: apoptosis, 
cell cycle, marker of stress and cancer related genes. In some cases the same genes may be 
described in different parts of the list. 
 
 
Tab. 2: The 16 genes present in the microarray chip during establishment of the method and used in the first 
experiment of gene expression analysis. The “*” indicates genes which are not allocated to a single target. 
 
 
 
 
The genes 1A, C3, CLU, PCNA, IGFBP1, CaBP9k and CAII were already described in the 
paragraph above. 
 
Estrogen Receptor α (ERα): 
ERα was the first receptor that binds the natural estrogen E2 to be discovered. It is expressed 
in many tissues and organs as reported by Gustafsson in 1999: CNS, breast, cardiovascular 
system, liver, urogenital tract and bone. In uterine tissue of ovariectomised rats the expression 
of ERα is repressed after 72 h exposure to E2 (Green et al., 2001; Diel et al., 2003). 
Estrogen Receptor ß (ERß): 
ERß was the second estrogen receptor to been discovered, cloned by Kuiper (Kuiper et al., 
1996). It is expressed in the following tissues: CNS, breast, cardiovascular system 
gastrointestinal tract, bone and urogenital tract (Gustafsson, 1999). ERß is down regulated in 
Target Gene
Each
tissue Estrogen Receptor ß
Clusterin
Calcium Binding Protein 9 k Dalton
Bone Carbonic Anhydrase II
Vessel Cyclooxygenase 2 
Liver Insulin-like Growth Factor 1
IGF binding protein 1
Uterus Complement C3
Breast Insulin-like Growth Factor 1*
Cell cycle Proliferating Cell Nuclear Antigen
progression Ki-67
HSP Heat Shock Protein 70
Cancer Cyclooxygenase 2*
Apoptose Insulin-like Growth Factor 1*
Control Cytochrome c Oxydase  Subunit 1
Cyclophilin
ß-Actin
Hexokinase1
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the uterus by E2 treatment as already described for ERα (Green et al., 2001; Diel et 
al., 2004). 
 
Cyclooxygenase 2 (Cox-2): 
This gene presents the peculiarity, in opposite to its relative isoform Cox-1, that is not 
affected by E2 exposure, to be highly responsive to estrogens. Cox-2 is involved in regulation 
of gastrointestinal motility, vessel dilatation and immune response (Eberhart & Dubois, 
1995). It plays a role in tumor genesis, it is an enzyme that catalyzes the synthesis of 
prostaglandins.  
Insulin-like Growth Factor 1 (IGF-1): 
IGFs are growth factors in many cell lines and tumors, sensitive to estrogenic administration 
in liver, uterus (Sahlin, 1995) and breast (Chan et al., 2001). IGF-1 gene expression is 
repressed after a 48 hours exposure to the pure antiestrogen ICI 182,780 in MCF-7 (human 
breast cancer cell line) (Huynh et al., 1996). The IGF-1 is stimulated by E2 and treatment in 
ovariectomised rats (Ghahary et al., 1990). 
Ki-61: 
This proliferation marker encodes for the protein MIB-1 used to assess cell cycle progression 
(Bruno et al., 1992; Sullivan et al., 1993). 
Heat Shock Protein 70 (HSP70): 
HSPs are an important family of endogenous protective proteins, their over expression is 
protective against cardiac injury. They are also generally used as a control for general types of 
stress in a cell, an up regulation of their expression is an indication of a stress response of the 
organism. Exposure to E2 enhances the protein level of HSP70 in brain of male and female 
rats (Lu et al., 2002). The sensitivity of HSP70 to estrogen is already shown in uterine tissue 
of ovariectomised rat treated by E2 for 4 h (Rivera-Gonzalez et al., 1998). 
Controls: 
It is difficult to find information about genes which are constitutively expressed also during 
the estrogen exposure. For three of four genes reported here evidence is provided for the 
independence of expression to estrogens treatment, the last one is a good candidate because of 
its pivotal role in the basal cell metabolism. 
Cyclophilin (Ppia): 
Cyclophilin was also isolated with the name of Peptidyl Propyl Isomerase A (Ppia), and is an 
ubiquitous protein. This gene seems not to be influenced by estrogenic treatment in the uterus 
of ovariectomised rats (Weisinger et al., 1999). It has been already used as a control in low-
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density cDNA array analysis by Choi (Choi et al., 2001), or in a rat renal model treated by E2 
(Michel and Famworth, 1992). 
 
ß-Actin (ß-Act): 
ß-Act gene expression seems not to be influenced by estrogenic treatment in the uterus of 
ovariectomised rats (Weisinger et al., 1999), it is also used as control gene in many 
commercial microarray chips. 
Hexokinase1 (HK1): 
HK1 catalyzes the phosphorylation of glucose to glucose-6-phosphate, it is the first enzyme of 
the catabolic pathway of glucose. For its position in this metabolic pathway its gene 
expression may be considered independent from exposure to estrogenic substances. HK1 is 
also included in many commercial microarray chips as a housekeeping control gene. 
 
4. Tools 
A first series of experiments was conducted in cell culture to identify new molecular markers 
of estrogenic action in response to different compounds and to improve the characterization of 
the already known markers. Thereafter, attention was moved to the in vivo experiment, to 
verify the estrogenic sensitivity in an experimental in vivo model. 
 
4.1 In vitro models 
For the study on the influence of the test compounds on the expression of target genes two 
cell lines are used. 
 
4.1.1 RUCA-I cell line 
This cell line derives from rat endometrial adenocarcinoma cells. RUCA-I is already used as 
tool for the investigation of estrogenic substances with both estrogens (Vollmer et al. 1995; 
Tueshaus et al., 2003) and phytoestrogens (Hopert et al., 1998; Dopp et al., 1999). There is 
evidence, deriving from analysis of the protein level of complement C3 and fibronectin, that 
RUCA-I is estrogen/antiestrogen sensitive only by culture on an extra cellular matrix (ECM), 
particularly on a layer of reconstituted basement membrane (Vollmer et al., 1995, Hopert et 
al., 1998). 
 
4.1.2 Fe33 cell line 
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Fe33 cell line derives from rat hepatoma cells stably transfected with human ERα. This cell 
line is proven as a tool to study the effects of EE, an increase of angiotensinogen expression is 
reported after 24 hours of EE treatment (Krattenmacher et al., 1994), the same substance for 
the same time course stimulates the expression of IGFBP-1, CaBP9k and Major Acute Phase 
protein (MAP) (Diel et al., 1995). 
 
4.2 In vivo model 
Wistar rats were chosen as the animal model for the in vivo studies. The three day 
uterotrophic assay is a classical method used for the study of the activity of estrogenic 
substances (Watanabe et al., 1992; Diel et al., 2002; 2004; Zierau et al., 2004). The 
Organization for Economic Co-operation and Development (OECD) directive requires this 
test for each drug with estrogenic activity before it appears on the market. It consists of 
ablation of the ovary, ovariectomy, the natural source of sex hormones (that result as first 
consequence in atrophy of the uterus), following treatment with the test substance for three 
days, the wet weight of the uterus is measured. This procedure allows for the study of 
substance’s estrogenicity without the interference of the internal production of steroidal 
hormones. After the ovariectomy the rats are treated for three days with the substances. The 
carrier of the substances is used as negative control and E2 as positive control of the 
treatment. 
The tissues studied are uterus and liver, which are the tissues of origin of the two cell lines 
chosen for this work. It would be interesting to investigate the effects of the different 
substances in other targets of estrogens e.g. bone, breast or blood vessel. The aim of my work 
is focused on the establishment of a new technology in our laboratory rather than to perform a 
complete and comprehensive analysis of the activity of the respective test compounds in the 
entire organism. 
 
4.2.1 Uterus 
The uterus is considered as the principal target organ for the investigation of estrogenicity. As 
already reported the uterus is not only routinely investigated for the estrogenic activity of 
different substances in the organism, it is also a required test of drug with estrogenic potency 
according to the OECD guide lines. The uterine tissue shows also a strong responsiveness to 
estrogen treatment in the regulation of gene expression (Kang et al., 2003; Wu et al., 2003; 
Diel et al., 2004; Zierau et al., 2004). 
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4.2.2 Liver 
The choice to investigate the liver derives from the fact that a key role of this tissue is 
estrogen metabolism. Yager and Liehr reviewed the role of estrogens in tumorogenesis in rat 
liver (Yager and Liehr, 1996). The oral consumption of hormones in HRT has an interaction 
with cardiovascular diseases due to induction of C-reactive protein release from liver (Miller 
et al., 2003). There is evidence that indicates that estrogen depresses hepatic lipid oxidation 
and promotes triglyceride synthesis (Giwer et al., 2002) along with that estrogen treatment 
also has an influence on risk reduction in cardiovascular disease by lowering the production 
of blood cholesterol (Parini et al., 2000). The responsiveness of some genes in the liver to 
estrogens has already been reported (Diel et al., 2004; Geis et al., 2005). After this short 
overview on the multiple effects which are triggered by estrogen treatment in the liver, it has 
to be emphasized that liver tissue was selected because this project was a collaborative project 
and the data obtained should be comparable to that obtained in the rainbow trout, the 
experimental model of the collaborators. 
 
5. Methods for the gene expression analysis 
5.1 Microarray 
5.1.1 The “tale” of the microarray 
Since 1995, the microarray is a tool used for the analysis of the gene expression. In the 
beginning, it was created as a high-capacity system to monitor the quantitative expression of 
multiple genes in parallel. The amazing result for that time, ten years ago, was the possibility 
to perform a differential expression measurement of 45 genes of Arabidopsis thaliana using 
2 µg of total cellular mRNA (Schena et al., 1995). The microarray is drawn up as a 
development of the northern blot technique; it is interesting to note that many reagents, like 
the wash buffers, are shared by both methods. The innovation is the change of point of view. 
In northern blot analysis the RNA target is run in a gel to separate it according to its 
molecular weight. It is then transferred to a membrane where a probe, a marked specific 
nucleotide sequence, is spread on the membrane, it is washed and where it hybridizes and 
allows to identify an RNA. In this way a single probe looks for homology in a population of 
different targets. In the microarray the probes, different DNA sequences corresponding to 
specific genes, are fixed, in a known configuration, onto a solid matrix. Then they are 
hybridized with the target RNA-probes, which were previously reverse transcribed into cDNA 
and labeled. In the microarray the point of view is inverted, the probes are affixed on the solid 
matrix and the targets are hybridized to them.  
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At present it is hard to define the quantity of probes, genes or sequences, which are analyzable 
in a single experiment. As an example it is reported that the “GeneChip® rat expression set” 
from Affymetrix® (USA) allows for simultaneous study of the expression of 31.042 transcript 
sequences.  
Multiple companies offer a large choice of ready to use microarray chips, for various studies 
and analysis, e.g. discovery of new genes, description of genes potentially involved in 
development, physiological and pathological processes, studies of gene regulation, diagnosis 
of diseases (via the identification of gene expression patterns that may represent a illness) 
state, drug discovery and toxicology (review by Murphy 2002). 
Usually microarray chips are relatively large, they include more than 5000 genes or EST 
(Expressed Sequence Target) sequences, and the analysis of the result is entrusted to 
computer software created specifically for the chip. This type of chip can be really useful for 
preliminary studies, general application or a clearly developed goal, because it is an inflexible 
system that does not allow any change or development of the goal. The fact remains that this 
type microarray chips are very expensive and they relegate the scientist to the position of aq 
generic user. 
The goal of my work is the description of the long way to establish a microarray DNA chip 
for the detection of the estrogenic potency of different substances in the environment, starting 
with the selection of the genes on the chip (around 100), until the production and application 
of the DNA microarray chip. This work places itself in a free area of the research and the 
market, with the production of a small, user friendly and “intelligent” chip, in which every 
component can be substituted in order to develop and improve the researcher’s needs. 
The other advantages of a internally produced small microarray chip are lower costs, constant 
monitoring of the full procedure, and the possibility to change and improve the performance 
of every step. On the other hand, the establishment and development of a microarray DNA 
chip is always complicated and time consuming, independent from the size of the chip itself. 
 
5.1.2 Description of the microarray process 
The microarray process can be divided in 3 main steps, the disposition of the probes on the 
solid matrix, the hybridization of the target to the probes and the analysis of the resulting data 
(fig. 8). Like every process, the microarray’s components are sensitive to the manufacturing 
process, it is recommended to use component from the same manufacture to avoid 
interference problems between different reagents and materials. 
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A microarray experiment starts with the selection of genes (probes), usually from literature 
surveys, to be investigated. These genes are disposed and affixed in an ordered manner onto 
the solid support (chip). The preparation of the targets, derived from differentially treated 
animals, cell cultures, or biopsies from treated patients, starts with the extraction of the RNA, 
the labeling of the samples and thereafter they are ready to be hybridized to the probe present 
on the chip. The resulting chip is scanned with an appropriate reader, elaborated and analyzed.  
Each step of this process is a source of variability, an attempt is made to review briefly each 
step of the process and the different methods currently in use. Starting from the precise 
location and linkage of the probes on the solid matrix, many parameters have to be defined. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8: The microarray process is shown starting from the choice of the probes (genes), proceeding through 
hybridization to the differentially treated and labeled target and the scan of the derived chip. The last three 
images of the scanned microarray are from:  
http://www.mun.ca/biology/scarr/cDNA_microarray_Assay_of_Gene_ Expression.html. 
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Probes on the solid matrix 
 
Fig. 9: Schematization of the different steps to produce a microarray chip. 
 
Kinds of probes: 
At present two types of probes are in use: oligonucleotides and cDNA. The oligonucleotides 
are single-strand DNA probes synthesized on the basis of sequence information present in the 
database. The length of the oligonucleotides plays a central role in the specificity of 
hybridization with the samples, usually a range from 20 to 80 nucleotides is used. Short 
oligonucleotides are less specific in their binding between probes and targets, whereas long 
oligonucleotides might create problems due to its secondary structure hindering the pairing 
with homologous sequences of the target samples. It is also possible to present a modification 
at one end, to improve linkage to the solid matrix, or a “spacer” (an unspecific 
oligonucleotide sequence) to keep a distance between the oligonucleotides and the surface 
where they are affixed, so to improve the space for hybridization with the target. The cDNA 
probes are usually PCR products, with a size of 100-2000bp, derived from cDNA clones from 
a plasmid library. In our laboratory oligonucleotides are in use. They were considered more 
stable and easier to use. 
Kind of solid matrix: 
The solid matrix has an influence on the process for the stability of the linkage, the kind of 
reagents and on the background signal that it can deliver. The slides that are commonly used 
are glass, like microscope slides, or membranes of different materials, like nylon or cellulose. 
At present the membranes are not in use anymore due to their instability and porosity. 
Membranes present the advantage as to allow reuse up to five times, but they deliver a strong 
background signal because of their own fluorescence (Murphy, 2002). 
The glass slides are often covered, coated, with polymers which allow for better linkage 
between the probes and the slide itself as well as reducing the reflectivity of the slide and 
therefore delivering a weaker background signal. The market offers many types of slides 
kind of probes
kind of solid matrix
probe disposition
spot buffers
link of the probes to the solid matrix
Oligonucleotides
PCR products
Glass slide
Membrane
Physical contact
Ink-jet 
Warm treatment
UV exposure
Probes on the solid matrix
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ready to use, and it is also possible to coat the slides in the laboratory. The choice of different 
coats depends on the type of probe used. For example the epoxy silane coated slide allows for 
use of both oligonucleotides and cDNA (Call et al., 2003; Warsen et al., 2004), in contrast, 
the poly-L-lysine coating is used for just cDNA probes (DeRisi et al., 1997), like aminosilane 
coated slides (Hegde et al., 2000). Ready to use epoxy silane coated slides were already 
present in our laboratory at the beginning of the project. 
Probe disposition: 
The disposition of the probes onto the slide can be achieved by contact (mechanical spotting) 
or noncontact (ink jetting). For spotting the probes are loaded by a pin, profiting form the 
viscosity of fluids, and transferred to the slide surface by physical contact. The pin is then 
washed after which it is ready to load another probe and dispose it on the solid surface. The 
inkjet mechanism is similar to an inkjet printer for computers, the probe is loaded into a 
miniature nozzle and “shot” onto the solid surface, after which the nozzle is washed and 
loaded again with a new probe. For mechanical spotting the equipment required is cheaper 
and more durable, in comparison with an ink jetting printer. In our laboratory a spotter device 
was already present at the start of the project, therefore only the mechanical disposition 
according to the possibility presents in our laboratory, will be considered. 
Spotting buffer: 
The probes, oligonucleotides or PCR products, prior to the spotting process need to be 
dissolved in a print or spot buffer, according of the disposition method used. The purpose of 
the spot buffer is to perform spot trace that is circular, regular, with a homogeneous 
distribution of the samples (probes) and relative small. The spot trace should be small, first to 
reduce the spot area, consequently reducing the amount of hybridized material during the 
subsequent hybridization step, and second to concentrate the spotted sample to get a higher 
signal reducing the spotted material amount.  
It is necessary to mention that the buffer has to deliver as little fluorescent signal as possible, 
to avoid false positive signals stemming from the buffer rather than from the probes. The spot 
buffer is also responsible for the viscosity of the spotting solution; it has to be remembered 
that high concentrated DNA solutions present a high viscosity. Normally the slides bought 
from a company are provided with the optimized spot buffer for the slides themselves and 
instructions for use according to the use of oligonucleotide or cDNA probes. In the case of 
customized slides the buffer consists of a solution of SSC (Shalon et al., 1996; Khan et al., 
1999; Cheung et al., 1999), SDS/NaOH (Call et al., 2001), NaPO4/SDS (Shearstone et al., 
2002), SSC/Betaine or SSC/NaCl (Huang et al., 2002), DMSO/SSC (Hegde et al., 2000; 
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Antani et al., 2000), salmon sperm DNA, BSA, and obvious mixture of those components. 
The viscosity of the buffer in relation to the hydrophobic/hydrophilic nature of the slide 
surface against the buffer plays a central role for spot deposition. The DNA solution presents 
a remarkably high viscosity, which interferes with the disposition of the probe onto the slide. 
The increase of the viscosity of the buffer can cause problems at two stages: the loading of the 
probe in the pin and the disposition of probe on the slide surface. The viscosity of the spot 
buffer can influence the whole spotting process. A too fluid spot buffer does not allow for 
loading of sufficient sample on the pin to perform a considerable number of spots, in this way 
it obliges to refill the pin several time with enormous time expense. Moreover, a too fluid spot 
buffer produces a large spot during the deposition of the probe onto the slide, increasing the 
spot area and the dilution of the probe which in the spot trace delivers a weaker signal at the 
end of the process after the scan of the hybridized chip. In the case of a too viscous solution, 
the quantity of probe loaded by the pin will be too great and the first spots will not be regular, 
non-circular. Hence, a too viscous spotting buffer produces a non-regular spot trace. 
The hydrophobic relationship between spotting buffer and slide has to be considered for the 
size of the spot trace. A hydrophilic surface in combination with an aqueous buffer delivers a 
large and irregular (non-circular) spot, a hydrophobic slide with a hydrophilic buffer 
concentrates the spot in the center delivering a high signal that sometimes may be too high. 
Stable linkage of the probes to the solid matrix: 
At the end of the spotting process the probes have to be linked (coupled) on the slide surface. 
This is a crucial event because, in the following steps, the slide will be in contact with other 
solutions and washing buffers several times. The coupling reaction is commonly performed 
by baking the spot slides in a warm and dry oven to allow the evaporation of the buffer and to 
supply sufficient energy to create a link between the probe and the polymer of the slide (Call 
et al., 2001). Another method is exposure to Ultra Violet (U.V.) light to provide enough 
energy for the formation of covalent bond between the DNA of the probes and the functional 
group of the coated glass surface (Taylor et al., 2003). After which the unlinked probes are 
usually washed and the slides are dried by centrifugation or N2 stream. At that point, the slide 
can be stored in a dark dry cool place for several months, before use. 
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Hybridization 
 
Fig. 10: Schematization of the preparation of the target samples for the hybridization, in the microarray 
technology. 
 
 
RNA isolation: 
The preparation of the probes starts with RNA isolation from the biological sample, for 
example, cell culture or tissues. The purity of the RNA is a critical factor for the hybridization 
performance, in the case of eukaryotes the isolation of mRNA can deliver a better result, but 
again is more expensive and time consuming. The sample RNA is converted into target 
cDNA by the use of the reverse transcriptase enzyme, for the reverse transcription of 
eukaryotic RNA oligo(dT) priming is recommended instead of a random priming to avoid the 
production of false positives in the form of immature mRNA or other types of short RNA 
(tRNA, rRNA). 
Target labeling: 
The sample can be labeled during the cDNA synthesis reaction using a pre-labeled primer for 
reverse transcription (Shi et al., 2003) or by incorporating modified nucleotides into the 
cDNA (Zhao et al., 2003) In both cases the label is usually a fluorophore: a Cyanine or an 
Alexa analogue (both molecules emit fluorescence when excited with a laser of a know 
energy and wave length). It is also possible to incorporate radioactive nucleotides like 33P 
dCTP (Duggan et al., 1999). The incorporation of modified nucleotides into the cDNA can be 
performed in two ways, and therefore it is possible to choose between a direct and indirect 
labeling. The handling of the first method is easier and less time consuming, it is also known 
as “one-step labeling”. It consists of the incorporation of modified nucleotides during the 
RNA isolation
Target labeling
Hybridization buffer
Pre-hybridization wash
Cover for hybridization
Hybridization chamber
Wash after hybridization
Hybridization RNA
mRNA
Fluorescence
Radioactive
Direct
Indirect
Frames + covers
Coverslips
Lifterslips
Yes
No
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reverse transcription of RNA (Yu et al., 2002). The handicap of this method is its cost and the 
inability to stop the procedure, after the labeling, the target has to be hybridized to the probes 
as soon as possible. In the case of indirect labeling, also called “two-step labeling”, instead of 
labeled nucleotides, modified nucleotides are incorporated during the cDNA synthesis, that 
present a group that allows for the formation of a covalent bond with the labeling molecule in 
a second step (Badiee et al., 2003; Hui et al., 2003). The advantages of this method are the 
lower costs and the ability to stop the reaction after cDNA synthesis and freeze the target 
samples performing the labeling of the cDNA in a second step. However “two-step labeling” 
is clearly more time consuming. 
In the development of this technique some manufactures are attempting to improve the signal 
arising from the hybridization amplifying the cDNA, or the cRNA (Young et al., 2004), to 
reach a larger copy number of genes with low expression levels. However there is no proof of 
linear duplication of the present genes, thus it may deliver false positive results. 
In order to reduce the number of hybridization experiments of different targets to the probes 
spotted in the array, other researchers try to hybridize at the same time, on the same array, 
targets marked with three different labels, instead of the classical two, for example Cy3, Cy5 
(Cyanine analogues commonly used as label) and Alexia 594 incorporated as dye-label, are 
able to reduce the expense and the time consumption to 50 % (Forster et al., 2004), however 
the equipment required also include a scanner that can read all three fluorophores at the same 
time, this is uncommon for the available scanners. 
Hybridization buffer: 
For the hybridization reaction the hybridization buffer is key component, it is responsible for 
the efficiency of the interaction between the probes and target, consequently of the signal 
intensity, and it is also correlated to the background luminosity. A good hybridization buffer 
has to produce as little background signal as possible, to enhance hybridization of the 
samples, and to block unspecific binding of target to the probes, in order to avoid false 
positive signals. 
Like for the spot buffer, the manufacture provides along with the slides a hybridization buffer. 
The basic composition of which is normally from SSC solution and other components in 
which SDS is often present. To block the interaction of unspecific samples with the probes an 
exogenous DNA can be used (like Salmon sperm DNA) or other registered substances. 
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Pre-hybridization wash: 
Some slide producers have evolved a series of pre-hybridization washes to enhance the 
effectiveness of the hybridization, which also decrease the background signal. It can vary 
depending on the protocol, kind of slide or hybridization buffer. 
Cover for hybridization: 
The hybridization solution, consisting of the hybridization buffer and the dye-labeled 
samples, has to be applied to the spotted area of the slide in order to come into direct contact 
with the probes. To delimit and protect this area many covers are available, the choice 
depends on the kind of incubation procedure during the hybridization. Some covers close 
hermetic the spotted zone in contact with the hybridization solution, this allows to move the 
slide gently during the incubation and delivers a more equally distributed signal in the spotted 
area (like hybridization frames and cover from GeneScan, Germany). Other types of cover are 
in use, and many of them are simply slide covers (coverslips from Thermanox, USA) or slide 
covers with two parallel spacers positioned on the two edges to keep a free volume between 
the cover and the spotted area, this allows to use more hybridization solution along with better 
distribution (lifterslips from Eriescientific company, USA). 
Hybridization chamber: 
The hybridization must be carried out in a warm and moist chamber saturated by steam. There 
are many types available on the market. The temperature and the length of time of incubation 
are variable and have to be adjusted empirically. The temperature of hybridization should 
allow for annealing between the probes and the target sample, which depends on the length of 
the probes and its GC content. The oligonucleotides due to their single stranded need less time 
for incubation in comparison with double strand cDNA probes. 
Wash after hybridization: 
After hybridization the slides are washed by rinsing in different solutions, commonly SSC and 
SDS with decreasing stringency with to wash away the unlinked labeled samples from the 
slides. Washing the slides after hybridization with distilled water should be avoided, in this 
case the hybridization reaction would be disturbed resulting in a sensible decrease of 
performance of the signal. 
At the end of the wash the slides have to be dried by centrifugation or N2 stream. To the 
present time there are no indications concerning an influence of the way to dry the slides on 
the final result of the process, therefore it is only a matter of handling, costs and facilities. 
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End flow analysis 
Fig. 11: Schematization of the steps involved in the end flow analysis of a hybridized microarray chip. 
 
Scanning/image acquisition: 
At the end of the process the hybridized array has to be evaluated by scanning with a specific 
laser which can read each dye individually. The setting of the parameters to scan a slide, the 
power of the laser and the PMT (photon multiplier tube) intensity, has to be adjusted for every 
slide. The ideal fit settings of parameters allow the acquisition of the slides with the higher 
signals, along with the possibility to detect the weaker signals. Concerning the settings for the 
intensity of the laser beam, reaching saturation of the higher signals must be avoided. When 
the saturation of the signal is reached the spot appears as a white mark and the instrument 
cannot distinguish any increase in the intensity of the signal. The intensity of the signal is 
directly correlated to the amount of labeled target linked to the probes affixed on the slide. 
Evaluation of the signal: 
After the scan of the biochip the signal stemming from the image has to be translated in an 
absolute value. Usually the scanner is provided with software for the evaluation of the signal. 
The software for the analysis of the signal presents many parameters which can be adjusted. 
The more parameters that are available, the more the software allows for a the fit of the 
evaluation method to an individual array. The most important parameter is the definition of 
the area from the signal which the samples stem from, and the area wherefrom the 
background signal derives. It is pretty simple to define as the sample’s signal is the signal 
from the area of the spot, but the definition of the background area can vary, it can be the area 
surrounding the spot trace, or another non spotted area. 
Normalization of the signal: 
After subtraction of background signal, which eliminates the signal originating from the non 
spotted area, the signal has to be normalized. Normalization is necessary for three reasons. 
First, the dyes used for the labeling of the two samples may be incorporated with differing 
efficiencies. Second, one of the two dyes used for the labeling of the samples may deliver a 
higher signal intensity compared to the other dye, even when it is present in the same 
quantity, due to its characteristic. Third, in the gene expression analysis the isolated RNA 
quantity from the two samples may vary, this is due to normal experimental variability and 
Image acquisition
Evaluation of the signal
Normalization of the signal
End flow analysis
Large number of genes
Small number of genes
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has to be normalized to avoid false results stemming from differing quantities of RNA 
isolated; as normally performed for the gene expression analysis by real time RT-PCR. 
In the gene expression analysis, normalization of the signal is a central point to avoid having 
false positive results in the differential gene expression analysis. According to the size of the 
chip the tendency is to use three different methods, for normalization. 
For large chips (more than 1000 spots/genes), normalization of the signal stemming from the 
two dyes can be performed by calculating the average signal of all spots; statistically working 
with a large number of genes, the differential expression of all genes is equal to zero, some 
genes will be up regulated and some other down regulated so resulting at the end in a general 
expression level that stays constant. In small chips (less than 1000 spots/genes) this procedure 
is impossible as the genes are too few to normalize according to previous method. In this case 
genes which are constitutively expressed have to be used. This is the case for housekeeping 
genes, their expression is not affected by the experimental conditions of the study. The choice 
of housekeeping genes have to be targeted, because under some experimental conditions, 
housekeeping genes can also vary in their expression levels. For example, in a study of food 
deprivation the gene for the glucose metabolism pathways should be avoided, because also 
when “normally” the genes of this pathways are constitutively expressed, the glucose 
metabolism is constant in standard condition, but when there is a paucity of the glucose itself 
this pathway is obviously repressed. 
A “third” way for the normalization of the signal is the use of an external control. Some 
“spikes” are spotted together with the probes, spikes are oligonucleotides coding for foreign 
genes, for example genes of Arabidopsis thaliana used in experiment for gene expression in 
Wistar rat. During reverse labeling of the cDNA target samples, some mRNA coding for the 
genes present in the spikes is added to the reaction in a known quantity. Therefore, during 
hybridization the foreign labeled target can hybridize only with the “spikes” delivering a 
signal for the two dyes that differs only due to the natural fluorescence of the dyes, as the 
quantity of hybridized material is the same. This method presents the problem that is a 
completely external method of normalization of the signal. Using this method the mRNA 
quantity reverse transcribed and the efficiency of the reverse transcription for the two samples 
has to be exactly the same. Another example of “spikes” can be the polyT (Timidine) 
sequence present in every eukaryotic cDNA. In this case a polyA (Adenine) oligonucleotide is 
spotted in the array and it will find homology with all cDNA molecules reverse transcribed. 
This method also has the advantage of being an internal method of normalization of the 
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signal, because it is linked with the reverse transcription of the mRNA samples, and so it can, 
in addition, also be used to normalize the cDNA quantity of the two samples. 
 
5.2 Real time RT-PCR 
5.2.1 Real time RT-PCR origin and present application 
The real time RT-PCR (reverse transcription polymerase chain reaction) technology has 
recently reached a level of sensitivity, accuracy and practical ease that supports its use as a 
routine bio instrument for gene expression analysis (Diel et al., 2003, 2004), disease diagnosis 
(reviewed by Hui et al., 2003; Aldape et al., 2002), detection of pathogens (reviewed by Uhl 
et al., 2002) or single nucleotide polymorphism (SNP) genotyping (Ulvik & Ueland, 2001). 
 
5.2.2 Real time RT-PCR process description 
The generalized method consists of a classical PCR reaction with online quantification of 
synthesized product after each amplification cycle. There are different products available on 
the market which differs in their detection mechanism for the PCR product. Our laboratory is 
equipped with the Icycler® real time RT-PCR (Biorad, USA). It uses SYBR green 1 as a 
fluorescent dye which when bounds to double stranded DNA, exhibits high fluorescence. The 
increase of fluorescence emission is measured after every cycle at the end of the elongation 
step resulting in a quantitative measure which represents the amount of double stranded DNA, 
the PCR product. 
 
5.2.3 Role of the real time RT-PCR in my work 
In my work, the real time RT-PCR is important as a reference method for gene expression 
analysis by microarray technology, a procedure already performed by other authors (Rajeevan 
et al., 2001). At the beginning of the work the real time RT-PCR was also used for the 
identification of novel, along with the in depth characterization of known molecular markers 
for the estrogenic activity of different substances in in vitro and in vivo experiments. 
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6. The aim of my thesis  
The major goal of my Ph.D. thesis was to establish the microarray technology and adapting it 
to the equipment present in the laboratory. This consisted of a spotter robot, epoxy-silane 
coated glass slides and a scanner equipped to detect fluorescence of Cy3 and Cy5 dyes. All 
necessary parts and steps to establish the microarray technology were optimized and the most 
efficient conditions chosen after a series of experiments. 
Thereafter, a selection of 16 genes, reported at point 3.2 of this chapter, were used to test 
whether the molecular effects of the two synthetic estrogens EE and NP can be visualized in 
the cell line Fe33. Obtained results were verified by real time RT-PCR for 4 genes of the 
entire selection: IGFBP1, CaBP9k, PCNA and CAII and the housekeeping gene 1A as control 
gene for the normalization of the gene expression. 
At the end of this work a DNA chip of 16 genes was tested and characterized. 
In parallel, using real time RT-PCR, the gene expression of IGFBP1, CaBP9k and CAII, was 
investigated in the Fe33 cell line after exposure to Gen, Dai and 8PN. The gene expression 
profile of C3, PCNA and Clu was investigated in the RUCA-I cell line (rat adenocarcinoma 
cell line) after treatment with E2 and the pure antagonist ICI 182,780 (ICI) in differentially 
cultured cells, on a layer of an extra cellular matrix, collagen 1 or directly on the plate floor. 
To relate the observed effects in vitro to the situation in vivo, effects of exposure to EE, Gen, 
Dai and 8PN were additionally analyzed by gene expression profiling of CA II and PCNA in 
both liver and uterus of ovariectomised rats. As positive control for the same experiment 
served expression profiling of C3 in uterus and IGFBP-1 in liver. 
In this way the knowledge on the effect of xenoestrogens on cell proliferation is improved, 
which is important with the regard to safety issues. Regulation of CA II expression was 
investigated in depth in new target tissues, namely liver and uterus. 
The study of the gene expression of C3 in uterus and IGFBP-1 in liver is crucial as a positive 
control for estrogenic activity of xenoestrogens in these two target tissues. 
The estrogenic regulation of gene expression of a newly identified differential display 
fragment was investigated using real time RT-PCR. This fragment was investigated in the 
ovariectomised rat uterus and liver treated by EE, Gen, Dai, 8PN and 6DMAN. Since it was 
characterized by interesting response patterns to different estrogens and phytoestrogens, 
cloning of additional genomic information was pursued. 
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1. Materials 
1.1. Substances 
Estradiol and Genistein: Sigma (Germany) 
Ethinylestradiol: Schering AG (Germany) 
Daidzein: Roth (Germany) 
8-prenylnaringenin and 6-(1,1-dimethylallyl)naringenin: synthesized at the Institute of 
Organic Chemistry of Dresden University of Technology, as previously described (Gester et 
al., 2001), 
Nonylphenol: Hüls, technical mixture (Germany). 
 
1.2. Media and media constituent 
Culture medium: DMEM/F12 and 5 % w/v DCC (Biochrom, Germany). 
1 % w/v Gelatin (Sigma, Germany). 
 
1.3. Equipment 
Cell culture plates (TPP, Switzerland). 
Homogenizer Mikro-Dismembrator-s (B-Braun biotech international, Germany). 
Agarose gel transilluminator Gel Printer 2000i (MWG-Biotech, Germany). 
Real time RT-PCR tool: iCycler® Thermal Cycler with iQ real-time Detection System 
(BioRad, Germany). 
96 wells thin-wall PCR plate (Biorad). 
384 wells plate (Genomix, USA). 
Robot spotter Microgrid II® (BioRobotics, United Kingdom). 
Hybridization chambers: Flat block® (Biozym, Germany) incubated in the cycler PTC-200® 
(Byozim, Germany), ArrayIt Hybridization Cassette® (TeleChem international, USA). 
Scanner: Scanarray 4000® (PerkinElmer, USA). 
Scanner software: ScanArray®(PerkinElmer, USA). 
Evaluation of signal software: Quantarray® (PerkinElmer, USA). 
 
1.4. Reagents 
TRIzol® RNA extraction kit (Invitrogen, USA). 
DNase1® (Roche, Germany). 
RNaseOUT® (Invitrogen, USA). 
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Superscript II RNase H-® reverse transcripts Kit (consisting of: 5x first strand buffer, DTT 0,1 
M and Superscript RNase H-® ) (Invitrogen, USA). 
Platinum® Taq DNA polymerase (Invitrogen, USA). 
Epoxy-silane coated slides ArrayLink hyphop® (GeneScan, Germany). 
Spotting buffers: GeneScan: ArrayLink print buffer 2x (GeneScan, Germany), 
PeqLab: Nexterion Spot buffer 2x (Schott Nexterion, Germany). 
RNeasy® Mini Kit column (Qiagen, USA). 
Cy-dye labeled nucleotides (Amersham, USA) (the supplier did not specify the 
concentration). 
Cy-NHS esters (Amersham, USA)  
RNase H (Invitrogen, USA). 
Microcon YM-30® column (Millipore, USA). 
Lifterslip (Eriescientific company, USA). 
mRNA isolation kit: Nucleo Trap mRNA® mini kit (Macherey-Nagel, USA). 
OneStep RT-PCR® (Qiagen, USA). 
DNA ladder 100bp and 50bp (Invitrogen, USA). 
Primers (MWG Biotech, Germany). 
Oligonucleotides (Scenion AG, Germany). 
 
2. Cell culture, animal experiments and RNA isolation 
2.1 Fe33 cell line 
Fe33 cell line (FTO-2B rat hepatoma cells, stable transfected with a human ERα expression 
plasmid by Kaling et al., 1990, provided by Schering, Germany) was cultured in DMEM/F12 
medium supplemented with 5 % w/v DCC at 37°C, 5 % v/v CO2. 
For treatment the Fe33 cells were cultured in tissue culture plates, coated with a layer of 1 % 
w/v gelatin. After one day in culture with DMEM/F12 medium supplemented by 5 % DCC, 
the cells were washed with 1 x PBS and cultured for 24 hours using DMEM/F12 medium 
supplemented with 1 % DCC. After washing the cells with 1x PBS, cultured in DMEM/F12 
medium supplemented with 1 % DCC, the cells were treated with the substances in a 
concentration and time dependent manner. Because the substances were diluted in ethanol the 
ratio of the volume of substances to the total volume of the cell culture medium was 1:1000 
(i.e. a volume of 10 µl of substance was used to treat the cells cultured in 10 ml of culture 
medium). 
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2.2 Animal experiments 
The animal experiments were conducted by Dr. Patrick Diel in the department of Molecular 
and Cellular Sport Medicine, DSHS, in Köln (Germany), the materials and methods of the 
animal treatment were previously published (Diel et al., 2004). 
Briefly, female Wistar rats were ovariectomised (ovx) by ablation of the ovary, the natural 
source of female sex hormones. A first experiment consisted in the treatment of the ovx 
animals with subcutaneous (s.c.) injection of E2 and EE at the dose of 3 µg/kg/day, 
10 mg/kg/day Gen for 7, 24 and 72 h and 20 mg/kg/day Dai for 72 h. A second experiment 
consisted in the treatment of the ovx animals with subcutaneous (s.c.) injection of 
30 µg/kg/day E2 and 10 mg/kg/day 8PN. Investigation of the 8PN effect in vivo was 
performed only at the time point of 72 h due to the paucity of quantity of the substance at the 
time of the performed animal experiment. For both experiment the carrier of the substances 
was EtOH (negative control). A third experiment consisted in the treatment of the ovx 
animals with subcutaneous (s.c.) injection of E2 and EE at the dose of 4 µg/kg/day, 
40 mg/kg/day Dai for 7 and 24 h and 10 mg/kg/day Gen for 24 h. The carrier of the 
substances was EtOH (negative control). 
The animal experiment conducted in our laboratory under the supervision of Dr. Oliver Zierau 
consisted briefly, after ovariectomy of female Wistar rats, in the treatment with s.c. injection 
of E2 at the dose of 10 µg/kg/day, 15 mg/kg/day 6-(1,1-dimethylallyl)naringenin (6DMAN) 
or 8PN for 7 and 24 h. The carrier of the substances was EtOH (negative control). 
 
2.3 RNA isolation 
The RNA isolation was performed with the TRIzol® RNA extraction kit. 
 
2.3.1 RNA isolation from tissues 
Starting from material frozen in liquid nitrogen, the whole uteri or up to 200 mg of liver was 
homogenized using the homogenizer Mikro-Dismembrator-s. Each organ or part of them was 
homogenized with 1 ml of TRIzol®. 
 
2.3.2 RNA isolation from cell culture 
After treatment the cell culture plates were washed with 1x PBS followed by add of 1 ml of 
TRIzol® per plate. The cells were scrapped and the suspension was collected in 2 ml 
Eppendorf tube. 
 
Material and Methods_____________________________________________________________________ 
 
40 
2.3.3 TRIzol® protocol for RNA isolation  
Starting from a suspension of TRIzol® and cells or homogenized tissue, the material was 
incubated at room temperature for 5’. 0,2 ml of chloroform was added per ml of TRIzol, this 
mixture was shacked for 15” and incubated at room temperature for 2-3’. Centrifugation of 
the samples followed for 15’ at 12.000 x g at 4°C. The mixture separated in two phases: the 
upper colorless aqueous and the lower red; the upper phase was transferred into a fresh tube 
and 0,5 ml of isopropyl alcohol per ml of starting TRIzol® was added, after incubation for 10’ 
at 4°C a samples were centrifuged at 4°C for 10’ at 12.000 x g, the supernatant was discarded. 
The RNA pellet at the bottom of the tube was washed with 1 ml of ice cold 75 % v/v EtOH 
per ml of starting TRIzol®, centrifugation for 5’at 7.500 x g at 4°C followed, the supernatant 
was again discarded. The pellet was dried, using a Speedvac centrifuge, the RNA pellet was 
dissolved in HPLC water. Samples were stored at –80°C. 
 
3. PCR / real time RT-PCR 
3.1 PCR primers 
The PCR primers were designed using the freely available on-line software: “Primer3” 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) according to the parameters listed 
in tab. 1. 
 
Tab.1: Parameter for primer design. 
PCR product size 150-250 bp 
Primer size 20-24 bp 
Max complementary <4 
Max 3’ complementary <2 
Primer annealing temperature 59-61°C 
GC% <40% 
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The primers used for classical PCR analysis are listed in tab. 2a, those used for the real time 
RT-PCR are listed in tab. 2b. All primers were synthesized by MWG-Biotech (Germany). 
 
Tab. 2a: PCR primers sequence  
 
 
 
 
 
 
 
 
 
 
 
 
 
Tab. 2b: Real time RT-PCR primers sequence 
 
 
 
 
 
 
 
 
 
 
3.2 DNase treatment 
3 µg of total RNA was digested in 10 µl of total reaction volume containing 1 µl of 10x 
DNase1 buffer (Sambrook et al., 1989) 1 µl of DNase1® 1 U/µl, 1 µl RNaseOUT® 40 U/µl, 
incubated at 37°C for 1 h. 1 µl of RNA after the DNA digestion was tested by real time RT-
PCR using the housekeeping gene primer pair Cytochrome C oxidase subunit 1 (1A), to check 
the presence of remaining genomic DNA in the sample; as positive control a proofed cDNA 
solution was used, and HPLC water served as negative control. The DNA digestion was 
considered successful when the sample delivered a signal of the amplification similar to the 
negative control. 
Gene Forward Reverse PCR product Melting temperature Blast ID 
primer primer size (bp) of the PCR product gene
Cytochrome C tga gca gga ata gag tag aaa tga 261 86°C 343181
oxidase subunit 1 (1A)  gta ggg aca gc tgg agg aag ca
Complement C3 (C3) aca gcc ttc ccg agc gca cca cag 276 92°C NM 016994
gga gca tca aca gag gca cag agt c
Clusterin (Clu) ccc tcc agt cca cca tgc ggc ttt 303 91°C M64723
aga tgc tca aca c tcc tgc ggt att c
Proliferation cell gag caa ctt gga atg cca agc tcc cca 158 88,5/89°C Y00047
nuclear antigen (PCNA) cca gaa cag g  ctc gca gaa aac t
Carbonic Anhydrase 2 gac tgg ctg ttt taa tgg gtt cct 231 88,5/89°C NM 019291
(CAII)  ggg tat ttt tga gca cta tc
Calcium binding protein tgt ctg act ctg cct tca gga ggc 181 88,5°C 3287250
9k dalton (CaBP9k) gca gca ctc act g  tgg gga act ctg
Insuline like growth factor caa cag aaa gca gaa gaa gga ggg 234 88,5°C 204736
binding protein 1 (IGFBP1) gga gat gag a  agg aaa caa c
r52 ccg gaa tag act aga gag cca cct 120 85°C
acc ata cag ca tca gat ttt tc
r52E ttc aaa gtc tat tgg aac aag tac 270 84 °C
cca ttt tcc tga aag tct caa cg
primer name Forward Reverse PCR product
primer primer size (bp)
r52 ccg gaa tag act aga gag cca cct 120
acc ata cag ca tca gat ttt tc
r52A gac ata ctg cct cca aac cca c 186
cac tct act cca ttc tta tta atc
r52B agt cct ggt ga atg aag aaa gag 109
tga aag tga gc cgg aaa gag ac
r52C aac tac aga g cta ttc ata gtc 309
gtg gca gat gat caa gca gga tt
r52D ggt gca tct tt gca gtg aaa gt 385
tgc ttt tag ttg g gta agc ctc agt
r52E ttc aaa gtc tat tgg aac aag tac 270
cca ttt tcc tga aag tct caa cg
r52F atg tgg gtt cta agt gtg cga ct 385
gga ttc agg tc gta tgt atg agg
r52G tta ccc act aa aaa cca aac c 268
cac aaa ctc ctc aag caa aga aac
r52H aga aat aag acc gga aaa gcg aga 310
tca tta tat agc c gag aga gag ag
r52I ttc tgc att ag gct tcc cca gc 299
gac ttc att ggt tat ggt att att
r52L aag acc tga atttagaggct 205
agc cat ttt tgg ggtatgatgtgc
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3.3 cDNA synthesis 
After successful DNase digestion the samples were reverse transcribed using the kit: 
Superscript II RNase H-® reverse transcriptase. The resulting RNA after DNA digestion was 
added to 1 µl of oligo (dT) primer (15T, 100 µg/µl), 1 µl of dNTP mix (10 mM), the volume 
was filled to 12 µl and heated for 5’ at 65°C, and immediately cooled in ice. After a brief 
centrifugation 4 µl of 5x first-strand buffer, 2 µl DTT (0,1 M), 1 µl of RNaseOUT® was 
added, the tube was mixed gently by pipetting and incubated at 42°C for 2’, the addition of 
1 µl of Superscript II RNase H-® (200 U/µl) followed with gently mixing by pipetting. The 
sample was incubated at 42°C for 50’ followed by heating to 70°C for 15’. The obtained 
cDNA was stored at –20°C. 
 
3.4 PCR reaction  
The PCR was performed using Platinum® Taq DNA polymerase. PCR reactions consisted of a 
first denaturing cycle at 95°C 3’, followed by 50 cycles of 10” at 95°C, 10” at 60°C and 1’ at 
72°C per 1000 bp of amplified region. The PCR conditions are summarized in tab. 3. 
The resulting PCR product was run on agarose gel (1 % w/v) stained by ethidium bromide 
and compared to the DNA 1kb ladder. The gel was visualized by the gel transilluminator Gel 
Printer 2000i. 
 
Tab. 3: PCR condition. 
 
 
 
 
 
3.5 Real time RT-PCR analysis 
The real time RT-PCR was performed with Platinum® Taq DNA polymerase using the 
iCycler® Thermal Cycler with iQ real-time Detection System. All reactions were run in 
triplicates. After vortexing 50 µl aliquots of the mix were pipetted in each well of the 96 wells 
thin-wall PCR plate. PCR reactions consisted of a first denaturing cycle at 95°C 3’, followed 
by 50 cycles of 10” at 95°C, 10” at 60°C and 20” at 72°C. Fluorescence was quantified during 
the 60°C annealing step and product formation was confirmed by melting curve analysis 
(55°C–95°C). The conditions for PCR are summarized in tab. 4. 
 
 
final concentration
MgCl2 50mM 4mM
primer mix (forward and reverse) 10!M 0,1!M
10x PCR buffer 1x
dNTP 10mM 0,1mM
Platinum® Taq DNA  polymerase 5U/!l 0,5U
HPLC H20 to 49!l
PCR reagents 
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Tab. 4: PCR condition for each real time RT-PCR primer. 
 
 
 
 
 
 
 
3.6 Calculation of data 
The relative mRNA amounts of the target genes were calculated after normalization against 
an endogenous reference gene, the house keeping gene 1A, and relative to the negative 
control, with the arithmetic formula 2-ΔΔCT (Winer et al., 1999) and schematized below. 
CT: automatically calculated by the iCycler software. It indicates the PCR cycle thereafter the 
PCR product reach a definitive value detectable from the instrument. 
R: relative expression of the probe compared to the standard (sample treated by the carrier 
substance). The R value is at the exponent because there is a doubling of DNA quantity at 
every cycle. 
Target: target gene studied. 
Standard: reference gene (housekeeping gene) that is independent of the treatment. 
 
R= 2-ΔΔCT =2ΔCT(target)-ΔCT(standard) 
where 
ΔCT target: CT control (target) - CT probe (target) 
ΔCT standard: CT control (standard) - CT probe (standard) 
(Arithmetic formula kindly provided by Georg Kretzschmar, master thesis). 
 
4. Microarray analysis 
4.1 Spotting 
The spotting of the probes (oligonucleotides) on the slide was performed using the robot 
spotter Microcrid II®. Each sample loaded by the pins was pre-spotted on 3 pre-spotting 
slides, performing a single spot for each pre-spotting slide, thereafter it was spotted on the 
target slide by a triple strike (three times spot at the same position). Before to load the pin 
with a new sample it was washed twice in HPLC water bath for 2” and once in a HPLC water 
flow for 0,5” and dried for 2,5” by air flow. 
reagents 
primer pair 1A C3 Clu PCNA CaII IGFBP1 CaBP9k r52 r52E
MgCl2 50mM 4mM 4mM 4mM 4mM 3mM 2mM 4mM 5mM 3mM
primer mix (forward and reverse) 10!M 0,1!M 0,2!M 0,2!M 0,2!M 0,1!M 0,4!M 0,2!M 0,1!M 0,1!M
2x SYBR green in 10x PCR buffer 
dNTP 10mM
Platinum® Taq DNA  polymerase 5U/!l 
Fluorescein calibration dye 400nM
HPLC H20 to 49!l
real time RT-PCR reagents
final concentration of reagents
1x
0,1mM
0,5 U
10nM
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4.1.1 Oligonucleotides 
The oligonucleotides, listed in tab. 5a and 5b, were designed and synthesized by Scenion AG 
(Germany). The oligonucleotides were provided in two different forms: with and without an 
amino (-NH2) modification at the 5´ end of the oligonucleotide. They were stored at –20°C at 
the concentration of 100 pmol/µl (µM). 
 
Tab. 5a: Oligonucleotide sequences. Oligo ID: identification number of the oligonucleotide by the company 
Scenion, gene: gene name, short: abbreviation of the gene name, blast ID gene: identification number of the 
sequence in the NCBI databank, length: length in nucleotides of the oligonucleotides, hyb zone: zone of 
sequence homology between the oligonucleotide and the sequence reported in the databank. 
 
 
 
 
 
 
 
 
 
 
 
Tab. 5b: Oligonucleotides sequences. Hybridization zone: description of the region of homology between the 
oligonucleotide and the sequence reported in the databank, sequence: sequence of the oligonucleotide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.2 Slides 
The oligonucleotides were spotted on epoxy-silane coated slides ArrayLink hyphop®, the 
slides were not pre-treated. 
Oligo ID gene short blast ID gene CDS Length hyb zone
13592132-0-0 Beta-actin ß-act gi:13592132 1-1128 50 941-990
1373280-0-0 Estrgen receptor ß ERß gi:1373280 417-1874 51 2426-2476
14010866-0-0 Heat schock protein 70 kDa HSP70 gi:14010866 178-2103 52 2308-2359
207523-0-0 Clusterin Clu gi:207523 63-1406 51 1384-1434
27718982-0-0 Ki-67 (Proliferation marker) Ki-67 gi:27718982 316-792 50 650-699
3207507-0-0 Hexokinase 1 HK1 gi:3207507 92-2848 52 3590-3641
460557-0-0 Cyclooxigenase-2 COX-2 gi:460557 125-1939 51 3821-3871
56434-0-0 Insulin Growth Factor 1 IGF-1 gi:56434 1-327 53 241-293
56861-0-0 Prolifering cell nuclear antigen PCNA gi:56861 63-848 60 897-956
6978814-0-0 Estrogen receptor alpha ER @ gi:6978814 210-2012 52 2030-2081
8394008-0-0 Cyclophilin Ppia gi:8394008 43-537 50 659-708
9506444-0-0 Carbonic anhydrase 2 CA2 gi:9506444 9-791 52 1150-1201
207644-1-0 Calcium binding protein 9k dalton CaBP9k gi:207644 63-302 58 325-382
34317 Cytochrom-c Oxygenase subunit 1A 1A gi:343182 1418-2962 52 1944-2044
NM_016994 Complement C3 C3 gi:8393023 42-5033 56 1019-1074
204736 Insulin Growth Factor Binding Protein 1 IGFBP1 gi:204736 121-939 53 793-845
PoliA Poli A (54 A) PoliA 54
short note of the hybridization zone Sequence
ß-act in the CDS region AGAAGGAGATTACTGCCCTGGCTCCTAGCACCATGAAGATCAAGATCATT
ERß in the not translated zone GACCCTTGGGTTACATCCTTAGAGCCTGCTTATTTGGTCTGTCTGAATGTG
HSP70 in the not translated zone ATCTAAGTAGCTGTGTAAAAATGGTGTTTCCTTCCTGCGAACACCTCAGCAC
Clu 50% in the CDS, 50% in the not translated region GCAGGAAAAGCCGCATGGAATGAGACAGAAGCATCAGTTTTCTATATGTAG
Ki-67 in the CDS region CTAGAGTCACTTTGGACAATGAACCTAAGCCAAGAGTAACTCGAGGGGCC
HK1 in the not translated zone ATTTCCATCGCCCGAATTCTTTAGTGAGCCATTGTTGTACGTCTAGTAAACT
COX-2 in the not translated zone AAACTGCGTAGAGCCAATATTGACTCACCTACACACGTTATACAGATTGAC
IGF-1 at the 3' extremity region of translated region CACACTGACATGCCCAAGACTCAGAAGGAAGTACACTTGAAGAACACAAGTAG
PCNA in the not translated zone TGCCAGCGTGTTCTGAGGTCTTTTCTGTCACCAAGTTTGTACCTGAGTATTCTTAAATAT
ER a in the not translated zone, not similarity with hER@ ACAAGGTTCTGCGAATCCCTGAAACGTTTTACCCATGTCCTGTATGACTTTA
Ppia in the not translated zone CCATATTTTCCTCATTCCCCTTCAAGTCTAGCAGGATTGCAAAGTTAAGT
CA2 after a short poliA, not in CDS TCCACATCATGAGACAAACTGAGGCAATTTAGGCAAATCAGGTAAAACAGTC
CaBP9k in the not translated zone ACCACCTACTGATTGAATCCTATCCAATCCCAAAGATCTAGCTGTGAGAGCAAGATAC
1A in the CDS region CGT CCT ACT ACT TCT CTC ACT GCC AGT ATT AGC AGC AGG TAT CAC TAT ACT C
C3 in theCDS in zone CTC TGT CAC TGT TAT CCT GCA CTC AGG TAG CGA CAT GGT AGA GGC AGA GCG CAG TG
IGFBP1 in the CDS region TAT CAC AGC AAA CAG TGC GAG ACA TCT CTG GAT GGA GAA GCT GGG CTC TGC TG
PoliA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA
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4.1.3 Spotting buffer 
The oligonucleotides, before spotting, were mixed with equal volume of the different spotting 
buffers and pipetted into a 384 well plate. 
Spotting buffer list (the final concentration is showed): 
GeneScan printing buffer® 1x  
3x SSC/1,5 M Betain 
GeneScan printing buffer® 1 x + 1,5 M Betain 
GeneScan printing buffer® 1 x + 10 % v/v DMSO 
GeneScan printing buffer® 1 x + 100 µg/ml BSA 
GeneScan printing buffer® 1 x + 2 µg/ml Salmon sperm DNA  
 
4.1.4 Coupling reaction 
The coupling reaction (linkage of oligonucleotides on the slides surface) could be performed 
using a warm steam saturated bath or by irradiation with 600-1.000 mJoule of UV light. 
For the warm bath treatment the slides were placed on a support in a plastic box with the 
bottom covered by wet paper towels. The box was closed and incubated in a water bath at 
50°C for 2 h, this resulted in a saturation of steam in the box.  
The UV irradiation was conducted by exposing the slides at 254 nm UV radiation for various 
lengths of time. We used a 4 W 254 nm UV lamp, at a distance of 10 cm from the slides. 
 
4.1.5 Wash of unlinked oligonucleotides from the slides 
The slides, after the spotting and the coupling reaction, were washed twice in a freshly 
prepared solution of 2 x SSC/0,1 % SDS and twice in double distilled water for 5’, shaking at 
room temperature. The slides were then dried by centrifugation and stored in a dark dry box. 
 
4.2 Hybridization 
4.2.1 cDNA synthesis and labeling 
After RNA isolation from cell culture, the RNA was treated with DNase1. 100 µg of RNA 
was digested for 3 h at 37°C in a volume of 100 µl, in the presence of 10x DNase1 buffer, 20 
units of DNase1®(1 U/µl), 800 units RNaseOUT® (40 U/µl). 
1 µl of the resulting RNA after DNA digestion was tested by real time RT-PCR using the 
housekeeping gene primer pair 1A, to check for the presence of remaining genomic DNA in 
the sample; as positive control a reference cDNA solution was used, and HPLC water as 
negative control. The DNA digestion was considered successful when the sample delivered a 
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signal of the amplification similar to the negative control. The samples were stored at –20°C. 
Before the labeling of the samples the RNA contained in the DNase reaction was purified 
through the RNeasy® Mini Kit column. 
Direct labeling 
To reverse transcribe and direct label the samples the Superscript II RNase H-® reverse 
transcriptase kit modified by GeneScan (Germany) was used. Starting with 50 µg of total 
RNA, 5 µl of oligo(dT) (15T, 100 µg/µl) primer solution was added for a resulting total 
volume of 23,5 µl. The sample was heated to 65°C for 10’ and cooled on ice for 5’. 
5 µl of dNTP mix without dTTP (2 mM per nucleotide), 2,5 µl dTTP (2 mM), 3 µl of Cy3-
dUTP or Cy5-dUTP (1 mM), 10 µl 5x first-strand buffer, 5 µl DTT 0,1 M, 1 µl Superscript II 
RNase H-® (200 U/µl) was added. After incubation at 42°C for one hour 1 µl Superscript II 
RNase H-® was added, mixed by pipetting and incubated for one hour at 42°C. 1 µl of 
RNase H (5 U/µl) was then added, mixed by pipetting and incubated at 37°C for 10’. Then 
stored in dark and ice. 
Indirect labeling 
To perform reverse transcription and indirect labeling the Superscript II RNase H-® reverse 
transcriptase kit was used. The protocol was obtained from Yu et al. (2002). 
1st step: 25 µg of purified RNA in 16 µl HPLC water was added to 2 µl oligo(dT) (15T, 
100 µg/µl) primer, incubated at 70°C for 10’ and immediately cooled in ice for 5’, then 
quickly spinned down. To the RNA sample: 6 µl of 5x first strand buffer, 3µl of DTT 0,1M, 
20U of RNase OUT® (40 U/µl), 1,5 µl of Superscript II RNase H-® reverse transcriptase 
(200 U/µl), 0,6 µl of 50x dNTP stock solution (dATP 25 mM, dCTP 25 mM, dGTP 25 mM, 
dTTP 5 mM, aa-dUTP 20 mM from Sigma, USA) was added. The samples were incubated at 
42°C for 1 h, then 1 µl of Superscript II RNase H-® was added and mixed gently by pipetting. 
The incubation mixture was incubated one more hour at 42°C. Followed by addition of 1 µl of 
RNase H (5 U/µl) which was mixed by pipetting and incubated at 37°C for 10’. The resulting 
cDNA solution was adjusted to a volume of 500 µl with HPLC water and pipetted in a 
microcon column YM-30®, centrifuged at 14.000 x g for 12’, the filtrate was discarded, the 
column was washed with 400 µl HPLC water and centrifuged at 14.000 x g for 12’. To 
recover the cDNA 23 µl of HPLC water was added to the microcon column and it was 
transfered upside down in a new tube, centrifugation at 1.000 x g for 2’ followed. The 
resulting volume of cDNA was 20 µl. The cDNA was stored at –20°C.  
2nd step: 1 µl of Na(CO3)2 (pH: 9, 1 M) was added to the cDNA solution up to a final 
concentration of 50 mM. The resulting 21 µl solution of cDNA and sodium carbonate were 
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transferred into the brown Eppendorf tube containing the Cy-NHS ester (the ester of the Cy3 
or Cy5 ready to react with the aminoallyl group of aa-dUTP to form the covalent bound 
between the aa-dUTP incorporated in the cDNA and the Cy-NHS ester) and mixed by 
pipetting, incubated in darkness and at room temperature for 2 h. The quenching reaction 
(block of the spare dyes, after the link of Cy-NHS esters to the aa-dUTP) was performed by 
pipetting 4,5 µl of hydroxylamine (4 M) into the sample, and the reaction mixture was left in 
darkness for 15’ at room temperature. 
 
Independently from the labeling before hybridization the cDNA was cleaned using a 
microcon column YM-30®. The resulting labeled cDNA was adjusted to a volume of 500 µl 
with HPLC water and pipetted into a microcon column YM-30®, centrifuged at 14,000 x g for 
12’, the filtrate was discarded, the column was washed with 400 µl HPLC water and 
centrifuged at 14,000 x g for 12’. 23 µl of HPLC water was added to the microcon column to 
recover the cDNA and it was place upside down in a new tube, centrifugation at 1,000 x g for 
2’ followed, the final volume of cDNA was 20 µl. The cDNA was stored in ice and dark until 
the start of hybridization process. 
 
4.2.2 Hybridization protocol 
We tested four different hybridization protocols from different companies: GeneScan 
(Germany), Genetix (UK), Amersham (USA) and Peqlab (Germany). 
The hybridization protocols are summarized in tab. 6. 
Tab. 6: Hybridization protocol.  
 
 
 
 
 
 
 
 
 
 
 
 
 
protocol pre-treatment hybridization solution pre-heat sample slide wash dry
cDNA 20!l
H20 95,9!l 100°C 1' 1x 2xSSC/0,5%SDS 65°C 5'
GeneScan no 20xSSC 30,8!l ice 5' 1x 0,5xSSC RT 5' stream of N2
2% SDS 7,8 !l 1x 0,1xSSC RT 5'
Arrayblock solution 15,5!l
genHYB 2x 2x 2xSSC/0,1%SDS RT 5'
Genetix no cDNA 45°C 2' 2x 2xSSC RT 5' stream of N2
ratio 1:1
slide:
5xSSC/0,2%SDS/1%BSA 60°C 20'
sample: cDNA-PoliA 7,5!l 1x 1xSSC/0,1%SDS 55°C 5'
Amersham cDNA 94°C 3' Hybridization buffer 4x 7,5!l no 2x 0,1xSSC/0,1%SDS 55°C 10' stream of N2
ice 5' formamide 100% 15!l 1x 0,01xSSC/0,1%SDS 55°C 10'
+1!g  PoliA (54A) per slide
final volume 7,5!l
70°C 45'+ RT 30'
slide:no wash of unlinked 
oligonucleotides after the spot
1x 0,1% Triton-x100 RT 5' Nexterion hyb buffer 1x 2xSSC/0,2%SDS RT 10'
PeqLab 2x HCl 0,0037% RT 2' cDNA no 1x 2xSSC RT 10' stream of N2
1x 100mM KCl RT 10' ratio 2:1 1x 0,2xSSC RT 10'
1x H20 RT 1'
1x Nexterion QMT Blocking solution 50°C 15'
1x H20 RT 1'
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4.2.3 Hybridization of the samples 
The hybridization had to be conducted in a humid hybridization chamber, three different 
chambers were tested. 
Using the Flat block® hybridization chamber the slides were incubated in the cycler 
PTC-200®, the Flat block was filled with 8 ml of water. 
Following the user protocol of the ArrayIt Hybridization Cassette® the slides were placed in 
the cassette with 400 µl H2O and incubated in a water bath at 50°C. 
A third type of hybridization chamber that reaches the saturation of steam was built using a 
plastic box with the bottom covered by wet paper towels, the slides were placed inside on a 
support to avoid contact between the slides and the wet towels. The box was closed and 
incubated in a bath at 50°C to reach a saturation of steam in the box. 
The slides were placed in the hybridization chamber, the area with the spotted 
oligonucleotides on the slides was covered by a lifterslip 18x18 mm, 15 µl of hybridization 
solution was pipetted directly under the lifterslip carefully avoiding the formation of air 
bubbles between the slide and the cover (lifterslip). 
 
4.3 Scan and analysis of the hybridized slides 
The scan of the hybridized slides was performed using the scanner Scanarray_4000® in 
combination with the software ScanArray® 3.1. The resulting images from the scan of the 
slide acquired by the Scanarray_4000® were evaluated using the software Quantarray® 3.0. 
 
4.4 Grubb’s statistical outlier test 
Each sample was spotted in replicates (3-7) and subjected to the test. The significance was set 
to 95 %. The “P” values of significance are reported in tab. 7. A “P” value greater than the 
limiting value reported in the tab. 7, according to the number of values composing the 
analyzed group, did not pass the test. The equation of Grubb’s outlier test (P: limiting value, 
V(max/min): the maximum or minimum value of the group, MW: average value, SD: standard 
deviation). 
 
 
 
Tab. 7: Limiting values of P setting the significance of test to 95% (n: number of values analyzed). 
 
 
 
P=_____________|V(max/min)-MW|
SD
n 95% n 95% n 95%
3 1,153 6 1,822 9 2,109
4 1,436 7 1,938 10 2,177
5 1,671 8 2,031 12 2,287
Material and Methods_____________________________________________________________________ 
 
49 
4.5 Normalization and gene expression analysis 
To normalize the signal stemming from Cy3 and Cy5 which is affected by variable 
incorporation rates and fluorescent signal intensities of the Cy-dyes (Cy5 delivers a higher 
fluorescent signal intensity than Cy3). The value of Cy5 was divided by a factor stemming 
from the average values of the ratio Cy5/Cy3 of the housekeeping genes (ß-Act, 1A, Ppia and 
HK1). This factor was calculated in the following way: each housekeeping gene group of 
values was subjected to the Grubbs test, and then the average for each housekeeping gene and 
the ratio Cy5/Cy3 was calculated. The average value of the Cy5/Cy3 ratio calculated from all 
housekeeping genes was taken as normalization factor. 
After the normalization of all Cy3 values, the relative gene expression of each sample was 
calculated from the ratio between treated and untreated samples labeled by the two different 
Cy-dyes. 
 
5. Sequencing 
5.1 mRNA isolation 
Starting with total RNA extracted from uterus, a DNA digestion was performed (for reagents 
see at 3.2). 100 µg of RNA was treated in a total volume of 300 µl containing: 10x DNase1 
buffer, 15 U of DNase1 (1 U/µl), 600 U RNase OUT (40 U/µl), and incubated at 37°C for 2 h. 
1 µl of the resulting RNA after DNA digestion was tested by real time RT-PCR using the 
housekeeping gene primer pair 1A. As positive control a reference cDNA solution was used, 
and HPLC water served as negative control. The DNA digestion was considered successful 
when the sample delivered an amplification signal similar to the negative control. 
The RNA contained in the DNase reaction was purified through the RNeasy® Mini Kit 
column and eluted in 100 µl. Thereafter the mRNA was isolated using the Nucleo Trap 
mRNA® mini kit, the RNA was eluted in 90 µl, quantified, and stored at –20°C. 
 
5.2 cDNA library screening 
Liver cDNA library of adult Wistar rat created by Bento Soares, with insert of size of 1kb was 
screened (RZPD, Germany). The library consists in 6 primary pool and secondary pool. The 
bank was screened by real time RT-PCR using gene specific primers (r52, 1A, C3) as probe. 
 
5.3 Gene specific reverse transcription 
The gene specific reverse transcription was performed using the kit OneStep RT-PCR®. The 
resulting mRNA after isolation by Nucleo Trap mRNA® was used as template for the reverse 
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transcription. 150 ng mRNA was added to 10 µl of 5x Qiagen OneStep RT-PCR Buffer®, 2 µl 
dNTP (10 mM), 5 µl specific primer for reverse transcriptase (6 µM) reported in tab. 8, 2 µl 
Qiagen OneStep enzyme®, 40U RNase OUT®(40 U/µl), in a total volume of 50 µl, incubated 
at 50°C for 30’. Sample was stored at –20°C. 
 
Tab. 8: Sequence of the primer for the gene specific reverse transcription 
Primer name Sequence Annealing temperature 
cDNA1 aga gcc acc ttc aga tt 50°C 
 
5.4 Sanger method with labeled primer 
For the sequencing reaction the Sanger method with labeled primer was used (Sanger et al., 
1977). The primer should have a length of 15-20 bp, an annealing temperature of 55-60°C and 
a label of IRD800, fluorescent marker, at the 5’ end. The primers are listed in tab. 9.  
 
Tab. 9: Sequence primer, modified at the 5’end by IRD800 used for the sequence reaction. 
Primer name Sequence 
r52seq1 ggg gca aag cag tca tc 
r52seq2 gcc aac ata gaa tcc tgt cc 
r52seq3 gtg ccc ttt cgc tta gg 
 
The sequencing reaction was conducted by Andreas Blecha in the institute for Genetics of 
Prof. Dr. Gerhard Rödel at the Technische Universitaet Dresden. 
 
5.5 In silico studies of the fragment r52 
The resulting sequences of r52 were compared and analyzed using the software “Blast” (basic 
local alignment and search tool) (Altschul et al., 1992), “blast2sequences” and “Rat genome 
project” present at the web site of National Center of Biotechnology Information 
(http://ncbi.nlm.nih.gov). To search for ORFs (open reading frames) in the sequenced region 
of r52 I used the software “ORF finder” present at the web site of National Center of 
Biotechnology Information (http://ncbi.nlm.nih.gov). To study the promoter region of the r52 
sequence the following software were used: “promoter finder”, “promoter 2.0 prediction 
server”, “GC Promoter Finder” and “Eukaryotic Promoter Database” from the web site 
http://www.bioinformatics.vg/biolinks/bioinformatics/Promoter%2520Scan.shtml,  
“match Public” from http://www.gene-regulation.com. The software “Mfold” 
(Zuker M., 2003) was used for the prediction of RNA secondary structure. 
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This chapter is subdivided into three main categories: results of the gene expression analysis 
using real time RT-PCR, the establishment of the microarray technology in the laboratory and 
its first application to verify the reliability of the method, and the study of a newly identified 
sequence that presents an interesting gene expression profile in the uterus. 
The effects of estrogens and xenoestrogens on gene expression were always correlated with 
the control treatment (carrier of the substance) set to one. A change larger than twice the gene 
expression of the control was considered to be stimulation, a reduction to less than 50% of 
control level was repression. 
Significance of all data obtained using the real time RT-PCR was determined by the Student’s 
t-test (* p < 0,05). Expression analysis performed on the micro array was performed just once, 
which does not allow for statistical analysis. 
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1. Gene expression analysis using the real time RT-PCR 
 
1.1 Gene expression analysis in uterus models 
1.1.1 Results of the vitro experiments in the RUCA-I cell line 
The cell culture, cell treatment and RNA extraction was performed in the Institute for 
Molecular Medicine at the University of Lübeck (Germany) in the group of Prof. Dr. Günter 
Vollmer. The method of cell culture was already published (Hopert et al., 1998; Tüshaus et 
al., 2003). Reverse transcription and analysis of gene expression was performed in our 
laboratory; every result comes from the average of at least two independent cDNA synthesis 
and two independent real time RT-PCR analyses per cDNA synthesis, delivering a mean 
value deriving from at least four independent values. 
The cells were cultured on a layer of reconstituted basement membrane (ECM), Collagen I 
(COL1) and without any coating of the plate floor (plastic). The genes C3, CLU, PCNA and 
CAII were studied. 
The effects of E2 treatment on the regulation of C3 are reported in fig. 1. There was a 
detectable effect only in culture on ECM (fig. 1a), the presence of some substances with 
estrogenic activity in the cell medium was detected by down regulation in response to the pure 
antagonist ICI 182,780 (ICI) that resulted in a reduction of C3 expression level. No effect was 
detectable by any substances culturing the cell on the plastic floor of the cultural plate 
(fig. 1b) or on the floor coated by a layer of COL1 (fig. 1c). 
 
 
 
 
 
 
Fig. 1a      Fig. 1b 
 
 
 
 
 
Fig. 1c 
Fig. 1: Gene expression analysis by real time RT-PCR, correlated to control (set to one) of C3 expression after 
24 h of treatment, in RUCA-I cell (rat uterus cancer cell line). ECM: cell culture plate coated by reconstituted 
basement membrane, Plastic: cell culture plate not coated, COL1: cell culture plate coated by Collagen 1. Cells 
were treated by EtOH (Contr), E2 and ICI. Significance: Student’s t-test *: p<0,05. 
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The effects of E2 treatment on the regulation of CLU are reported in fig. 2. A stimulation of 
expression was visible only in culture on a layer of ECM (fig. 2a). 
 
 
 
 
 
 
Fig. 2a      Fig. 2b 
 
 
 
 
 
Fig. 2c 
 
Fig. 2: Gene expression analysis by real time RT-PCR, correlated to control (set to one) of Clu after 24h 
treatment, in RUCA-I (rat uterus cancer cell line). ECM: cell culture plate coated by extra cellular matrix, 
Plastic: cell culture plate no coated, COL1: cell culture plate coated by Collagen 1. Cells were treated by EtOH 
(Contr), E2 and ICI. Significance: Student’s t-test *: p<0,05. 
 
The expression of PCNA was also studied, but it was not affected by any of the treatments 
and appeared to be independent of cell culture substrate (data not shown). 
The gene expression of CAII in RUCA-I using the real time RT-PCR could not be verified. 
This might be due to a low level of CAII expression in RUCA-I that could not be detected 
using this method. 
 
 
1.1.2 Results of the in vivo experiments in rat uterus 
After the in vitro tests, the focus was moved to a more complex level, an entire organism. The 
animal experiments from which the material analyzed and reported in fig. 3, 4, 5, 6, 7, 8, 9 
and 10 were performed by our collaborator Dr. Patrick Diel in the department of Molecular 
and Cellular Sport Medicine, DSHS, in Köln (Germany), as reported in Materials and 
methods 2.2. 
In our laboratory RNA was extracted from tissue (Materials and methods 2.3.1), pooled 
according to the treatment, with at least 6 animals per treatment, and reverse transcribed to 
cDNA (Materials and method, 3.2 and 3.3). 
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Each result derives from the mean value of at least three independent cDNA syntheses and 
two independent real time RT-PCR analyses per cDNA synthesis, delivering a mean value 
calculated from at least from six independent experiments. 
The animal experiments, from which the material for the analyses reported in fig. 11 were 
derived, were performed in our laboratory under the supervision of Dr. Oliver Zierau.  
In fig. 3 the effects of E2 and EE on C3 gene expression in ovariectomised rat for 7, 24 and 
72 h are shown, both substances induced a time dependent up regulation of C3 gene 
expression. 
 
 
 
 
 
 
 
 
Fig. 3: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in rat uterus of C3 in a 
time dependent manner (7-24-72h) by a treatment (s.c. injection) of EtOH (Contr), E2 (3µg/kg/day) and EE 
(3µg/kg/day). Significance: Student’s t-test *: p<0,05. 
 
In fig. 4 the effects of isoflavones on C3 expression are shown whereas Gen was measured in 
a time dependent manner (7, 24, 72 h) with Dai at the time point of 72 h. Only the treatment 
by Gen for 24 h triggered a significant increase of the relative gene expression to 5 times that 
of the control, no significant effect was detectable by Gen at all other time points of treatment 
and following administration of Dai. 
 
 
 
 
 
 
 
 
 
Fig. 4: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in rat uterus of C3 in a 
time dependent manner (7-24-72h) by a treatment (s.c. injection) of EtOH (Contr), Gen (10mg/kg/day) and Dai 
20mg/kg/day. Significance:  Student’s t-test *: p<0,05. 
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In fig. 5 the effect of 8PN administration for 72 h on C3 expression is shown. The 8PN 
mimicked the activity of the positive control E2 (at a 1000 higher concentration dose) with 
roughly half the increase of C3 gene expression reached by E2. 
 
 
 
 
 
 
 
 
 
Fig. 5: Gene expression analysis, through real time RT-PCR, correlated to control (set to one), in rat uterus of C3 
after 72h treatment (s.c. injection) by EtOH (Contr), E2 (30µg/kg/day) and 8PN (10mg/kg/day). Significance: 
Student’s t-test *: p<0,05. 
 
 
The same material was used to analyze the gene expression of PCNA and CAII. The effects of 
E2, EE, and Gen for 7, 24 and 72 h and Dai for 72 h, on PCNA gene expression are shown in 
fig. 6. The treatment with E2 and EE induced an up regulation of the relative gene expression 
of PCNA to more than 200 % compared to the control level after 7 and 24 h but this was 
shown to not be statistically significant. The administration by Gen and Dai did not have any 
remarkable effect. 
 
 
 
 
 
 
 
 
 
Fig. 6: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in rat uterus of PCNA 
in a time dependent manner (7-24-72 h) by treatment (s.c. injection) of EtOH (Contr), E2 (3µg/kg/day), EE 
(3µg/kg/day), Gen (10mg/kg/day), Dai (20mg/kg/day). Significance: Student’s t-test *: p<0,05. 
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In fig. 7 the effects of 8PN and E2 following a 72 h treatment on PCNA expression were 
compared. E2 triggered an increase of the relative gene expression of PCNA to more than 
double that of control which was mimicked in part by 8PN. For both samples no significance 
was found. 
 
 
 
 
 
 
 
 
Fig. 7: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in rat uterus of PCNA 
after 72 h of treatment (s.c. injection) by EtOH (Contr), E2 (30µg/kg/day) and 8PN (10mg/kg/day). Significance: 
Student’s t-test *: p<0,05. 
 
 
The effects of E2, EE and isoflavones on CAII expression are shown in fig. 8. Estrogen and 
EE induced a down regulation of CAII gene expression which became more pronounced 
according to the progression of time (7, 24 and 72 h). Gen triggered a down regulation 
reaching roughly 50 % of control expression, with a significant effect after 7 and 24 h of 
treatment. Dai after 72 h did not show any particular activity. 
 
 
 
 
 
 
 
 
 
 
Fig. 8: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in rat uterus of CAII in 
a time dependent manner (7-24-72h) by treatment (s.c. injection) of EtOH (Contr), E2 (3µg/kg/day), EE 
(3µg/kg/day), Gen (10mg/kg/day), Dai (20mg/kg/day). Significance: Student’s t-test *: p<0,05. 
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Treatment by 8PN for 72 h did not show any influence on CAII expression (fig. 9). 
 
 
 
 
 
 
 
 
 
Fig. 9: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in rat uterus of CAII 
after 72h of treatment (s.c. injection) by EtOH (Contr), E2 (30µg/kg/day) and 8PN (10mg/kg/day). Significance: 
Student’s t-test *: p<0,05. 
 
 
 
In another animal experiment the effects of E2 and Dai for 7 and 24 h, and Gen for 24 h, in rat 
uterus were studied only for C3 expression and are shown in fig. 10. E2 induced a strong up 
regulation of C3 gene expression with an increase from 7 h to 24 h, to seven and thirty times 
respectively in comparison to the control level. After 24 h only Gen induced a significant up 
regulation of C3 at the level reached by E2 after 7 h of treatment. Treatment with Dai did not 
lead to any remarkable change. 
 
 
 
 
 
 
 
 
 
 
Fig. 10: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in rat uterus of C3 in a 
time dependent manner (7-24h) by treatment (s.c. injection) of EtOH (Contr), E2 (4µg/kg/day), Gen 
(10mg/kg/day) and Dai (40mg/kg/day). Significance: Student’s t-test *: p<0,05. 
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The animal experiments performed in our laboratory are reported in fig. 11. C3 gene 
expression was analyzed. The effects of E2 and the two flavones 8PN and 6DMAN are 
presented in fig. 11a and b, for 7 and 24 h of treatment respectively. After the first 7 h E2 and 
the two flavones induced a similar up regulation, reaching to the doubling of the relative gene 
expression of C3. After 24 h E2 showed a stronger effect in comparison to 6DMAN and 8PN, 
which reached a significant up regulation to 43 and 16 times of relative gene expression 
respectively at a dose that is 1000 higher the positive control E2. 
 
 
 
 
 
 
Fig.11a               Fig.11b 
 
Fig. 11: Gene expression analysis, through real time RT-PCR, correlated to control (set to one), in rat uterus of 
C3 in a time dependent manner (7-24h) by treatment (s.c. injection) of EtOH (Contr), E2 (10µg/kg/day), 
6DMAN and 8PN (both 15mg/kg/day). Significance: Student’s t-test *: p<0,05. 
 
 
1.2 Gene expression analysis in liver models 
 
1.2.1 Results of in vitro experiments in the Fe33 cell line 
The genes IGFBP1, CaBP9k, PCNA and CAII were studied in the Fe33 cell culture model, 
they were cultured and treated as reported in the “Material and methods 2.1”. 
A single cell culture experiment was performed per treatment. Each result comes from the 
average of at least three independent cDNA syntheses and two independent real time RT-PCR 
analyses per cDNA synthesis, delivering a mean value deriving from at least six independent 
values. 
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The effect of E2 and the phytoestrogens Gen, Dai and 8PN for 7 and 24 h treatment on 
IGFBP1, CABP9k and CAII gene expression are shown in fig. 12a, 12b and 12c respectively. 
In each of them, a clear up regulation of their expression is seen in the case of E2 treatment, 
which is the positive control.  
The phytoestrogens Gen and 8PN mimics the effects of the positive control after 7 h of 
treatment. The other genes show no significant effects after treatment with the three 
phytoestrogens. 
 
 
 
 
 
 
 
Fig. 12a        Fig. 12b 
 
 
 
 
 
Fig.12c 
Fig. 12: Gene expression analysis of IGFBP1 (12a) CaBP9k (12b) and CAII (12c) using real time RT-PCR, in 
rat hepatoma cell line Fe33. Cells were treated with EtOH (Contr), 10-8M E2, 10-6M Gen, Dai and 8PN for 7 and 
24 h. Significance was determined by Student’s t-test (* p < 0,05). 
 
 
 
The effect of the treatment by EE in Fe33 in a dilution series from 10-9M to 10-6M and in a 
time course of 1, 3, 7 and 24 h on the expression of IGFBP1, CaBP9k, PCNA and CAII, is 
shown in fig. 13, 14, 15 and 16 respectively. 
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61 
Fig.13 shows a clear up regulation of IGFBP1 gene expression after the treatment with E2 and 
EE. The potency of EE was always comparable or even stronger than the positive control. 
 
 
 
 
 
 
 
 
 
Fig. 13a                Fig. 13b 
 
 
 
 
 
 
 
 
 
Fig. 13c                Fig. 13d 
 
Fig. 13: Gene expression analysis of IGFBP1 using real time RT-PCR, in the rat hepatoma cell line Fe33. Cells 
were treated with EtOH (Contr), 10-8M E2 and EE in a dose dependent manner for 1 (a), 3 (b), 7 (c), and 24 h 
(d). Significance was determined by Student’s t-test (* p < 0,05). 
 
In fig. 14 the effect of treatment by EE on the expression of CaBP9k is shown. In all figures a 
clear up regulation of CaBP9k gene expression is detectable. The effect of EE was always 
comparable to that of E2, and was sometime greater. The substances triggered a time and dose 
dependant up regulation of CaBP9k expression. 
 
 
 
 
 
 
 
 
 
Fig. 14a                Fig. 14b 
 
 
 
 
 
 
 
 
 
Fig. 14c                Fig. 14d 
 
Fig. 14: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in Fe33 (rat hepatic 
cell line) of CaBP9k. Cells were treated with EtOH (Contr), E2 and EE in a dose dependent manner for 1 (a), 3 
(b), 7 (c), and 24h (d).Significance Student’s t-test *: p<0,05. 
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62 
Fig. 15 shows the effects of EE treatment on PCNA gene expression in the cell line Fe33. The 
stronger effect of PCNA stimulation was detectable after 1 h (Fig. 15a) by EE 10-8M. The 
effect on stimulation of PCNA declined according to later time points, until to a tendency of 
down regulation after 24 h of treatment for the doses of 10-8, 10-7 and 10-6M (fig. 15d). E2 and 
EE present always comparable results. 
 
 
 
 
 
 
 
 
 
 
Fig. 15a                Fig. 15b 
 
 
 
 
 
 
 
 
 
 
Fig. 15c                Fig. 15d 
 
Fig. 15: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in Fe33 (rat hepatic 
cell line) of PCNA. Cells were treated with EtOH (Contr), E2 and EE in a dose dependent manner for 1(a), 3(b), 
7(c), and 24 h(d).Significance: Student’s t-test *: p<0,05. 
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Fig. 16 shows the effects of administration of EE for 1, 3, 7 and 24 h, at different doses, to the 
Fe33 cell line on the expression of CAII. A clear time and dose dependent effect was 
detected. The most prominent effect on the up regulation of gene expression was seen after 
7 h of treatment by a dose EE 10-6M (fig. 16c). The effects of EE were always comparable to 
those of the positive control, E2 10-8M. 
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Fig. 16: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in Fe33 (rat hepatic 
cell line) of CAII. Cells were treated with EtOH (Contr), E2 and EE in a dose dependent manner for 1(a), 3(b), 
7(c), and 24 h(d).Significance: Student’s t-test *: p<0,05. 
 
 
 
The effects of treatment with NP in Fe33 in a dilution series from 10-8M to 10-5M and in a 
time course of 1, 3, 7 and 24 h on the expression of IGFBP1, CaBP9k, PCNA and CAII, is 
shown in fig. 17, 18, 19 and 20 respectively. 
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Fig. 17a shows that treatment with NP for 1 h induces an up regulation of IGFBP1 gene 
expression only at a dose of 10-6M. After 3 and 7 h (fig. 17b and 17c) E2 and NP 10-5M the 
relative gene expression level of IGFBP1 doubled. 
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Fig. 17c                Fig. 17d 
 
Fig. 17: Gene expression analysis of IGFBP1 using real time RT-PCR, in the rat hepatoma cell line Fe33. Cells 
were treated with EtOH (Contr), 10-8M E2 and NP in a dose dependent manner for 1 (a), 3 (b), 7 (c), and 24 h 
(d). Significance was determined by Student’s t-test (* p < 0,05). 
 
Gene expression of CaBP9k was only slightly influenced by treatment with NP (fig. 18). It 
was shown to only have stimulation statistically significant by NP treatment with a dose of 
10-7M after 24h of exposure (fig. 18d).  
 
 
 
 
 
 
 
 
 
Fig. 18a                Fig. 18b 
 
 
 
 
 
 
 
 
 
 
Fig. 18c                Fig. 18d 
 
Fig. 18: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in Fe33 (rat hepatic 
cell line) of CaBP9k. Cells were treated with EtOH (Contr), E2 and NP in a dose dependent manner for 1(a), 
3(b), 7(c), and 24 h (d). Significance: Student’s t-test *: p<0,05. 
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Fig. 19 shows the effects of NP administration on the expression of PCNA in the cell line 
Fe33. The only effect on gene regulation induced by NP appeared after 3 and 24 h (fig. 19b 
and 19d). For the earlier time point treatment with a dose of 10-5 and 10-7M induced a 
doubling of gene expression that was significant according to the Student’s t-test, and 
comparable to the positive control E2. After 24 h only the doses of 10-7 and 10-8M lead to an 
increase in gene expression that was also statistically significant, as with treatment with E2.  
 
 
 
 
 
 
 
 
 
 
Fig. 19a                Fig. 19b 
 
 
 
 
 
 
 
 
 
 
Fig. 19c                Fig. 19d 
 
Fig. 19: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in Fe33 (rat hepatic 
cell line) of PCNA. Cells were treated was EtOH (Contr), E2 and NP in a dose dependent manner for 1(a), 3(b), 
7(c), and 24 h (d). Significance: Student’s t-test *: p<0,05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
PCNA 3h
0
0.5
1
1.5
2
2.5
3
3.5
Contr E2 10-8M NP 10-8M NP 10-7M NP 10-6M NP 10-5M
R
el
at
iv
e 
ge
ne
 e
xp
re
ss
io
n *
*
**
*
PCNA 7h
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
Contr E2 10-8M NP 10-8M NP 10-7M NP 10-6M NP 10-5M
R
el
at
iv
e 
ge
ne
 e
xp
re
ss
io
n
*
PCNA 24h
0
0.5
1
1.5
2
2.5
3
Contr E2 10-8M NP 10-8M NP 10-7M NP 10-6M NP 10-5M
R
el
at
iv
e 
ge
ne
 e
xp
re
ss
io
n
**
*
PCNA 1h
0
0.5
1
1.5
2
2.5
3
Contr E2 10-8M NP 10-8M NP 10-7M NP 10-6M NP 10-5M
R
el
at
iv
e 
ge
ne
 e
xp
re
ss
io
n
Results_________________________________________________________________________________ 
 
66 
Treatment with NP in Fe33 resulted in a slight general stimulation of CAII gene expression 
(fig. 20). The only clear stimulation of CAII expression was obtained after 3 h of treatment at 
the highest concentration (fig. 20b), which is statistical and biological significant, with the 
doubling of relative gene expression and is perfectly comparable to the positive control, E2. 
For the other time points no remarkable changes were detected. 
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Fig. 20: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in Fe33 (rat hepatic 
cell line) of CAII. Cells were treated with EtOH (Contr), E2 and NP in a dose dependent manner for 1(a), 3(b), 
7(c), and 24 h (d). Significance: Student’s t-test *: p<0,05 
 
 
 
1.1.2 Results of in vivo experiments in rat liver 
After these preliminary in vitro tests on the substances, attention was moved to a more 
complex level, the situation in an intact organism. The logical evolution of the level 
complexity starting from a rat hepatic cell line was the in vivo analysis with the investigation 
of effects on the rat liver. 
The RNA material analyzed in fig. 21, 22, 23, 24 and 25 is the same as already described for 
the uterus analysis in point 1.1.2 of this chapter (fig. 3-9). 
The gene expression of IGFBP1, PCNA and CAII was studied. 
The conditions for the analysis of IGFBP1 gene expression were established in our laboratory 
by Renate Geis (Geis et al., 2005). 
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The effects of E2 and EE, and the isoflavones, Gen and Dai, on IGFBP1 gene expression are 
shown in fig. 21. E2, EE and Dai showed stimulation of IGFBP1 expression after 72 h of 
treatment. EE and Gen stimulated the expression of IGFBP1 after 7 h of treatment. Only Gen 
produced a change in the gene expression level which showed a statistical significance after 
72 h of treatment with a reduction of the IGFBP1 expression to approximately 40 % of the 
control level. 
 
 
 
 
 
 
 
 
 
 
Fig. 21: Gene expression analysis of IGFBP1 using real time RT-PCR, in liver of ovx rats. Animals were treated  
in a time dependent manner (7, 24 and 72 h) by s.c. injection of EtOH (Contr), E2 and EE (3µg/kg/day), Gen 
(10mg/kg/day) and Dai (20mg/kg/day). Significance was determined by Student’s t-test (* p < 0,05). 
 
 
 
E2 and 8PN in a 72 h treatment protocol induced a stimulation of the IGFBP1 expression to 
roughly 200 % (fig. 22), but only treatment by E2 was statistical significant. 
 
 
 
 
 
 
 
 
Fig. 22: Gene expression analysis of IGFBP1 using real time RT-PCR, in liver of ovx rats. Animals were treated 
for 72 h by s.c. injection of EtOH (Contr), E2 (30µg/kg/day) and 8PN (10mg/kg/day). Significance was 
determined by Student’s t-test (* p < 0,05). 
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Fig. 23 shows the effects of E2, the xenoestrogen, EE, and the isoflavones Gen and Dai on the 
gene expression of PCNA. After 72 h E2 induced a slight repression of the gene expression to 
60 % of the control level, delivering a significant value according the Student’s t-test. For the 
other treatment protocols no regulation could be shown. 
 
 
 
 
 
 
 
 
 
Fig. 23: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in rat liver of PCNA in 
a time dependent manner (7-24-72h) by treatment (s.c. injection) of EtOH (Contr), E2 (3µg/kg/day), EE 
(3µg/kg/day), Gen (10mg/kg/day), Dai (20mg/kg/day). Significance: Student’s t-test *: p<0,05. 
 
The expression of PCNA in liver was not affected by neither E2 or 8PN after 72 h (data not 
reported). 
In fig. 24 the gene expression analysis of CAII is shown. E2 and EE triggered, after 72 h, a 
significant change in CAII expression decreasing it to 50 % of the control level. Gen showed 
a similar effect after 7 h of treatment, with the same statistical significance. No alteration to 
gene expression was seen with Dai or the other treatment conditions. 
 
 
 
 
 
 
 
 
Fig. 24: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in rat liver of CAII in 
a time dependent manner (7-24-72 h) by treatment (s.c. injection) of EtOH (Contr), E2 (3µg/kg/day), EE 
(3µg/kg/day), Gen (10mg/kg/day), Dai (20mg/kg/day). Significance: Student’s t-test *: p<0,05 
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In fig. 25 the effects of E2 and 8PN on CAII expression after 72 h of treatment are shown. For 
both treatments a slight reduction of gene expression became apparent, E2 reached 60 % and 
8PN reached about 80 % of the control level. 
 
 
 
 
 
 
 
 
Fig. 25: Gene expression analysis by real time RT-PCR, correlated to control (set to one), in rat liver of CAII 
after 72h of treatment (s.c. injection) with EtOH (Contr), E2 (30µg/kg/day) and 8PN (10mg/kg/day). 
Significance: Student’s t-test *: p<0,05. 
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2. Establishment of the microarray technology 
One task of my thesis was the establishment of the microarray technology in our laboratory. 
The microarray is a complex process which presents many opportunities of choice for every 
step, as already reported in the “Introduction” at the point 5.1.1. 
All the steps that present different options and that were performed in this thesis are reported 
in table 1. 
The results of the most important experiments are reported and briefly illustrated. 
 
Tab.1: Summary of the optimization of the microarray technology.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1 Spotting 
2.1.1 Oligonucleotide modification 
The oligonucleotide modification was suggested using epoxy silane coated slides, to improve 
the binding of the oligonucleotides to the surface of the slides improving their stability during 
the many washes to which the slides are exposed. 
In our case the amino modified oligonucleotides always gave a higher signal compared to the 
not amino modified oligonucleotides, not influencing the background signal. 
Step Different possibility Result Reason Illustrated at point
Process: chip production 2.1
probe disposition spot/print spot presence of the spotter
kinds of probes oligonucleotides/PCR product oligonucleotide stability, time saving, practical hadling
kind of matrix glass slide/membrane glass slide best support, currently the only one used
epoxy silane Call et al., 2003;
slide coat Poly-L-lysisn epoxy silane best fit with oligonucleotides Warsen et al., 2004
amino silane
oligonucleotide no modification/ modification more stability of oligonucleotides 2.1.1
modification NH2 group at 5' end throught the washes
spot buffer home made/ GeneScan best fit with the slides 2.1.2
GeneScan/ PeqLab best signal  Fig. 26-27
spot concentration same/different amount different every gene presents a different 2.1.3
of oligonucleotide sample specific expression level Fig.28
link of oligo on slide warm wet chamber/ warm wet best reproducibility across all samples 2.1.4
U.V. cross link chamber Cy5/Cy3 ratio close to one Fig.29
Process: hybridization 2.2
RNA isolation total RNA/mRNA total RNA cheaper/ no difference
hybridization buffer suppliers: GeneScan (bankrupt) PeqLab PeqLab 2.2.1
Genetix/ Amersham/ PeqLab  producer best result fig.30-31
prehybridization wash protocol of the supplier prewash best result, to test because of different 2.2.2
of hybridization buffer /no prewash source of slide and hybridization buffer fig.32
amount of different amount reverse 12,5ng best compromise between 2.2.3
hybridization sample transcribed RNA starting RNA background/sample signal fig.33
target labeling fluorescence direct/indirect fluorescence no possibility to use radioactivity 2.2.4
radioactivity direct _ direct, better result fig.34
Cy3/Cy5 ratio in balanced/unbalanced 3:1 Cy3:Cy5 best result of signal intensity of samples 2.2.5
 labeling of sample amount of Cy dye cheaper fig.35
hybridizatio chamber 3 mosted chambers: Flat Block best handling, 2.2.6
Flat Block/ Array IT/ self made reproducibility and quality of results fig.36
hybridization time  time courses: 2-24h 20h best result signal intensity of sample
and temperature  tempeatures: 37-60°C  45°C compared to background
Process: end flow analysis 2.3
normalization of the signal average of all spot/ external control/ house keeping best suitable solution for a
house keeping genes genes  little array (less than 1000 spot)
quantitation of the signal Fixed circle/ Histogram/ Fixed circle best fit with a self spotted chip array 2.3
 through the software Adaptative fig.38
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2.1.2 Spotting buffer 
The optimization of the spot buffer was a key issue for the establishment of the microarray 
technology, the quality the shape of the spot and the distribution of the oligonucleotides 
within the spot mark is dependent on this optimization. The viscosity of the DNA solution 
plays a central role during the spotting of the probes, and, for this reason different spot buffers 
were tested. 
The effects of two different spotting buffers on the spot signal distribution are presented in 
fig. 26. The buffers were provided by the companies GeneScan and PeqLab. The first 
difference that was apparent from the comparison of these buffers was the magnitude of the 
signal, the GeneScan spotting buffer, on the left, gave a lower signal (the scale of the signal 
intensity was: blue, green, yellow and red, the saturation of the signal is indicated by the 
white) and the PeqLab spotting buffer was better distributed in all surfaces of the spot trace, 
on the right, gave a higher signal which were more concentrated in the middle of the spot. A 
preferential spot mark was considered the better distributed signal from GeneScan. 
 
 
Fig. 26: The results of a scan of a slide of microarray spotted using two different spotting buffers are presented. 
The spotting was performed using two different spotting buffers, GeneScan on the left and PeQLab on the right, 
with the same pattern of oligonucleotides. 
 
To optimize the distribution of the signal in the spot trace, the oligonucleotides corresponding 
to the gene 1A were spotted with different spotting buffers and different additions of 
substances to the GeneScan spotting buffer. 
The results of this test are shown in fig. 27. The signal from the spot with GeneScan spotting 
buffer provided the second higher signal, which was also well distributed in the spot trace. 
The spotting buffer from GeneScan with the addition of betaine 1,5 M or DMSO 10 % (v/v) 
or 3X SSC/1.5 M betaine, gave undesirable results in all three cases, with a spot signal that 
was too concentrated in the center of the spot mark. The GeneScan spotting buffer containing 
additionally BSA (100 µg/ml) or salmon sperm DNA (2 µg/ml) provided superior results. 
Following BSA addition the spot was well distributed within the spot mark, unfortunately it 
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was possible to identify a signal also from the relative negative control the same buffer 
spotted without nucleotide. The signal that came from this negative control could be produced 
by linking of the labeled samples to the BSA protein or by the fluorescence of the protein 
itself. For gene expression analysis the negative control of GeneScan spotting buffer used 
with the addition of BSA (100µg/ml) was subtracted from the signal of oligonucleotides 
spotted with the same spotting buffer. 
The results using salmon sperm DNA added to GeneScan spotting buffer delivered a signal 
that was higher than from the GeneScan spotting buffer alone, however in this case the 
negative control also exhibited a strong signal (data not shown) and for this reason, it was 
abandoned. 
 
Fig. 27: Effects of different spotting buffers and compounds added to the GeneScan spotting buffer. Laser Power 
and PMT gain set to 100%. The distribution of the spotted samples was reported in table 2. 
 
 
Tab. 2: Distribution of the spotted samples on the slide: 10 columns and 9 rows. The oligonucleotides are 
reported with the spot concentration and the spotting buffer used. Negative controls: GeneScan spotting buffer + 
one volume of HPLC water (GS), GeneScan spotting buffer supplemented with 100µg/ml of BSA + one volume 
of HPLC water (GS BSA), PoliA 0,1µM was spotted with GeneScan spotting buffer. The oligonucleotide 1A 
was spotted 5 times on one row. 
 
 
 
 
 
 
 
 
 
 
1 2 3 4 5 6 7 8 9 10
1 PoliA 0,1!M GS BSA PoliA 0,1!M GS BSA GS BSA GS BSA GS BSA PoliA 0,1!M PoliA 0,1!M PoliA 0,1!M
2
3
4
5
6
7
8 GS GS GS GS GS GS GS GS GS GS
9 PoliA 0,1!M GS BSA PoliA 0,1!M GS BSA GS BSA GS BSA GS BSA PoliA 0,1!M PoliA 0,1!M PoliA 0,1!M
1A 1!M GS spotting buffe+ BSA 100!g/ml1A 2!M in GS spotting buffe+ BSA 100!g/ml
1A 2!M in GS spotting buffer+ Salmon sperm DNA 2!g/ml 1A 1!M GS spotting buffer+ Salmon sperm DNA 2!g/ml
1A 2!M in GS spotting buffer+Betaine 1,5M 1A 1!M GS spotting buffer+Betaine 1,5M
1A 2!M in GS spotting buffer+DMSO 10% 1A 1!M GS spotting buffer+DMSO 10%
1A 2!M in GeneScan spotting buffer 1A 1!M GeneScan spotting buffer
1A 2!M in 3XSSC/1,5M Betaine 1A 1!M 3XSSC/1,5M Betaine
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2.1.3 Oligonucleotides spot concentration 
The oligonucleotide spot concentration was optimized for every gene. This allows for the 
acquisition of the slides with the higher intensity of Laser Power and PMT (photon multiplier 
tube) gain, allowing for detection of signals from low expressed targets, without reaching 
saturation in the case of highly expressed genes. 
In fig. 28 the optimization of the 16 target genes was shown. In tab. 3 the optimized spotting 
concentration of the target oligonucleotides are summarized. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28: Influence of quantity of spotted oligonucleotides on the signal intensity. Oligonucleotides reported: ERß, 
HSP70, Clu, Ki-67, HK1, Cox2, IGF1, PCNA, Era, CA2, IGFBP1, C3, CaBP9k, ß-act, Ppia, 1A. Signal 
intensity after signal background subtraction is shown on the Y axis, concentration of spot oligonucleotides (µM) 
is reported on the X axis. Labeling of the cDNA samples: dUTPCy3 and dUTPCy5. 
 
Tab. 3: Determined spot concentrations of the target oligonucleotides. 
Target oligonucleotide Spot concentration Target oligonucleotide Spot concentration
ERß 15!M ER! 15!M
HSP70 15!M CA2 10!M
Clu 10!M CaBP9k 15!M
Ki-67 10!M C3 5!M
HK1 15!M IGFBP-1 10!M
Cox2 20!M ß-act 1!M
IGF-1 20!M Ppia 1!M
PCNA 10!M 1A 1!M  
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2.1.4 Coupling (linkage) of the oligonucleotides on slide surfaces after the spotting 
The effectiveness of the coupling reaction was crucial for the establishment of the microarray 
technology because of the many washing steps to which the slides are exposed. Two different 
methods were tested: coupling by UV irradiation for different length of time, and coupling in 
a humid, steam saturated warm box. 
Across the slides coupled by different protocols the warm steam saturated box produced the 
superior result (Fig. 29). The lower right image, coupled by warm bath, presents the higher 
signal from the spots indicating a higher quantity of oligonucleotides present on the slide. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 29: Comparison of different coupling treatment. The oligonucleotides were coupled to the slides after the 
spot by irradiation of UV light with 254nm of wave length, for 1’ (left upper panel), 10’ (right upper panel) and 
30’ (left lower panel), or incubated in a saturated of steam chamber for 2 h at 50°C (right lower panel). 
 
2.2 Hybridization 
2.2.1 Hybridization buffer 
The hybridization buffer is one of the key part of the microarray procedure, many factors are 
dependent on its quality: the quality of the hybridization between the target oligonucleotides 
spotted on the slides and the cDNA samples labeled by Cy-dye, the signal from the spots that 
was correlated to the quality of the hybridization and the signal background, which should be 
as weak as possible. Usually the producers supplied the slides together with the relative 
hybridization buffer, but after the bankruptcy of our slide supplier (GeneScan) and having a 
large amount of slides ready to use, I was required to substitute the hybridization buffer. For 
this reason the following experiments were necessary. 
In fig. 30 are shown the results of three different hybridization buffers, from three different 
companies: GeneScan, Genetix and Amersham. The slides were evaluated with fitted setting 
of Laser Power and PMT gain to avoid saturation of the signal, and to have standard 
 
 
Results_________________________________________________________________________________ 
 
75 
experimental conditions. The image of the array hybridized using GeneScan hybridization 
buffer (fig. 30a) indicated the high quality of this buffer as there was a low background signal 
and the oligonucleotides gave a clear signal that could be easily evaluated. The image of the 
array hybridized using the Genetix hybridization buffer (fig. 30b), showed a strong 
background that in some cases was stronger than the signal from the oligonucleotides. For this 
reason they were not usable anymore. The last image (fig. 30c), produced using the 
Amersham hybridization buffer was the least satisfactory. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 30a               Fig. 30b         Fig. 30c 
 
Fig. 30: Presentation of the results using three different hybridization buffers: fig. a shows the result of a slide 
hybridized using GeneScan hybridization buffer, fig. b shows the result of a slide hybridized using Genetix 
hybridization buffer and in fig. c shows the result of a slide hybridized using Amersham hybridization buffer. 
Cy3 channel is shown. 
 
After the unsatisfactory results obtained from the Genetix and Amersham buffers, the 
hybridization buffer from PeqLab was tested. 
Fig. 31 shows two arrays, spotted on the same slide to reduce any variation, hybridized with 
the two different hybridization buffers. The slide was scanned only once with fitted setting of 
Laser Power and PMT gain to avoid any saturation of the signal. The slide was treated 
according the GeneScan protocol (no pre-wash, and wash after hybridization as described for 
the Genescan hybridization buffer), unfortunately the choice to use the same slide had the 
disadvantage of restricting the hybridization procedure to just one. The choice was made to 
follow the GeneScan protocol to be sure to have a signal at the end of the hybridization. In 
this case the GeneScan hybridization buffer, on the left side, resulted as the better buffer. It 
produced less background and higher level of signal intensity from the oligonucleotides. The 
better result from the GeneScan hybridization buffer was understandable because the parallel 
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use of the GeneScan epoxy silane coated slides and the GeneScan hybridization protocol was 
followed. This is a good example that in the microarray technology the use of components 
derived from the same supplier is crucial. However, the results obtained from the PeqLab 
hybridization buffer were satisfying. 
 
Fig. 31: Representation of the results using two different hybridization buffers. GeneScan on the left, and 
PeqLab on the right. Cy3 channel is shown. 
 
 
2.2.2 Pre-hybridization treatment of the slides 
The PeqLab hybridization protocol suggested, performing a pre-hybridization treatment of the 
slides (Material and methods 4.2.2). To control the effectiveness of this pre-treatment with 
our slides, produced by another company (GeneScan), the pre-hybridization procedure 
starting from three different points of the protocol was tested: the complete pre-hybridization 
treatment, a pre-hybridization treatment starting from the step of incubation in the Nexterion 
QMT blocking solution for 15’ at 50°C and no pre-hybridization treatment. 
The results are shown in fig. 32, note that not all nucleotides could be quantitatively 
evaluated. In tab. 4 an overview of the oligonucleotides according to the ability to analyze 
their signal is shown. After background subtraction the signal of some nucleotide resulted as 
negative values. 
It was possible to determine that the complete pre-hybridization protocol produced always a 
more stable result. It delivered a small standard deviation, also when in some cases where the 
signal intensity was smaller than the one produced by a pre-hybridization starting at the 
blocking step. 
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Fig. 32: Comparison of the effects of pre-hybridization treatment of the slides performed according the PeqLab 
protocol and started at different points: complete pre-hybridization protocol (block and wash), a pre-
hybridization treatment starting from the Nexterion QMT blocking solution for 15’ at 50°C (block) and no 
pre-hybridization (no). The housekeeping genes ß-act, HK1 and Ppia were tested. The signal intensity (after 
background subtraction) is reported on the Y axis, the spot concentration (µM) is reported on the X axis.  
 
Tab. 4: Overview of signals which could be evaluated, after background subtraction, according to 
pre-hybridization treatment, oligonucleotide spot concentration and gene. 
 
Oligonulceotide/
Gene 20 10 5 2,5 20 10 5 2,5 20 10 5 2,5
ß-act I I I I I I I I I 0 0 I
HK1 I I I 0 I I I 0 I I 0 0
Ppia I I I I I I I I I 0 I I
I 0 no quantitation possible
Block and wash Block
quantitation
no treatment
 
 
 
2.2.3 RNA quantity hybridized to the array 
Another point to optimize in the establishment procedure of the microarray technology was 
the quantity of RNA used in the reverse transcription and labeling of the samples, which 
reflectes the quantity of sample hybridized to each array. In fig. 33 the influence of the 
quantity of RNA hybridized per array is shown. Two quantities were tested, 6,25 µg RNA per 
array (reported as low) and 12,5 µg RNA per array (high). 
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For this test the housekeeping genes 1A, Ppia, HK1 and ß-act were used. It was possible to 
show that the intensity of the signal, after background subtraction, using more RNA was 
always higher for each oligonucleotide than using less RNA. It has to be noted that the 
background increased when using more RNA, however it was compensated by an increase in 
the absolute signal. It is remarkable that the oligonucleotides spotted at the concentration of 
20 µM delivered a intensity of signal generally lower than the signal intensity delivered by the 
probes spotted at the concentration of 10µM. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 33: Influence of quantity of RNA on the signal intensity of the oligonucleotides. The housekeeping genes 
1A, Ppia, HK1 and ß-act were used. Low: 6,25µg RNA/array, high: 12,5µg RNA/array. Signal intensity 
(background subtracted) reported on the Y axis, concentration of spot oligonucleotides (µM) on the X axis. Both 
channel are shown (Cy3 and Cy5)  
 
 
 
2.2.4 Direct/indirect labeling of the samples 
The labeling of the cDNA samples during the reverse transcription of RNA presented the 
possibility to choose between two protocols: direct labeling (one-step labeling) and indirect 
labeling (two-steps labeling) as described in the Introduction 5.1.2 and the Materials and 
methods 4.2.1. Both options were tested. 
In fig. 34 images produced by two slides hybridized using the different protocols are shown. 
The slides were scanned with Laser Power and PMT gain set to 100 % to better visualize the 
effects of the two different protocols. Comparing the left image (direct labeling) with the right 
(indirect labeling), it is clear that the general fluorescence (background) image was lower in 
the left image. The negative signal stemming from some spots shown by the indirect labeling, 
those were darker than background (the overall signal resulted negative because the 
background was brighter than the spot). Moreover, in the right image, it is clearly possible to 
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identify the zone where the lifterslip (the cover set on the spotted array area where the 
hybridization solution was pipetted) was posed. In the lower part of the image the is a clear 
border between a green region (lifterslip) and a blue on (not hybridized zone). The left image 
presents good background intensity although the scan set was so high that some 
oligonucleotides reached the signal saturation (white spots), due to the scan performed with 
setting of Laser Power and PMT gain to 100%. 
 
 
 
 
 
 
 
 
Fig. 34: Comparison of direct to indirect labeling of cDNA samples. Slide hybridized by cDNA labeled by direct 
protocol (left image) and slide hybridized by cDNA labeled by indirect protocol (right image). Slides were 
scanned with Laser Power and PMT gain set to 100%. The Cy3 channel is shown 
 
 
2.2.5 Cy-dye ratio in the labeling reaction 
For gene expression analysis an extra step is the normalization of the values. As Cy5 dye gave 
always higher signal intensity in comparison to Cy3 dye. The Cy-dye labels were also one of 
the most expensive reagents. To try to reduce as far as possible the different of signal 
intensities using the two Cy-dyes, and their consumption, three different quantities and ratios 
of the Cy-dyes were tested: 3µl (from the stock solution reported in Material and Methods) of 
both dUTP-Cy3 and dUTP-Cy5 (pro RNA reverse transcription and labeling), 3 µl of dUTP-
Cy3 and 1 µl of dUTP-Cy5, and 1µl of both dUTP-Cy3 and dUTP-Cy5. The resulting ratio of 
Cy5/Cy3 was calculated after the subtraction of background signal. 
The results of three different experiments are shown in fig. 35. The images of the slides were 
obtained with a fitted setting of Laser Power and PMT gain. A good signal ratio of Cy5/Cy3 
was considered to be close to one. The housekeeping genes 1A and Ppia were investigated 
spotted at a concentration of 1 or 2µM. 
The ratio of the signal intensity Cy5/Cy3 was generally close to one, independent of the 
quantity of Cy-dye used and for all three housekeeping genes. The least expensive but valid 
solution appeared to be the use of Cy3:Cy5 at the ratio of 3:1. 
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Fig. 35: Signal ratio Cy5/Cy3, according to different ratio of dUTPCy3 and dUTPCy5 dye (Cy3 and Cy5) used 
in the cDNA synthesis and labeling. The signal ratio Cy5/Cy3 (after background subtraction) of different 
oligonucleotides (1A and Ppia) is shown on the Y axis, according to different concentration of spotted 
oligonucleotides (1-2 µM). The slides were scanned with fitted setting of Laser Power and PMT gain. An 
average over three experiments is shown. 
 
2.2.6 Hybridization chamber 
To hybridize the slide a warm humid chamber was needed. During the establishment 
procedure of the microarray technology three different hybridization chambers were tested: 
Flat block hybridization chamber, ArrayIt Hybridization Cassette hybridization chamber and a 
self made steam saturated box (described in the Materials and methods, 4.2.3), the results are 
shown in fig. 36. 
For the Flat block (on the left), the image shown was really good, the signal from the 
oligonucleotides was sharp and no shadows around the spot field were presents along with a 
low background signal. The low background signal was also visible comparing to the lower 
side of the image. There it is possible to recognize the mark of the lifterslip the green line. 
There is no difference in fluorescence outside or inside the lifterslip zone. 
Moving attention to the other images, a clear reduction of quality is seen. The middle image 
(ArrayIt Hybridization Cassette hybridization chamber) presents a lower quality compared to 
the left image, the right image (self made hybridization chamber) is of the lower quality 
 
 
 
 
 
 
 
Fig. 36: Influence of different hybridization chambers. Flat block hybridization chamber (left image), ArrayIt 
Hybridization Cassette hybridization chamber (middle image) and a self made steam saturated box (right image). 
The hybridization was conducted for 16h at 45°C for all hybridization chambers. The slides were scanned with 
Laser Power and PMT gain set to 100%. Channel Cy3 is shown. 
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2.3 End flow analysis 
After the scan of the slides, performed using a scanner that can measure fluorescence emitted 
by the labeling compound, in this case Cy3 and Cy5 dyes, the images had to be evaluated 
using software that recognizes the signal stemming from the samples against the general 
signal (background), and is able to translate it into a numeric value. 
The software provided with the scanner, Quantarray presented the possibility to choose from 
three different options for the evaluation of the signal coming from the spot field, usually a 
round circle, and from the background, the not spotted area, exemplified in fig. 37. 
 
 
 
Fig. 37: exemplification of spot/background zone. 
 
The histogram option decomposed the spotted area in pixels and measures the signal of each, 
without distinction between spot and background signal. It considered as signals value all 
pixels with a value higher than a threshold, and as background all signal below, independent 
of the position of the pixel, inside or outside the spot mark. The fixed circle method uses a 
mask that was produced according to two variable parameters: the diameter of the spot zone 
and the diameter of the background zone. It considered all pixels inside in the spot zone to be 
signal, and all pixels in the background zone to be background. The adaptive method uses the 
same mask of the fixed circle but adapted the diameter of the spot field to each spot. In fig. 38 
the results derived from the three methods for the calculation of the signal are compared. 
It was possible to note that the adaptive and the fixed circle methods gave similar values of 
intensity, in contrast to the histogram method which reported lower signal intensity. Between 
the adaptive and the fixed circle methods, the fixed circle was considered more suitable to this 
study for its stability independently from the spot quality. 
 
 
 
 
 
 
Fig. 38: The influence of different analytic options of the software Quantarray on the resulting signal intensity is 
reported ion the Y axis. Concentration of the spotted oligonucleotides (0,25-0,5-1-2,5-5-10 µM) are shown in the 
X axis. Samples: negative control (H2O), 1A amino modified at the 5’end (1A-NH2) and unmodified 1A (1A). 
Analytical methods: adaptive method (AM) (upper left diagram), fixed circle (FC) (upper right diagram) and 
histogram (H) (lower diagram). 
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2.4 Final conditions for the microarray experiment 
After the microarray technology was optimized, the decision on materials, methods and tools 
employed for the gene expression analysis are reported in tab. 5 
 
Tab. 5: List of the materials, methods and tools used in the microarray gene expression analysis. 
step tool
oligonucleotide modifiaction aminomodification at the 5'end
oligonucleotide spot concentration see table 1
spotting buffer GeneScan spotting buffer for all nucleotides,
GeneScan spotting buffer + BSA 100!g/ml for ß-act, 1A, Ppia
coupling reaction steam saturated box at 50°C for 2h
hybridization buffer PeqLab hybridization buffer
pre-hybridization of the slides PeqLab pre-hybridization of the slides
RNA quantity pro array/hybridization 12,5!g RNA
labeling direct labeling
dye quantity/ratio 3!l dUTPCy3/1!ldUTPCy5
hybridization chamber Flat block hybridization chamber
hybridization duration 20h
hybridization temperature 45°C
evaluation method fixed circle  
 
 
The image shown in fig. 39 represents one example of the final result after the establishment 
of the microarray method. The background was low and the signal from the oligonucleotides 
spots is sharp. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 39: Resulting images after the optimization process of the microarray (particular, central array), the 
parameters used for spot, hybridization and calculation of the slides are reported in table 5, in the left image the 
Cy3 fluorescence was acquired with Laser Power set to 75 and PMT gain to 80, in the right image the Cy5 
fluorescence was acquired with Laser Power set to 57 and PMT gain to 80. 
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3. Gene expression analysis using the Microarray 
At the end of the process for the establishment of the microarray method in our laboratory, 
this method was tested for its capacity in the analysis of the gene expression, compared to a 
more conventional procedure. To achieve this task the same RNAs extracted from the Fe33 
cell line treated by EE and NP were analyzed by the real time RT-PCR and by microarray (the 
gene expression analysis using the real time RT-PCR was conducted only for four genes 
reported above in this chapter: IGFBP1, CaBP9k, PCNA and CAII, and already shown in 
point 1.2 of this chapter). In this case the real time RT-PCR served as reference method, to 
verify the results of the gene expression derived from analysis made using the microarray. 
The RNAs extracted from Fe33 cells were analyzed just once. Each slide was spotted with 
three array areas, and scanned twice, once avoiding any saturation of signal (standard setting) 
and a second time at a higher intensity of scanning, to get a signal from every spotted 
oligonucleotide. In this second run some oligonucleotides reached saturation of the signal and 
they were not suitable for the gene expression analysis and were discarded. The final result 
were six value groups per gene: three from the three arrays acquired according the first set of 
parameters, and three from the three arrays acquired with the second setting of parameters. 
Some arrays on the slides could not be evaluated. 
The hybridization and scanning procedure described is exemplified in fig. 40. The control 
sample was labeled by dUTP-Cy3 and the treated sample by dUTP-Cy5, no array swap was 
performed. 
 
Fig. 40: Description of the procedure for the calculation of the mean value using the microarray for the gene 
expression analysis. Array spotted area: area where the oligonucleotides probes are affixed; “1”, “2” and “3”: the 
three array spotted areas and the relative deriving value; “a” and “b”: the value after the scan of the relative 
spotted area; “1c” “2c”, “3c”: the mean value calculated using the two values which stem from the same array 
area. 
 
microarray slide
array spotted
area standard slide scan
second slide scan
at an higher intensity
1
2
3
a
b
values
1a
2a
3a
1b
2b
3b
mean value
(1a+1b)/2=1c
(2a+2b)/2=2c
(3a+3b)/2=3c
(1c+2c+3c)/2
Results_________________________________________________________________________________ 
 
84 
The first microarray DNA chip containing 16 genes (Introduction 3.3) was designed for the 
investigation of the estrogenic effect of different substances in different tissues of the 
organism. To establish the method of the microarray in our laboratory the liver cell line Fe33 
was chosen. The gene expression reported in this part of the work concern only the gene that 
are responsible to exposure to estrogens only in this cell line, and they are reported in tab. 6. 
Some of those genes were shown by the analysis performed with the microarray to not be 
regulated in the cell line Fe33, even when they had already been shown to be estrogen 
responsive in this cell line. This result can be explained by the lower sensitivity of this method 
of gene expression analysis compared to other already proved tools for gene expression 
investigation present in our laboratory, eg. real time RT-PCR. In the case where the 
expression of some genes was not affected by estrogen exposure no diagram was reported. 
 
Tab. 6: Estrogen responsiveness of different genes representing 3 main gene groups after treatment with 
estrogenic substances (EE and NP) in the gene expression analysis by microarray. E2 served as positive control. 
 
 
3.1 Effects of 17α-Ethinylestradiol on gene expression in Fe33cell line in a time and dose 
dependent manner 
The effects of administration of EE on the gene expression of IGFBP1 are reported in fig. 41. 
After 7 h of treatment the relative gene expression of IGFBP1 was stimulated to levels of 
more then 250 % by E2, EE 10-6 and 10-7M. After 24 h only EE 10-6M reached an up 
regulation to more then three times compared to the control level. 
 
 
 
 
 
 
Fig. 41: Gene expression analysis by oligonucleotides microarray, correlated to control (set to one), in Fe33 (rat 
hepatic cell line) of IGFBP1. Cells were treated with EtOH (control), E2 and EE in a dose dependent manner for 
1, 3, 7 and 24 h. Dye labeling: control sample by dUTPCy3, treated sample by dUTPCy5. This experiment was 
conducted just once, the significance could not be calculated. 
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The effects of the administration of EE on the gene expression of CaBP9k are reported in 
fig. 42. EE at the dose of 10-6M induced a clear up regulation after 7 h of treatment. EE at the 
concentration of 10-7M stimulated CaBP9k expression after 3h with a higher effect after 24 h. 
EE 10-8 and 10-9M induced a doubling of gene expression level of CaBP9k after 3 and 24 h of 
treatment. 
 
 
 
 
 
 
 
Fig. 42: Gene expression analysis by oligonucleotides microarray, correlated to control (set to one), in Fe33 (rat 
hepatic cell line) of CaBP9k. Cells were treated with EtOH (control), E2 and EE in a dose dependent manner for 
1, 3, 7 and 24 h. Dye labeling: control sample by dUTPCy3, treated sample by dUTPCy5. This experiment was 
conducted just once, the significance could not be calculated. 
 
 
The effects of the administration of EE on gene expression of CAII are shown in fig. 43. The 
treatment with EE for 1 h induced a doubling of the relative gene expression only at the 
concentration of 10-6M. After 3 h EE at every dose, except for the concentration of 10-6M, 
triggered a stimulation of the gene expression reaching at least 250 % of the control level. 
After 7 h of treatment, only EE at the concentration of 10-6 and 10-7M stimulated clearly CAII 
expression. At 24 h of treatment only EE 10-6M reached more than double of relative gene 
expression. 
 
 
 
 
 
 
 
Fig. 43: Gene expression analysis by oligonucleotides microarray, correlated to control (set to one), in Fe33 (rat 
hepatic cell line) of CAII. Cells were treated with EtOH (control), E2 and EE in a dose dependent manner for 1, 
3, 7 and 24 h. Dye labeling: control sample by dUTPCy3, treated sample by dUTPCy5. This experiment was 
conducted just once, the significance could not be calculated. 
 
 
 
CaBP9k
0
2
4
6
8
10
12
14
16
18
E2 10-8M EE 10-9M EE 10-8M EE 10-7M EE 10-6M
R
el
at
iv
e 
ge
ne
 e
xp
re
ss
io
n
1h 3h 7h 24h
CAII
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
E2 10-8M EE 10-9M EE 10-8M EE 10-7M EE 10-6M
R
el
at
iv
e 
ge
ne
 e
xp
re
ss
io
n
1h 3h 7h 24h
Results_________________________________________________________________________________ 
 
86 
3.2 Effects of Nonylphenol on gene expression in Fe33cell line in a time and dose 
dependent manner 
The effects of the administration of NP on the gene expression of ERß are reported in fig. 44. 
NP induced after 3 h of treatment a clear stimulation of the relative gene expression of ERß, 
at a concentration of 10-5 and 10-6M reaching a doubling of relative gene expression. For the 
other doses and time points of treatment with NP no effects were detectable. 
 
 
 
 
 
 
 
Fig. 44: Gene expression analysis by oligonucleotides microarray, correlated to control (set to one), in Fe33 (rat 
hepatic cell line) of ER beta. Cells were treated with EtOH (control), E2 and NP in a dose dependent manner for 
1, 3, 7 and 24h. Dye labeling: control sample by dUTPCy3, treated sample by dUTPCy5. This experiment was 
conducted just once, the significance could not be calculated. 
 
The effects of administration of NP on the gene expression of IGFBP1 are reported in fig. 45. 
The administration of NP to Fe33 cells did not trigger any remarkable effect. E2 stimulated 
only after 7 h of treatment IGFBP1 gene expression (similar to what shown in fig. 41). 
 
 
 
 
 
 
 
Fig. 45: Gene expression analysis by oligonucleotides microarray, correlated to control (set to one), in Fe33 (rat 
hepatic cell line) of IGFBP1. Cells were treated with EtOH (control), E2 and NP in a dose dependent manner for 
1, 3, 7 and 24h. Dye labeling: control sample by dUTPCy3, treated sample by dUTPCy5. This experiment was 
conducted just once, the significance could not be calculated. 
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The effects of administration of NP on gene expression of CaBP9k are reported in fig. 46. The 
administration of NP to Fe33 cells did not trigger any remarkable effect on the CaBP9k gene 
expression. E2 induced an up regulation of the relative gene expression to more than 350 % 
after 7 h of treatment (the same was already shown in fig. 42). 
 
 
 
 
 
 
 
Fig. 46: Gene expression analysis by oligonucleotides microarray, correlated to control (set to one), in Fe33 (rat 
hepatic cell line) of CaBP9k. Cells were treated with EtOH (control), E2 and NP in a dose dependent manner for 
1, 3, 7 and 24 h. Dye labeling: control sample by dUTPCy3, treated sample by dUTPCy5. This experiment was 
conducted just once, the significance could not be calculated. 
 
The effects of administration of NP on gene expression of CAII are reported in fig. 47. The 
treatment with NP did not affect gene expression of CAII. Only E2 after 7h of treatment 
stimulated the expression of CAII (as reported in fig. 43). 
 
 
 
 
 
 
 
Fig. 47: Gene expression analysis by oligonucleotides microarray, correlated to control (set to one), in Fe33 (rat 
hepatic cell line) of CAII. Cells were treated with EtOH (control), E2 and NP in a dose dependent manner for 1, 
3, 7 and 24 h. Dye labeling: control sample by dUTPCy3, treated sample by dUTPCy5. This experiment was 
conducted just once, the significance could not be calculated. 
 
 
3.3 Validation of the gene expression measured by microarray 
To verify the results produced by gene expression analysis using the microarray, real time 
RT-PCR was used as reference method. To have direct comparison identical RNA materials 
were analyzed by the two methods. Both results were already shown in this chapter, here a 
direct comparison was performed. 
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3.3.1 Validation of the gene expression analysis performed by microarray with real time 
RT-PCR in Fe33 cell line treated with 17α-Ethinylestradiol in a time and dose dependent 
manner  
IGFBP1(fig. 48): IGFBP1 was clearly up regulated by estrogens in the Fe33 cell line and it 
was possible to demonstrate this using both methods: real time RT-PCR and microarray. 
Through this it is possible to recognize a trend in the gene regulation. The magnitude of the 
relative gene expression level differed considerably, the real time RT-PCR showed changes in 
the gene expression levels that were ten times higher than the changes detected by the 
microarray. It was hard to find a stable correlation factor for gene expression between the two 
methods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 48: Comparison of the gene expression pattern of IGFBP-1 using microarray technology and real time 
RT-PCR. Real time RT-PCR in the left side Y axis (black points), and microarray in the right side Y axis 
(obliques lines). IGFBP1 gene expression was analyzed in Fe33 cells (rat hepatic cell line). Cells were treated 
with EtOH (Contr), E2 and EE in a time and doses dependent manner. Dye labeling for the microarray method: 
control sample dUTPCy3, treated sample dUTPCy5. Calculation of significance was not possible, this 
experiment was conducted just once. 
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CaBP9k (fig. 49): CaBP9k gave a strong response to estrogens in Fe33 cells. It showed as in 
the case of IGFBP1, a clear stimulation of gene expression using both methods. The graph 
stemming from treatment with EE 10–6M is a good example, the two columns indicating the 
two different methods overlap almost perfectly. Also treatment with E2 and EE 10-8M are 
good example of the similarity of the trend of gene regulation detectable by both methods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 49: Comparison of the gene expression pattern of CaBP9k using microarray technology and real time 
RT-PCR. Real time RT-PCR in the left side Y axis (black points), and microarray in the right side Y axis 
(oblique lines). CaBP9k gene expression was analyzed in Fe33 (rat hepatic cell line). Cells were treated with 
EtOH (Contr), E2 and EE in a time and doses dependent manner. Dye labeling for the microarray method: 
control sample dUTPCy3, treated sample dUTPCy5. Calculation of significance was not possible, this 
experiment was conducted just once. 
 
 
PCNA: PCNA did not show a strong sensitivity to the estrogens in Fe33 cells. The microarray 
did not report any regulation of PCNA to estrogens exposure (data not shown). No 
comparison between the methods was possible. 
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CAII (fig. 50): The intensity of the response of CAII to the estrogens treatment was quite 
strong. A good example of conserved trend was the treatment with E2 10-8M or EE 10-9M. 
For the other cases only the direction of the gene regulation showed similarity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 50: Comparison of the gene expression pattern of CAII using microarray technology and real time RT-PCR. 
Real time RT-PCR in the left side Y axis (black points), and microarray in the right side Y axis (oblique lines). 
CAII gene expression was analyzed in Fe33 cells (rat hepatic cell line). Cells were treated with EtOH (Contr), 
E2 and EE in a time and doses dependent manner. Dye labeling for the microarray method: control sample 
dUTPCy3, treated sample dUTPCy5. Calculation of significance was not possible, this experiment was 
conducted just once. 
 
3.3.2 Validation of the gene expression analysis performed by microarray with real time 
RT-PCR, in Fe33 cell line treated with Nonylphenol in a time and dose dependent manner 
The microarray showed a regulation of the genes IGFBP1, CaBP9k and CAII only in 
treatment with E2 10-8M for 7 h (data not shown) reporting a stimulation that is roughly the 
half on that reported by real time RT-PCR. No regulation was shown for other time point and 
the NP administration, for this reason no comparison was possible between the results on gene 
expression of real time RT-PCR and microarray. 
 
3.3.3 Final consideration on the gene expression correlation factor 
According to these results it was not possible to find a stable correlation factor for gene 
expression detected by the two methods used. The largest difference between the two tools for 
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the gene expression analysis appeared to be sensitivity, both methods delivered comparable 
results however, with different orders of magnitude, the trends were similar. 
 
3.4 Dye-swap 
The dye swap is an experiment that was intended to change, to swap, the label dye of the 
sample. It consists of two experiments. In the first labeling, during the reverse transcription of 
RNA and the labeling reaction, the control sample was labeled with a dye, in this case Cy3, 
and the treated sample with the other dye, Cy5. The experiment was repeated a second time 
with the same kind of RNA but labeling the samples in the opposite way, control sample 
labeled with Cy5 and the treated sample with Cy3. The aim of this experiment was to test if 
the result of the analysis of gene expression is independent of the labeling reaction of the 
samples. The experiment can be considered successful when both experiments produce the 
same result in gene expression. This experiment was conducted only once, and therefore it 
was not possible to calculate any significance. 
The experiment reported here was only part of the full series of experiments performed during 
the thesis. In this case it was used the RNA extracted from Fe33 treated by EE 10-7M for 1, 3, 
7 and 24 h. In the first experiment the RNA was labeled with “standard”: the control sample 
treated by EtOH was labeled by Cy3 and the treated sample, EE 10-7M, by Cy5. In the swap 
experiment the labeling was inverted, indicated by “swap”. They are reported only for two 
examples. An identity of the result independent of the choice of labeling (“standard” or 
“swap”) was found. 
In fig. 51 the gene expression analysis of the gene CAII and IGFBP1 treated with EE 10-7M 
for 1, 3, 7 and 24 h is shown. In both cases the result produced in the “standard” and the 
“swap” labeling were similar. Therefore the control experiment could be considered 
successful. 
 
 
 
 
 
 
 
Fig. 51: Comparison of gene expression analysis, correlated to control (set to one), in Fe33 by oligonucleotides 
microarray, with the change of label on the sample. Labeling: control-Cy3, treated-Cy5 (standard) and control-
Cy5 treated-Cy5 (swap). The cells were treated with EtOH (control) and EE 10-7M in a time dependent manner 
(1-3-7-24 h). Genes investigated: CAII and IGFBP1. No statistical significance is calculated, because each 
experiment was conducted just once. 
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4. Investigation of the fragment r52 
The fragment r52 was identified using the differential display RT-PCR (ddRT-PCR) (Liang & 
Pardee, 2002) by Dr. Patrick Diel in the uterine tissue of differentially treated ovariectomised 
rats, E2 against the control. This sequence was selected for further characterization due to its 
sensitivity to E2 treatment, resulting in a strong repression following treatment. This 
technique consists, roughly, in a RT-PCR using a anchored oligo dT primer (8-10 T with 2 
specific bases at one extremity), to reverse transcribe mRNA starting directly at the point of 
the poli A tail, the other primer is a random decamer. To avoid any DNA contamination the 
RNA extracted from the samples is treated with DNAse. The results of the RT-PCR are 
separated through a poly acryl amide gel. Due to the low stringency condition this method 
delivers many false positive, for this reason every PCR product obtained has to be sequenced. 
The sequence of r52 fragment is reported in sequence A (286 bp) 
Seq. A 
 
(5´)- GTCAGTGAC NGAACCGGT ATGATTTGA AAACAAACA AGATGTGTG AGAAATTGG
 AAAGATCAA GATGACTGC TTTGCCCCC TTCTTTTTA AATCTAAGC AACCGGAAT
 AGACTACCA TACAGCATC TGTGAATTT TCAGGCAGT GCAGTCACT TTTACATAC
 ATGACTGAG ACAGCTACT AAACACCAA GAGTTCTGG GAAAAATCT GAAGGTGGC
 TCTCTGTAC CAAGCAGTT CTAAGAGAA GTTTGGCTA AAATTAGTA AGACCATCA
 TCACCAGAA AAAAAAA - (3´) 
 
 
4.1 Study of the sequence of the fragment r52 
The sequence identified by a differential display RT-PCR corresponds to the 3’ end of a 
putative mRNA that should be associated with a gene. The aim of this part of the work was to 
characterize the gene by discover the section of the gene upstream the already known 
sequence, searching for the 5’ end, and the promoter region along with identifying possible 
binding sites which confer estrogen responsiveness and could explain the strong estrogenic 
sensitivity of this gene. 
 
4.1.1 Primer walking sequence strategy 
The sequence A was “blasted” against the NCBI nucleotide data bank 
(http://ncbi.nlm.nih.gov). The standard blast result of the sequence A against the NCBI data 
bank did not deliver any suitable results, with only short matches of maximum 22 nucleotides. 
The sequence was also blasted against the gene bank of the “Rat Genome Resources” presents 
on the same web site. This time it found homology in the 4th chromosome, with an identity of 
95% (275/287bp), in the reverse strand of the sequenced chromosome (strand plus/minus) 
between 15.605.504 and 15.605.788 bp. 
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The sequence was contained in a region indicated as “similar to cyclin D-interacting myb-like 
protein 1” that in this position was the result of a computational analysis using the gene 
prediction method: GNOMON (a computational gene prediction method). 
A schematization of the homology region of the sequence A in chromosome 4 (purple) is 
shown in fig. 52. The sequence A (blue) found homology in the intron (yellow) region 
between the 4th and 5th exons (red) of the sequence indicated in the Rat Genome Project as 
“similar to cyclin D-interacting myb-like protein”. 
 
 
 
 
 
 
 
 
Fig. 52: Scheme showing the homology between sequence A (blue) and chromosome 4 of rat (purple), in the 
region of the gene “similar to cyclin D-interacting myb-like protein”. In red is shown the exon regions with the 
respective number, in yellow the intron regions are represented. The length of the sequences is reported in base 
pairs. The length of the fragments is not to scale. 
 
Using the chromosome sequence, 10 primer pairs were designed, r52A-r52L, to amplify the 
boundary regions of the sequence A (reported in Materials and methods, 3.1). The positions of 
the primer pairs in the sequence and the length of the amplified fragments are summarized in 
tab. 7. The start position was considered to be the first base of sequence A at the 3’ end. The 
template for the PCR reaction total RNA isolated according the point 5.1 of Materials and 
methods was used but without final mRNA isolation. The total RNA was reverse transcribed 
into cDNA as described in the Materials and methods 3.3. The resulting PCR products were 
analyzed with a run through an agarose gel. 
 
Tab. 7: Primer pairs listed with their positions in the sequence, considering as start position the first nucleotide of 
sequence A at the 3’ end, and length. 
 
 
 
 
 
 
 
primer pair position in length
the sequence
r52 103-222 120
r52A 668-854 186
r52B 403-512 109
r52C 988-1296 308
r52D 1475-1859 384
r52E 2129-2398 269
r52F 2519-2903 385
r52G 3075-3342 267
r52H 3531-3840 309
r52I 4187-4485 298
r52L (-280)-(-75) 206
Chromosome 4
similar to cyclin D-interacting myb-like protein
15.587.626 bp 15.610.004 bp5’ 3’
1 32 654
112bp 120bp 118bp 123bp 94bp 615bp8905bp 1362bp 1324bp 6761bp 2832bp
3’ 5’
SequenceA
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The scheme of the homology region of the primer pairs in the “similar to cyclin D-interacting 
myb-like protein” is shown in fig. 53. The numbers represent the distance in base pairs from 
the first base of sequence A at the 3’ end. The PCR products resulting from the use of the 
primer pairs reported in tab. 7 are indicated in green. 
 
 
 
 
 
 
 
Fig. 53: Scheme of the homology of the different amplification primer pairs (green) A-L in the terminal part of 
the gene “similar to cyclin D-interacting myb-like protein”. Exons 5 and 6 are represented in red, the introns are 
represented in yellow, and sequence A is represented in blue. The numbers in the image represent the distance in 
base pairs from the first nucleotide of sequence A. The length of the segments is not to scale. 
 
The primer pairs were also combined together, as reported in tab. 8, to amplify different parts 
of sequence and to determine if interruptions in the continuity of the cDNA sequence were 
present. 
Tab. 8: List of the primer pair combinations and lengths of the resulting amplified sequences 
 
 
 
 
 
 
 
 
 
 
 
After analysis of the different amplified fragments, it was possible to conclude that there was 
no interruption in the cDNA used as template starting from the primer r52L forward until the 
primer of r52H reverse, it was not possible to get a signal of amplification using the primer 
r52Hfwd in combination of the primer r52Irev. It has to be mentioned that the two primers 
found themselves at the boundary of an intronic/exonic region of the gene “similar to cyclin 
D-interacting myb-like protein”; after the 4064 bp of its 3’UTR region, as reported in the 
-280
A
B C
D
E
F
G
H
I
L
 similar to  cyclin  D-interacting  myb -like protein
65
sequence A
1 285 854 2902 3840 4485
948 1042 3928
4489
4064
primer mix amplify length
r52rev+r52Brev 448bp
r52rev+r52Arev 790bp
r52Bfwd+r52Arev 431bp
r52Cfwd+r52Drev 871bp
r52Dfwd+r52Erev 923bp
r52Efwd+r52Frev 774bp
r52Afwd+r52Crev 629bp
r52Afwd+r52Drev 1192bp
r52Afwd+r52Erev 1731bp
r52Dfwd+r52Frev 1426bp
r52Ffwd+r52Grev 823bp
r52Gfwd+r52Hrev 765bp
r52Hfwd+r52Irev /
r52fwd+r52Lfwd 500bp
Results_________________________________________________________________________________ 
 
95 
databank. The results are schematized in fig. 54 indicating with the azure segment the proved 
continuous fragment of cDNA. 
 
 
 
 
 
 
 
Fig. 54: Scheme of the homology of the different amplification primer pairs (green) A-L, the PCR product (azure 
bar) is the result of the amplification of the cDNA using different mixture of the primer pairs A-L. In orange is 
the homology region of the sequences 1, 2 and 3 in the terminal part of the gene “similar to cyclin D-interacting 
myb-like protein”. The sequenced regions seq. 1, seq. 2 and seq. 3 are shown in orange. The annealing region of 
the primer cDNA1 is reported in purple. The other colors were the same as in figure 79. The length of the 
segments is not to scale. 
To confirm the reliability of the data produced, three sequences were performed using as 
template the PCR products obtained from different primer pair combinations. The sequence 1 
was produced using, as template, the PCR product derived from the primer combination 
r52rev/r52Arev, whereas for sequences 2 and 3 the combination of r52Afwd/r52Erev was 
used. Fig. 54 reports the results of the homology of the three sequences (orange bars). The 
nucleotide sequences 1, 2 and 3 are reported below. 
 
Seq. 1: 597 bp 
(5´)- TCTGTCACT GACATGCGT TCACAATTT GAACTATGT ATGCTTCCA CCTAGTCCA
 AACCACTGK CCTTTCCTA CTGTGCTGA CTCTAGCCC TTCTGCCCT BBAGAATGT
 CTTSCTCAC AGCCACCAG AACAGTCCT GGTGATGAA AGTGAGCTT ATGCCATTT
 TTCTGCTCA GAATCATCC AATGCCTCC TTTCTCGTC TTTGCTGCA GCCTGTGAG
 GTCTCTTTC CGCTCTTTC TTCATCTGC TGTAACAAC AATGCACGG ATCACACTT
 GTGCCAKTG TACGCGTGC CCTATCGCC AAGTTTTGT GCTTGTCTT TCCTTAAAG
 TACGGTCCT GCAAGACTA GCTTCCTTC CTTTTCCCA AGTCGGATC ACCCTAGTT
 CGTACCTAA AATTTGGGA CATACTGCC TCACTCTAC TCCATTCCA TTCCCTGCT
 TTATCTTGT CCTTGGCTT ATATGAGTA TTAGCCAAC ATAGAATCC TGTCCATTT
 CTAGACTAT AAGTCCCGT GAAAAAGTT TCCKACCTA GTATTCATG TCTGTTGAG
 CAAATATGT GCAGTATAA TGATTGGTA AGAAGTGGG GGGGGGGGA
 GGGGGAAGC AAG -(3´) 
Seq. 2: 864 bp 
(5´) - CGTGAAAGT TTCCTACCT AGTATTCAT GTCTGTTGA GCAAATATG TGCAGTATA
 ATGATTGGT AAGACGTGG GTTTGGAAA TTAGATGAG CACATTTTC ACCGTGGAT
 TTTAGTTTG GGTAATTAG ATCCTACAA TTACTACTG TGCAGATGA ATCATTATT
 TTCTTGAAG TTTCAGAAA ATGATCAGA GCTTTGAGG TGACCATGA CGGCAACTA
 CAGAGGTGG CAGATGATG AACTTTCTG AGGGAACTG TGACACAAA TTCAGGTAT
 AGTACATAT TTTAAACTG GCTTCTGTG AGGAACATG GTTATKACA CACAACTTA
 AGTAAAARA TGATAAGGA TRTACCTTG ACAACATAG TGTCAATAA AGCAAGGCC
 CATCATCAC TGAGGTTTC TAGTCCCAA CATGTTGTA AGCAGAAAT AGATGCTCA
 TTGTGCTCC CTGTAGAGA CCATGGTTG GAATAGGAA GTGATGGGT GTGCCTTCA
 TCTGTGTCT AGAATCCTG CTTGGACTG TGAATAGCA GTGATTACC GTTGTGCTG
 TTCCGTTGG TGCTTGTCG AGCTAGATA GGTTTTCTC ATATGCTGT GAGGCTGAC
 TGGTAGCCA GGCCTTTCT GCTGTTCTT ACTGTGAAC TTCTTTTGC TGTCTTACA
 TAGTTTGAA TCTAAAATG AGTATGTAT TCTAAATTT ATGTCTACC TGATTGTGC
 ATCTTTTGC GTTTAGTTG GCTTATGCT TTTACTTCA TATCGTCAT TTAATGTCT
-280
A
B C
D
E
F
G
H
I
L sequence A
1 285
3840
4485
948 1042 3928
4489
4064
274 849
775 1639
1624 2284
Seq 1
Seq 2
Seq 3
PCR product
67
cDNA1
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 GAGANTTTT GAATTGAAA ATACTTGAA CATTTTTAT GAAGTATCA CAGTGCCCT
 TTCGCTTAG GAAGTAWAA GACTTCCGG GGTTGAWAT GTAATADTA AGWACCGA
 G - (3´) 
Seq. 3: 660 bp 
(5´)- GTAATATTA AGAACTGAA GAAGTAATA GAAAATTCT TTCTTCAGA TGAGGCTTA
 TCAAATCAT TTCACCTTT TTAATATAA AAATTGTAT GAGCTTTAC TATAAAAAG
 TCTTGTAAA TAAAATAAA GATCACAGA CCAAAGTTT ACCAGACTC CGTGCCTGT
 GCATTTCAA AGAAGTTCT CGTAGCTAG GCCATTCTG CCGCTGTGG AGCCTCACA
 CTGAGGCTT ACACTTTCA CTGCAGAGT TTGTGTTTA TACACATAA TCTACCACC
 AACACTGAG TGCTCTCTG GCAGGAGGA GAGTGGGAC CCCAGCCTT ATATCCTGT
 GTAACTCAT GTTCAGCAC CTGCATTCA GTCCTTCCT CATCCCTTA GAGTCAGCA
 TTTCTTACT CTCTTTTCT GAGTTATAC TTTACTCAC ATGTATGCT CATGTTACA
 TATATTATG GGCTGGATT CCGCATATG AAGGAGAAC ATGAAGTTT TTTTTCTTT
 CTGAGATTA TATGATATA TATTCAAAG TCTATCCAT TTTCCTGAA ACTTTTGTT
 ACTTCATTT TTTAGAGCT GAATAGTAT TCTAGTTTT TAAATTTTC ATCATTTAG
 TATTATTTC AATTGATAC TGAAAGGGC ATTTGACAA AACTCACCA TGCCTTCAT
 GATATAGTC CGG - (3´) 
 
The combination of sequence A, 1, 2 and 3 (2284 nucleotides) is reported below. The 
sequences 1, 2 and 3 were represented in the reverse and inverted strands to follow the 
direction of sequence A 
 
(5’) - (seq. 3)  ATWTCAACC CCGGAAGTC TTWTACTTC CTAAGCGAA AGGGCACTG
 TGATACTTC ATAAAAATG TTCAAGTAT TTTCAATTC AAAANTCTC AGACATTAA
 ATGACGATA TGAAGTAAA AGCATAAGC CAACTAAAC GCAAAAGAT GCACAATCA
 GGTAGACAT AAATTTAGA ATACATACT CATTTTAGA TTCAAACTA TGTAAGACA
 GCAAAAGAA GTTCACAGT AAGAACAGC AGAAAGGCC TGGCTACCA GTCAGCCTC
 ACAGCATAT GAGAAAACC TATCTAGCT CGACAAGCA CCAACGGAA CAGCACAAC
 GGTAATCAC TGCTATTCA CAGTCCAAG CAGGATTCT AGACACAGA TGAAGGCAC
 ACCCATCAC TTCCTATTC CAACCATGG TCTCTACAG GGAGCACAA TGAGCATCT
 ATTTCTGCT TACAACATG TTGGGACTA GAAACCTCA GTGATGATG GGCCTTGCT
 TTATTGACA CTATGTTGT CAAGGTAYA TCCTTATCA TYTTTTACT TAAGTTGTG
 TGTMATAAC CATGTT (seq. 2)  CCTCACAGA AGCCAGTTT AAAATATGT
 ACTATACCT GAATTTGTG TCACAGTTC CCTCAGAAA GTTCATCAT CTGCCACCT
 CTGTAGTTG CCGTCATGG TCACCTCAA AGCTCTGAT CATTTTCTG AAACTTCAA
 GAAAATAAT GATTCATCT GCACAGTAG TAATTGTAG GATCTAATT ACCCAAACT
 AAAATCCAC GGTGAAAAT GTGCTCATC TAATTTCCA AACCCACGT CTTACCAAT
 CATTATACT GCACATATT TGCTCAACA GACATGAAT ACTAGGTAG GAAACTTT
 (seq. 1)  TTCACGGGA CTTATAGTCT AGAAATGGA CAGGATTCT ATGTTGGCT
 AATACTCAT ATAAGCCAA GGACAAGAT AAAGCAGGG AATGGAATG GAGTAGAGT
 GAGGCAGTA TGTCCCAAA TTTTAGGTA CGAACTAGG GTGATCCGA CTTGGGAAA
 AGGAAGGAA GCTAGTCTT GCAGGACCG TACTTTAAG GAAAGACAA GCACAAAAC
 TTGGCGATA GGGCACGCG TACAMTGGC ACAAGTGTG ATCCGTGCA TTGTTGTTA
 CAGCAGATG AAGAAAGAG CGGAAAGAG ACCTCACAG GCTGCAGCA AAGACGAGA
 AAGGAGGCA TTGGATGAT TCTGAGCAG AAAAATGGC ATAAGCTCA CTTTCATCA
 CCAGGACTG TTCTGGTGG CTGTGAGSA AGACATTCT VVAGGGCAG AAGGGCTAG
 AGTCAGCAC AGTAGGAAA GGMCAGTGG TTTGGACTA GGTGGAAGC ATACATAGT
 TCAAATTGT GAACGCATG TCAGTGACA (seq. A)  GAACCGGTA TGATTTGAA
 AACAAACAA GATGTGTGA GAAATTGGA AAGATCAAG ATGACTGCT TTGCCCCCT
 TCTTTTTAA ATCTAAGCA ACCGGAATA GACTACCAT ACAGCATCT GTGAATTTT
 CAGGCAGTG CAGTCACTT TTACATACA TGACTGAGA CAGCTACTA AACACCAAG
 AGTTCTGGG AAAAATCTG AAGGTGGCT CTCTGTACC AAGCAGTTC TAAGAGAAG
 TTTGGCTAA AATTAGTAA GACCATCAT CACCAGAAA AAAAA - (3’) 
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4.1.2 Searching for the 5’ end of the fragment 
To try to find the complete sequence of this fragment, a liver cDNA library was screened 
using the “r52” primer pair of the real time RT-PCR as a probe, unfortunately it was not 
possible to find any sample that contained this fragment. It was not possible to recognize if 
the negative result was due to the absence of this fragment in the library, or from its low 
presence in the cDNA library, below the limit of the real time RT-PCR. 
After this unsuccessful approach with the cDNA library I attempted to get the complete 
cDNA of the fragment r52 with specific reverse transcription of the fragment r52 (described 
in Materials and methods, 5.2), the primer cDNA1 anneals with the “r52” fragment as shown 
in fig. 54. After reverse transcription with the specific primer for r52 the resulting cDNA was 
tested by real time RT-PCR with different primer pairs: 1A, C3 and r52. A signal of 
amplification was expected only in the r52 sample, for the presence of a single cDNA 
population, used as template, consisting of only the r52 fragment. All samples gave a signal of 
amplification, show the experiment to lack specificity. 
 
4.1.3 “In silico” analysis 
At the same time a different “in silico” analysis of the sequence A and her boundary region 
was performed. 
The first step was the search for an ORF (Open Reading Frame). Usually an ORF indicates a 
transcribed region of the genomic DNA. This was done to validate the theory that the 
sequence r52 was part of a gene encoding a protein. Towards this goal the software “ORF 
finder” present on the web site of the NCBI was utilized using sequence A as the investigated 
sequence. This search gave negative results. Looking for an ORF in the 10.000 nucleotides up 
stream of the r52Hrev primer showed the longest ORF to be 540 bp and not including the r52 
sequence (sequence A). The first ten matching ORFs did not give suitable results: 
invertebrates, plants or unicellular organisms proteins. The search for an ORF in the region 
between r52Lfwd and r52Hrev was also unsuccessful. The combination of the two sequences 
together, r52Lfwd-r52Hrev + 10.000 bp upstream r52Hrev, did not yield better results. 
The 10.000bp up stream of the r52Hreverse primer was investigated for the presence of a 
known promoter using various software packages for the promoter analysis (listed in the 
Materials and methods 5.5), none of them delivered a positive result. 
Another possibility was that the sequence r52 has a function without to be transcribed into a 
protein, as regulatory RNA. Towards this goal the folding of the RNA sequence was studied. 
To study the folding of the RNA of r52 into a possible secondary structure, the sequence A 
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was tested using the software “Mfold”. The resulting secondary structure is shown in fig. 55. 
The resulting (-dG) was -48,43, to have an order of magnitude lys-tRNA has a (-dG) of –
26,28, almost the half, indicating its stability. 
 
 
Fig. 55: Secondary structure of the sequence A RNA according to the software “Mfold”. 
 
4.2 Gene expression analysis of r52 by real time RT-PCR 
To verify the interesting behavior of the sequence r52 in response to estrogen treatment, its 
expression was studied in two tissues of ovariectomised rats in vivo: the uterine tissue and the 
liver, treated by estrogens, E2 and EE, and phytoestrogens, Gen, Dai, 6DMAN and 8PN. 
The results shown in fig. 56 to 61 came from a single animal experiment and a single RNA 
extraction. Every result derived from the pooled RNA of at least 6 animals and is presented as 
the average of at least three independent cDNA synthesis and two independent real time RT-
PCR analysis per cDNA synthesis. The results are reported according to the animal 
experiment performed. 
 
4.2.1 Gene expression of the fragment r52 in uterus 
The influence of the estrogens, E2 and EE, and the phytoestrogens: Gen, Dai, 6DMAN and 
8PN were tested in rat uterotrophic assay. The results shown in this section, derived from the 
analysis of the same RNA material used for the experiment reported in fig. 3, 4, 10 and 11 of 
this chapter 
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In fig. 56 the results of treatment with E2, EE, and Gen for 7, 24 and 72 h, and Dai for 72 h 
are reported. E2 and EE induced a down regulation of the r52 gene expression with an 
increase of the effect according to progression of the duration of treatment, which after 72 h 
reached 20 % of the control level. Gen treatment resulted in a light down regulation of r52, 
with only a reduction in the gene expression level to 60 % of the control level after 24 h, 
which is statistical significant. Dai did not influence r52 expression. 
 
 
 
 
 
 
 
 
Fig. 56: Gene expression analysis of r52 using real time RT-PCR, correlated to control (set to one), in rat uterus 
in a time dependent manner (7-24-72h). Treatment (s.c. injection): EtOH (Contr), E2 (3µg/kg/day), EE 
(3µg/kg/day), Gen (10mg/kg/day) and Dai (20mg/kg/day). Significance: Student’s t-test *: p<0,05. 
 
The effects of E2 and 8PN after a 72 h treatment are shown in fig. 57. It was possible to show 
that both substances induced a strong down regulation of gene expression of r52. 
 
 
 
 
 
Fig. 57: Gene expression analysis of r52 using real time RT-PCR, correlated to control (set to one), in rat uterus 
after 72h treatment. Treatment (s.c. injection): EtOH (Contr), E2 (30µg/kg/day) and 8PN (10mg/kg/day). 
Significance: Student’s t-test *: p<0,05. 
 
In fig. 58 the results of treatment by E2 and Dai for 7 and 24 h and Gen for 24 h on r52 gene 
expression in uterus are shown. In this case the gene expression of r52 was studied using two 
different real time RT-PCR primer pairs. One of these anneals in the original “r52” fragment, 
and another one that anneals to a new identified region, r52E. The choice to study the gene 
expression of two primer pairs designed in the same sequence derived from the need to verify 
that the amplified region of r52 (indicate in azure in fig. 53 ) was really the same sequence 
and not a chimera. 
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In this case E2 and Gen triggered a clear down regulation of the relative gene expression of 
r52 detected by both primer pairs with statistical significance. Dai did not produce any effect. 
A striking similarity between the results could be seen with primers, “r52” and “r52E”. 
 
 
 
 
 
 
 
Fig. 58: Gene expression analysis of r52 and r52E using real time RT-PCR, correlated to control (set to one), in 
rat uterus in a time dependent manner (7-24h). Treatment (s.c. injection): EtOH (control), E2 (4µg/kg/day), Gen 
(10mg/kg/day) and Dai (40mg/kg/day). Significance: Student’s t-test *: p<0,05. 
 
The effects of E2, 6DMAN and 8PN for 7 and 24 h are shown in fig. 59. The gene expression 
of r52 was studied using the same primers pair used in the previous experiment. After 7 and 
24 h of treatment (fig. 59a and b) it was possible to observe that E2 induced a strong 
repression of gene expression reported by both primers pair. 8PN mimicked the same effect, 
but less strongly, at both times and using different primers. After 7 h of treatment 6DMAN 
did not seem to influence the regulation of r52, delivering also a not statistical significant 
result with both primers. After 24 h of 6DMAN administration the primer pair “r52” showed a 
down regulation to 50 % of the control level, the primer pair “r52E”, after the same treatment 
showed a down regulation to 20 % of the control level, both results were statistical significant. 
 
 
 
 
 
 
Fig 59a             Fig. 59b 
 
Fig. 59: Gene expression analysis of r52 and r52E using real time RT-PCR, correlated to control (set to one), in 
rat uterus after 7 (a) and 24 h (b) of treatment. Treatment (s.c. injection): EtOH (Contr), E2 (10µg/kg/day), 
6DMAN and 8PN (15mg/kg/day). Significance: Student’s t-test *: p<0,05. 
4.2.2 Gene expression in liver 
To investigate if the interesting expression pattern of the fragment r52 in response to estrogen 
and phytoestrogen detectable in uterine tissue was present also in other tissues, its gene 
expression was tested in liver as well. 
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The RNA material used in these experiments was the same as already analyzed in fig. 21 and 
22 of this chapter. 
The effects of E2, EE and Gen after treatment for 7, 24 and 72 h and Dai for 72 h are reported 
in fig. 60. The treatment with E2 induced a doubling of the relative gene expression of r52 
after 72 h of treatment, but without statistical significance. EE showed in opposite a 
repression of the gene expression to half of the control level after 7 h, without a statistical 
significance. No clear effects were obtained for both of the other durations of treatment. Gen 
and Dai showed a tendency to repress the gene expression to values near to 50 % of the 
control, as Gen after 7 and 72 h of treatment showed statistical significance. 
 
 
 
 
 
 
 
 
Fig. 60: Gene expression analysis of r52 using real time RT-PCR, correlated to control (set to one), in rat liver in 
a time dependent manner (7-24-72 h). Treatment (s.c. injection): EtOH (Cont), E2 (3µg/kg/day), EE 
(3µg/kg/day), Gen (10mg/kg/day) and Dai (20mg/kg/day). Significance: Student’s t-test *: p<0,05. 
 
The effects of E2 and 8PN treatment for 72 h in liver were not relevant of r52 gene expression 
(data not reported). 
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1. Project overview 
 
Beneficial or potential adverse impacts of xenoestrogens on human health are still 
controversially debated. 
My thesis tries to contribute to this discussion by creating a methodology capable of 
performing a fast, cheap and high throughput mode of analysis to characterize different 
substances for their estrogenical activity using gene expression profiling. Towards this aim I 
used  in vitro and in vivo rat uterus and liver models. 
First I conducted a study using real time RT-PCR to investigate the response of 
estrogen/xenoestrogens treatment of some genes, C3, Clu, IGFBP1 and CaBP9k that are 
classical targets of estrogens in the studied tissues. The effects of those substances on 
proliferation were controlled by gene expression profiling of PCNA. Subsequently, I 
investigated, for the first time, the effect of estrogen/xenoestrogenes exposure on rat tissues, 
liver and uterus, of CA2, a classical target of estrogens in bone tissues. CA2 showed an 
interesting patter of answer to some of those substances also in these tissues. I characterized 
the response to estrogen/xenoestrogens in liver and uterus of a newly identified rat sequence 
as well individuated by our collaborator Dr. Patrick Diel. 
At the same time I established, for the first time, a microarray setup in our laboratory. The 
method consisted in a complete “in house” procedure from the spotting of the samples on 
glass slides to the analysis of the results; this allowed control of every single step of the 
procedure and to optimize it better to fit the goal of the thesis. 
Finally, I produced a microarray DNA chip with 16 genes that are estrogen sensible and were 
tested in a rat hepatic cell line after exposure to xenoestrogens: 17α-ethynilestradiol and 
nonylphenol. Those results were compared to those obtained from real-time RT-PCR analysis 
showing a similar expression pattern. 
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2. Analysis of estrogen sensitive genes in uterus and liver models, by real time RT-PCR  
2.1 Estrogen sensitive genes in uterus models (C3 and Clu). 
 
The genes C3 and Clu present an already proven responsiveness to estrogens exposure in both 
in vitro and in vivo rat uterus models (Sundstrom et al., 1989; Diel et al., 2001, 2004; Zierau 
et al., 2004). 
Using RUCA-I cell culture I showed that C3 and Clu gene expression is influenced only when 
the cells are cultured on a layer of ECM (Result: fig. 1 and 2), as already shown by 
morphological difference and gene expression analysis by RT-PCR (Vollmer et al., 1995). 
In uterus C3 presents a strong response to E2 treatment (Results: fig. 3, 5, 10 and 11), 
presenting a time depending up regulation following the length of the treatment, as already 
shown (Diel et al., 2004). The treatment with EE presented the same results (Results: fig. 3), 
as when treating the rats with the same amount of drug. EE can be considered as a pure 
agonist in uterus (Diel et al., 2004; Tinwell et al., 2002). The treatment with the 
phytoestrogen Gen resulted in a clear stimulation of C3 expression only after 24 h of 
treatment (Results: fig 4 and 10). It did not completely mimic the effect of E2, resulting 
always an order of magnitude weaker than E2 in stimulation C3 expression, even if used at 
3.000 times higher doses. In this case Gen can be considered a weak agonist in the uterus 
confirming already published results (Diel et al., 2001, Rickard et al., 2003). 
The other isoflavone Dai never showed any influence on C3 expression, also at doses 6000 
times higher than E2. With this result I show a case of no agonistic activity of Dai in rat 
uterus. The behavior of Dai in uterus is still debated because other evidences report its weak 
agonist activity (Hopert et al., 1998; Diel et al., 2000). 
The agonist activity of the two flavones 8PN and 6DMAN in uterus (Zierau et al., 2004; Diel 
et al., 2004, Humpel et al., 2005) was confirmed (Results: fig 5 and 11). Both substances act 
as agonist, mimicking the effects of E2, but their lower potency has to be underlined, the same 
effect is reached with a 300 times higher dose. 
 
2.2 Estrogen sensitive genes in liver models (IGFBP1 and CaBP9k) 
The genes IGFBP1 and CaBP9k are affected in their expression by estrogen treatment in liver 
models (Diel et al., 1995, 2004; Geis et al., 2005). Hepatic cell line, Fe33, exposed to E2 
presents a clear up regulation of both IGFBP1 and CABP9k (Results: fig. 12, 13, 14, 17, and 
18). 
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The same cell line treated by EE shows in both cases the pure agonistic effect of this 
substance, reproducing, in a stronger way, the stimulatory effect of E2 administration 
(Results: fig. 13 and 14). EE stimulates IGFBP1 and CaBP9k expression in both time and 
dose dependant manners, 10-7M can be considered the most active dose. The larger effect is 
present after 7, for IGFBP1, and 24 h, for CaBP9k. 
Moving the attention to an in vivo model the administration of E2 in rat liver triggered a 
doubling of IGFBP1 expression after 72 h (Results: fig. 21 and 22) confirming the 
responsiveness of IGFBP1 to estrogen in rat liver (Geis et al., 2005). 
The administration of EE at the same dose had similar effects, confirming its agonistic 
activity in vivo as well. In this way EE, confirmed its agonistic potency in the liver (Geis et 
al., 2005). 
Studying the gene expression of IGFBP1 and CaBP9k of hepatic cells, Fe33, treated by NP it 
could be possible to notice its weak agonistic activity (Results: fig. 17 and 18). NP reached 
the same effect as E2 in stimulating the gene expression of both genes with a concentration 
100 to 1000 fold higher. The mimicking effects were presents just in the first 3 h of treatment 
indicating a fast time course of the substance also. In this way the weak estrogenic potency of 
NP already proven in other in vitro tests was confirmed (Shelby et al., 1996; Wober et al., 
2002), but for the first time showed in a hepatic cell line focusing on gene expression. 
The isoflavone Gen in cell culture mimicked E2 effect only after 7 h of treatment (Results: 
fig. 12), at a dose 100 times higher than the positive control E2, indicating its weak estrogenic 
activity. The influence of Gen on IGFBP1 in vivo at a 3.000 times larger dose was similar to 
E2 for the first 7 h of treatment, after 72 h the effect was totally inverted (Results: fig. 21). 
This result confirms the weak agonistic activity of Gen (Dopp et al., 1999; Diel et al., 2001). 
Dai in cell culture did not show any particular effect on both IGFBP1 and CaBP9k expression 
(Results: fig. 12), even if used 100 times more concentrated. In vivo the effect of E2 was 
mimicked after 72 h but always using a 6.000 times larger dose. It is not possible to define if 
this result stems from its agonistic weakness or that Dai does not behave exactly as an agonist 
in the liver. 
The flavone 8PN showed its potency as estrogen agonist in cell culture stimulating the 
IGFBP1 expression after 7 h of treatment at a 100 times larger dose (Results: fig. 12). In vivo 
8PN used at a dose 300 times larger than E2 performed an even larger stimulation of IGFBP1 
expression (Results: fig. 22). The clear agonistic activity of 8PN was proven in liver as well. 
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2.3 Safety towards proliferation (PCNA) 
The effects of the different substances on cell and tissue proliferation were studied through 
the analysis of PCNA expression. This result has to be considered in the context of cancers. 
In RUCA-I cell culture, after 24 h of E2 treatment, the proliferation was not affected. This 
result may be due to the length of the E2 stimulation, in cell culture an effect on proliferation 
has to be studied at an earlier time point. 
In rat uterus, E2 presented a time dependent stimulation of PCNA expression with the higher 
effect after 24 h (Results: Fig. 6). This result is perfectly comparable to the uterotrophe assay, 
where a constant increase of uterine wet weight is shown (fig. 1). This shows clearly the 
necessity to avoid the use of E2 in HRT, because of its proliferative effect it may result in a 
uterus over proliferation. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: Effects of s.c. administration of Gen and 8PN on the uterine wet weight of ovariectomised Wistar rats. 
Uterine wet weights of ovariectomised (ovx) Wistar rats after administration of 10 mg/kg/BW Gen, 7 and 24 h 
after a single s.c. administration and after repeated administration of Gen 10 mg/kg/BW day, or 8PN 
10 mg/kg/BW day for 3 days. E2 (4 µg/kg/BW) served as reference compound. The uterine wet weight is 
indicated as relative uterine wet weight defining control (Contr) as 1. Significance: Student’s t-test<0.05. (Data 
kindly provided by Dr. Patrick Diel already published “Diel et al., 2003, 2004”). 
 
In the cell culture of hepatic cells, Fe33, a time dependent stimulation of PCNA was present 
with the higher effect after 1 and 3 h of treatment (Results: fig. 15 and 19). This result can 
explain the reason because the cell proliferation of RUCA-I resulted unaffected after 24h of 
E2 treatment, the duration was simply too long. 
In liver, E2 administration showed an anti-proliferative effect on the tissue indicated by the 
time dependent down regulation of PCNA (Results: fig. 23). This result can be controversial 
in human health because from one site in HRT, E2 does not stimulate liver proliferation, 
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showing its safety in the context of hepatic cancer. On the other site the repression of the 
normal liver proliferation could lead to other diseases. 
EE confirming its pure agonistic behavior mimicked the activity of E2 perfectly. In uterus, 
there was an identical result (Results: fig. 6). Also, in this case, the use of EE in HRT has to 
be deeply reconsidered, for the possible uterus over proliferation that can result after EE 
administration in menopause. In liver, EE was always comparable to E2 (Results: fig. 23). 
Also in this case the same consideration of E2 and its potential dangerous activity in liver are 
valid for EE. 
NP showed a stimulation of PCNA only after the first 3 h of treatment confirming its short 
term activity (Results: fig. 19). Stimulation of PCNA after 24 h of treatment mimicking the 
stimulatory effects of E2 at the same concentration or ten times more diluted, should be 
carefully considered, they are exactly at the border of doubling of PCNA expression. As 
reported in fig. 15 of the results the same treatment by E2 did not show any particular effect. 
NP shows a proliferative effect in Fe33 as already observed by Olsen in MCF-7, breat cancer 
cell line (Olsen et al., 2005), this has to be considered in the case of NP exposure, further 
analysis is needed. 
Gen administration in uterus did not show any activity on proliferation (Results: fig. 6). This 
result has to be compared to the uterotrophe assay (fig.1), also considering the effect of E2. 
After 7 and 24 h both compounds increased the uterus wet weight, after 72 only E2 continued 
to increase the uterus weight. This result compared to the gene expression analysis shows that 
the first 24 h increase of uterus wet weight is not a real proliferation but just water 
imbibitions. This result is confirmed by Diel (Diel et al., 2004) where immunohistological 
staining of uterine tissue shows that PCNA is up regulated only in the epithelium and not in 
the whole uterus. This result adds evidence to the safety to Gen environmental exposure. 
PCNA triggers only an epithelial proliferation of the uterus. In liver Gen did not affected the 
PCNA expression, resulting in this way as a “safe” compound in the case of cancer risk, 
corroborating the thesis of safety of Gen in cases of exposures. 
Dai did not show any particular activity in both uterus and liver. It did not have any influence 
on the PCNA expression. This compound like gen, could be considered “safe” with respect to 
influence on tissue proliferation. 
8PN exposure in uterus performed a slight up regulation of PCNA (Results: fig. 7). This result 
has to be kept in mind in case of 8PN exposure, consuming food containing this flavone. This 
result confirms the finding already shown on the effect of 8PN in the uterotrophe assay 
Discussion______________________________________________________________________________ 108 
(fig. 1). 8PN 300 higher concentrated performs perfectly the same effect of E2, increasing the 
uterus wet weight and stimulating PCNA expression, as reported by Diel (Diel et al., 2003). 
 
2.4 Characterization of novel response genes (CAII and r52) 
The gene CAII already has shown its estrogen responsiveness mainly in the bone tissues, as 
reported in the introduction 3.1. Here I showed that CAII also presents an interesting gene 
expression pattern in response to estrogenic treatment in uterus and liver, as already published 
(Caldarelli et al., 2005). 
In uterus the treatment by E2 resulted in a time dependent down regulation according to the 
progression of the time (Results: fig. 8), showing a complete opposite behavior to that of C3, 
this may be due to the different promoter region of these genes. CAII does not contain an 
ERE in its promoter, but two AP-1 interaction sites and 4 for the inhibition of NFκB 
(McGowan et al., 1997), in opposite C3 contains a triple ERE (Fan et al., 1996). The 
administration of EE lead to the same result (Results: fig. 8), confirming its sensitivity to pure 
agonistic substances. The administration of the phytoestrogens in uterus, Gen, Dai and 8PN, 
resulted in a light repression of CAII (Results: fig 8 and 9). Comparing those results to that of 
C3, I show an opposite behavior of the two genes. In this case CAII gene expression analysis 
shows that 8PN does not behave as a pure agonist in uterus, also when used at a concentration 
300 times higher that E2. In the cancer cell line RUCA-I it was not possible to perform a gene 
expression analysis of CAII due to the apparent absence of expression in this cell line (Results 
1.1). This particular result could derive from the absence of CAII in uterus cancer, but no 
studies are present so far on CAII expression in uterine cancer. 
The CAII expression results are influenced by estrogen treatment in liver models as well. In 
cell culture, Fe33, a time dependent stimulation of expression with the larger effect after 7 h 
of treatment due to E2 or EE administration is present (Results: fig. 16). The result of E2 or 
EE administration in liver on CAII expression is surprising, compared to the liver cell line. 
Here a time dependent down regulation is reported with the larger effect after 72 h of 
treatment. This may be due first from the different conditions a whole organism, that include 
more complex effects, compared to a single cell line. Another point as in the case of uterus 
and RUCA-I could be the different kind of tissues, a normal tissue in the in vivo experiment 
compared to a cancer cell line. This result adds more evidence to the interesting aspects of 
CAII behavior. 
CAII results are not influenced by the xenoestrogens in both in vitro and in vivo models 
(Results: fig: 12, 20, 24 and 25), showing in this way its lower sensitiveness, compared to 
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IGFBP1 or CaBP9K to weak estrogenic compound in liver. This may be due to the different 
promoter regions of the three genes; CAII presents only an AP-1 binding site instance 
compared to CaBP9k which presents an imperfect ERE in the promoter that differs by only 
one nucleotide. 
The newly identified sequence r52 presents a really interesting expression patter in uterus in 
response to estrogenic substances exposure. In the case of E2 and EE administration a time 
dependent down regulation of r52 is shown (Results: fig. 56). This result compared to C3 
expression and the uterotrophic assay showed a perfect reverse picture. The interesting aspect 
is the response of r52 to the phytoestrogens. In the case of the flavones 8PN and 6DMAN, 
generally considered pure agonist (Zierau et al., 2002, 2004; Diel et al., 2004), a strong 
repression of r52 expression is present (Results: fig. 57 and 59), as shown for E2 and EE 
administration. The response to Gen administration should be better characterized. In a first 
experiment the administration of Gen in uterus did not influence the r52 expression (Results: 
fig. 56) indicating the potency of r52 to distinguish between a pure agonistic substance, as E2, 
EE, 8PN or 6DMAN, to substances showing organ-selective response pattern, a SERM 
(Selective Estrogen Response Modulator) as Gen is indicated from several authors (Diel et al., 
2001) some of them showed even a weak estrogenic activity of Gen and Dai to ERα and a 
pure agonistic activity with ERβ using a reporter gene (Salvatori et al., 2003). A second 
animal experiment conducted with the same amount of Gen (10mg/kg/day) delivered a 
different result (Results: fig. 58). In this second case Gen behaved as a pure agonist 
mimicking perfectly the activity of E2. Further experiments are indeed to better characterize 
r52 expression profile in response to substances with estrogenic potency. In liver, E2 
administration resulted in a complex response pattern, however without any statistical 
significance. EE and Gen presented similar action repressing r52 expression. This fragment 
does not present a particular response pattern in this tissue. 
 
At the end of the gene expression profiling, different genes were proven for their utility to 
assess the risks of exposure to different substances with potential estrogenic effects. C3 and 
Clu confirmed their estrogen sensitivity in uterine models, as also IGFBP1 and CaBP9k for 
the liver ones. The information derived from PCNA expression profiling results is crucial to 
assess the risk of different substances on the proliferation site. Two novel genes, CAII and 
r52, were studied for their interesting response to estrogenic treatment in uterus and liver. 
At the end of this section is it also possible to summarize the activities of the different 
xenoestrogens in the models used. 
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EE acted always as pure agonist, mimicking the activity of E2 in both tissues and the gene 
expression pattern of every studied gene. NP also presented an agonistic activity but with 
lower potency, for this reason it can be considered a weak agonist. Gen presented a more 
complex pattern of activities. Gen presents a similar activity of E2 in response gene in uterus, 
without affecting cell proliferation, this last aspect shown not only in gene expression but also 
in uterotrophe assay. In liver Gen does not present a marked agonistic activity, this may be 
due to the absence of ERβ in liver (Gustaffson 1999) and the weak agonistic activity with 
ERα (Salvatori et al., 2003). From this evidence it could be considered a SERM, but further 
studies are needed (Diel et al., 2001, Salvatori et al., 2003). 
Dai behaves generally similarly to Gen but with an even weaker agonistic potency. 
8PN presents a marked agonistic activity at a concentration around 100-1000 higher than E2 
in both uterus and liver tissue, from this evidence it could be described as pure agonist. 
6DMAN presented also in uterus an agonistic activity, generally mimicking the effects 
produced by E2 administration but at a 100 time larger dose. 
 
3. Set up of the microarray technology and application for gene expression analysis 
The establish of the microarray technology in the laboratory has been a long and complicated 
process. In literature, little is reported on it at the level of optimization for every single step. 
Authors report just the final conditions used during the experiment, as for other methods. In 
some cases I tested different conditions reported from authors, as in the case of the labeling of 
the targets. The direct (Yu et al., 2002) and indirect (Badiee et al., 2003; Hui et al., 2003) 
labeling of the cDNA samples was tested delivering completely different results from those 
reported in the literature. In my case the indirect labeling of the samples was a disaster. In 
others cases I just tested the different options proposed by the producer, as in the case of 
coupling of the oligonucleotide on the slide, comparing the results of U.V. exposure to warm 
bath. In this case the last option was the most favorable. 
At the end of the established procedure I can report that as for other techniques that present 
the hybridization of probes to samples, like the northern southern or western blots, 
immunostaining and many others, every protocol is laboratory specific. Generally using the 
same material, it is possible to reach similar results using similar procedure, but a fine 
optimization has to be performed in every case. 
The reagents are also “producer specific” which means that a product usually “likes” to be 
used together in combination with others produced from the same company, as example for 
the case of spotting buffer, the slides, and the hybridization buffer, all of them should be from 
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the same producer. In my case, after the closure of GeneScan I was obliged to find another 
hybridization buffer.  
For the normalization of the data deriving from the array, I chose to normalize the signal to an 
internal control (housekeeping genes), that was a reasonable choice due to the size of the 
array itself, it presented less than 1000 spots, so a normalization on the overall signal was not 
possible. The positive results stemming from the experiment of dye swap confirms the quality 
of this choice. 
 
3.1 Reproducibility of the results obtained by the microarray 
The gene expression analysis using the microarray was performed just once for every sample, 
hence a direct comparison of the same RNA material is impossible. In both cell culture 
experiments evaluated by the microarray, treatment by EE or NP at different doses and time 
length (Results: 3.1 and 3.2), the same positive control was always present, the treatment by 
E2 10-8M. The gene expression of IGFBP1, CaBP9k and CAII resulted influenced by E2 in 
both experiments, producing in this way a sort of duplicate of the same experiment. In both 
experiments, E2 produced an up regulation of all three genes only after 7 h of treatment 
Results: fig. 41-43 and 45-47). This is a good indication of reproducibility of the method. 
 
3.2 Comparison of the gene expression results produced by real time RT-PCR and 
microarray 
The gene expression results produced by the microarray at the end of the establish process 
were compared to those obtained using a robust and routinely used method for our laboratory: 
the real time RT-PCR, set up by Renate B. Geis. They are reported in the Results section at 
the point 3.3.1. The use of real time RT-PCR to validate the gene expression data produced by 
microarray analysis was already successfully used by other groups (Mutch et al., 2001; 
Hwang et al., 2002) and also in those cases the real time RT-PCR showed an higher 
sensitivity to gene expression change. Here I showed that the microarrays are able to repeat 
the gene expression result produced by the real time RT-PCR with lower sensitivity.  
At the end of the process of setting up microarray technology I can be satisfied by the 
performance reached by this method. The reproducibility of the results showed with E2 
treatment in two different cell culture experiments (EE and NP group), the dye swap, and the 
comparison of gene expression results to the real time RT-PCR, indicate the stability and the 
reliability reached by this method in our laboratory. 
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The next step is to increase the number of genes present on the array so as to have a more 
general overview on the estrogenic effects of the different substances on different samples 
(cell culture and tissues). 
 
4. Characterization of the r52 sequence 
The sequence r52 presents a really interesting gene expression pattern in response to estrogens 
and particularly phytoestrogens in rat uterus as discussed above. 
The GC content (39,4 %) of the r52 is low for coding sequences. This is a first evidence that it 
could be something else then a protein coding mRNA. It is also uncommon that it localizes in 
an intronic region of a gene and in the complementary strand (Results: fig. 52). This sequence 
is also clearly not at the starting point of the poly A sequence present at the 3’ end of a 
mRNA, according form the results of the PCR product obtained using a primer pair that 
amplify the region downstream the r52, the primer pair formed by r52fwd and r52Lfwd 
(Results tab.8 and fig. 53). The PCR products got by combining the primer pairs, L to H, 
show also that this sequence should interrupt at the end of the intron between the exon 5 and 6 
(Results fig. 53). This result leads to imagine that the r52 putative mRNA ends at that point. 
The research of an ORF, which indicates a transcribed region, for approximately 5000 bp up 
stream the r52 seq. A did not produce positive result. No promoters were present in the same 
region as well. The three sequences performed starting from the sequence r52 confirm the 
continuity of the fragment until 1998 nucleotides up stream the end of already knew sequence 
(Results fig 53 and seq. 1, 2 and 3). Another evidence that r52 is not at the 3’ end of an 
mRNA is confirmed by the absence of poly adenilation signal (AAUAAA). Regrettably every 
attempt to get a complete cDNA sequence failed, first using a cDNA library and then a gene 
specific reverse transcription (Results 4.1.2). To explain why r52 was not found in the cDNA 
library, I can propose that this sequence is not exactly what was thought at the beginning: an 
mRNA coding for a protein. A cDNA library is produced starting from mRNA, for this reason 
that library may not contain r52. The attempt of gene specific reverse transcription lacked 
specificity. This negative result could be explained with a not perfect purification of the 
mRNA after the RNA isolation and DNAse digestion, to eliminate the present DNA that 
usually contaminate RNA isolation. Also the use of mRNA specific purification kit, did not 
help for this intend. In the resulting mRNA used for reverse transcription could be present, 
even in very low concentration, some short oligonucleotides, coming either from RNA or 
digested DNA, that during the reverse transcription can act as random primer and reverse 
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transcribed also other genes. For this reason at the end also the primer pair for 1A and C3 
could deliver a PCR product. 
After those results it is hard to define what exactly the sequence r52 is. In the case that this 
putative gene is not coding for a protein it could be also a regulatory RNA, a non coding RNA 
(ncRNA). The dogma DNA RNA Protein could be challenged by this find out in the past 
years. It is already known that some transcribed RNAs are not translated to proteins, as tRNA 
and rRNA. In the last 7-8 years the interest around those transcripts increased. An overview of 
the possible origin of ncRNA was already reviewed by Mattick (Mattick, 2003). A ncRNA 
can be transcribed as a protein coding gene, or derive from the introns of another gene, i.e. the 
HBI36 small nucleolar RNA (snoRNA) present in the serotonin receptor 5-ht2c gene 
(Cavaille et al., 2000). Another class of ncRNAs intron derived are miRNA (Ying &Lin 
2005), they are short single strand RNAs (around 21 nucleotides) involved in post 
transcriptional regulatory functions. For those reasons it is also clear the interesting possibility 
that this r52 sequence could be an ncRNA that is somehow affected in its expression by E2 
treatment in rat uterus. The sequence found by Dr. Diel presents already a considerable stable 
secondary structure. The secondary structure predicted using the software Mfold delivered a 
structure that present the –dG, free energy set free by folding, of -48,43 J. To understand the 
meaning of this result, the –dG set free folding the lys-tRNA correspond to -26,28 J and this 
tRNA has a stable secondary structure that allows to take part to the transcriptional 
machinery. So the r52 itself present a considerable stability in a secondary structure. Further 
studies to identify the complete sequence of r52 are indeed. To better characterize the r52 
sequence another experiment to perform could be to produce a BAC (bacterial artificial 
chromosome) of this gene cloning at its end a fluorescent protein (like eGFP) as fusion gene 
to allow experiment of microscopy and localize the protein. This modified BAC can be used 
also for a fast gene expression analysis avoiding performing real-time RT-PCR experiment 
but just measuring by flow cytometry the intensity of the GFP signal is response to different 
compounds.  
5. Conclusions 
At the end of my work I investigated the estrogenic potency of different Xenoestrogens that 
commonly occur in our daily life, in rat cells and tissue using well known estrogen sensitive 
genes like C3, Clu, IGFBP1 and CaBP9k. I focused on their effect on cell proliferation, 
studying PCNA expression. For the first time sensitivity of the gene CA2 was proofed in liver 
and uterus. A new identified mRNA sequence, r52, was characterized for its sensitivity to 
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estrogenic exposure. This sequence was investigated at the molecular level expanding the 
known nucleic sequence. 
I produce a microarray chip with 16 genes to investigate the estrogenic potency of different 
compounds. As proof of principle of the microarray method completely produced in house I 
compared the result of gene expression obtained by the chip to that obtained by real time 
RT-PCR finding a similarity of results. This new established method is less sensitive than the 
real-time RT-PCR but allows a high throughput of gene expression analysis producing at the 
end a more complete picture of the expression signature of a compound. 
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Abbreviations 
 
E2: 17ß-estradiol 
EE: 17α-ethinylestradiol 
NP: nonylphenol 
EtOH: ethanol 
Gen: genistein 
Dai: daidzein 
8PN: 8-prenylnaringenin 
6DMAN: 6-(1,1-dimethylallyl)naringenin 
ICI: ICI 182,780 (Faslodex) 
min: minute 
h: hour 
RT: room temperature 
bp: base pair 
M: Molar 
aa-dUTP: amino-allyl dUTP 
IGFBP1: insulin like growth factor binding protein 1 
CaBP9k: calcium binding protein 9k dalton 
PCNA: proliferating cell nuclear antigen 
CAII: carbonic anhydrase 2 
C3: component complement C3 
ERα: estrogen receptor alpha 
ERß: estrogen receptor beta 
Clu: clusterin 
Cox-2: cyclooxigenase-2 
IGF1: insulin growth factor 1 
HSP70: heat schock protein 70k dalton 
Ki-67: Ki-67 
1A: cythocrome-c oxigenase subunit 1A 
HK1: hexokinase 1 
Ppia: cyclophilin 
ß-act: beta actin 
DMEM/12F: Dulbeccos’s modification of Eagle’s medium F12 
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DCC: dextran-coated charcoal 
SSC: Sodium Chloride Sodium Citrate solution 
SDS: Sodium dodecyl sulfate 
PBS: phosphate buffered saline 
OVX: ovariectomised 
RUCA-I: rat uterus adenocarcinoma cells 
PMT: Photon multiplier tube 
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